10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549 

FORM 10-Q

(Mark One)

☒      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 

For the period ended March 31, 2023

☐      TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 

For the transition period from              to             

Commission file number 001-36157 

ESSENT GROUP LTD.

(Exact name of registrant as specified in its charter)

Bermuda	Not Applicable
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification Number)

Clarendon House

2 Church Street

Hamilton HM11, Bermuda

(Address of principal executive offices and zip code)

(441) 297-9901

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Shares, $0.015 par value	ESNT	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒  No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232-405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files.)  Yes ☒  No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act. 

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ☐  No ☒

The number of the registrant’s common shares outstanding as of May 5, 2023 was 107,258,772.

Essent Group Ltd. and Subsidiaries

Form 10-Q

Index

PART I.	FINANCIAL INFORMATION	1
Item 1.	Financial Statements (Unaudited)	1
	Condensed Consolidated Balance Sheets (Unaudited)	1
	Condensed Consolidated Statements of Comprehensive Income (Unaudited)	2
	Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited)	3
	Condensed Consolidated Statements of Cash Flows (Unaudited)	4
	Notes to Condensed Consolidated Financial Statements (Unaudited)	5
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	25
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	46
Item 4.	Controls and Procedures	46
PART II.	OTHER INFORMATION	47
Item 1.	Legal Proceedings	47
Item 1A.	Risk Factors	47
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	47
Item 6.	Exhibits	48
SIGNATURES		49

i

Unless the context otherwise indicates or requires, the terms “we,” “our,” “us,” “Essent,” and the “Company,” as used in this Quarterly Report on Form 10-Q, refer to Essent Group Ltd. and its directly and indirectly owned subsidiaries, including our primary operating subsidiaries, Essent Guaranty, Inc. and Essent Reinsurance Ltd., as a combined entity, except where otherwise stated or where it is clear that the terms mean only Essent Group Ltd. exclusive of its subsidiaries.

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q, or Quarterly Report, includes forward-looking statements pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts or present facts or conditions, such as statements regarding our future financial condition or results of operations, our prospects and strategies for future growth, the introduction of new products and services, and the implementation of our marketing and branding strategies. In many cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or the negative of these terms or other comparable terminology.

The forward-looking statements contained in this Quarterly Report reflect our views as of the date of this Quarterly Report about future events and are subject to risks, uncertainties, assumptions and changes in circumstances that may cause events or our actual activities or results to differ significantly from those expressed in any forward-looking statement. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future events, results, actions, levels of activity, performance or achievements. A number of important factors could cause actual results to differ materially from those indicated by the forward-looking statements, including, but not limited to, those factors described below, in Part I, Item 2 “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of this Quarterly Report, and in Part I, Item 1A “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2022 filed with the Securities and Exchange Commission. These factors include, without limitation, the following:

•the duration, spread and severity of the outbreak of novel coronavirus disease 2019 ("COVID-19"), which is currently ongoing and still evolving; the actions taken to contain the virus or treat its impact, including government and GSE actions to mitigate the economic impact of the outbreak; the nature and extent of the forbearance and modification options available to borrowers affected by the outbreak on mortgages we insure; reserve and other accounting estimates relating to the impact of the COVID-19 outbreak; borrower behavior in response to the outbreak and its economic impact; how quickly and to what extent normal economic and operating conditions can resume, including whether any future outbreaks interrupt economic recovery; how quickly and to what extent affected borrowers can recover from the negative economic impact of the outbreak; and whether and to what extent the outbreak and related economic conditions will exacerbate other risks and uncertainties facing our business, financial condition and business strategy;

•changes in or to Fannie Mae and Freddie Mac, which we refer to collectively as the GSEs, whether through Federal legislation, restructurings or a shift in business practices;

•failure to continue to meet the mortgage insurer eligibility requirements of the GSEs;

•competition for our customers or the loss of a significant customer;

•lenders or investors seeking alternatives to private mortgage insurance;

•increase in the number of loans insured through Federal government mortgage insurance programs, including those offered by the Federal Housing Administration;

•decline in the volume of low down payment mortgage originations;

•uncertainty of loss reserve estimates;

•decrease in the length of time our insurance policies are in force;

•deteriorating economic conditions;

•recently enacted U.S. Federal tax reform and its impact on us, our shareholders and our operations;

ii

•the definition of “Qualified Mortgage” reducing the size of the mortgage origination market or creating incentives to use government mortgage insurance programs;

•the definition of “Qualified Residential Mortgage” reducing the number of low down payment loans or lenders and investors seeking alternatives to private mortgage insurance;

•the implementation of the Basel III Capital Accord, which may discourage the use of private mortgage insurance;

•management of risk in our investment portfolio;

•fluctuations in interest rates;

•inadequacy of the premiums we charge to compensate for our losses incurred;

•dependence on management team and qualified personnel;

•disturbance to our information technology systems;

•change in our customers’ capital requirements discouraging the use of mortgage insurance;

•declines in the value of borrowers’ homes;

•limited availability of capital or reinsurance;

•unanticipated claims arise under and risks associated with our contract underwriting program;

•industry practice that loss reserves are established only upon a loan default;

•disruption in mortgage loan servicing, as a result of COVID-19 or otherwise;

•risk of future legal proceedings;

•customers’ technological demands;

•our non-U.S. operations becoming subject to U.S. Federal income taxation;

•becoming considered a passive foreign investment company for U.S. Federal income tax purposes; and

•potential restrictions on the ability of our insurance subsidiaries to pay dividends.

Readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on these forward-looking statements. All of the forward-looking statements we have included in this Quarterly Report are based on information available to us on the date of this Quarterly Report. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as otherwise required by law.

iii

PART I — FINANCIAL INFORMATION

Item 1.   Financial Statements (Unaudited)

Essent Group Ltd. and Subsidiaries

Condensed Consolidated Balance Sheets (Unaudited)

	March 31,		December 31,
(In thousands, except per share amounts)	2023		2022
Assets
Investments
Fixed maturities available for sale, at fair value (amortized cost: 2023 — $4,977,284; 2022 — $4,932,574)	$	4,602,284	$	4,489,598
Short-term investments available for sale, at fair value (amortized cost: 2023 — $347,800; 2022 — $252,282)	347,752		252,027
Total investments available for sale	4,950,036		4,741,625
Other invested assets	255,288		257,941
Total investments	5,205,324		4,999,566
Cash	68,633		81,240
Accrued investment income	36,896		33,162
Accounts receivable	61,282		57,399
Deferred policy acquisition costs	9,511		9,910
Property and equipment (at cost, less accumulated depreciation of $68,050 in 2023 and $67,352 in 2022)	18,514		19,571
Prepaid federal income tax	418,460		418,460
Other assets	108,886		104,489
Total assets	$	5,927,506	$	5,723,797
Liabilities and Stockholders’ Equity
Liabilities
Reserve for losses and LAE	$	216,022	$	216,464
Unearned premium reserve	157,529		162,887
Net deferred tax liability	383,116		356,810
Credit facility borrowings (at carrying value, less unamortized deferred costs of $3,872 in 2023 and $4,136 in 2022)	421,128		420,864
Other accrued liabilities	100,770		104,463
Total liabilities	1,278,565		1,261,488
Commitments and contingencies (see Note 7)
Stockholders’ Equity
Common shares, $0.015 par value:
Authorized - 233,333; issued and outstanding - 107,659 shares in 2023 and 107,683 shares in 2022	1,615		1,615
Additional paid-in capital	1,334,607		1,350,377
Accumulated other comprehensive loss	(324,037)		(382,790)
Retained earnings	3,636,756		3,493,107
Total stockholders’ equity	4,648,941		4,462,309
Total liabilities and stockholders’ equity	$	5,927,506	$	5,723,797

See accompanying notes to condensed consolidated financial statements.

1

Essent Group Ltd. and Subsidiaries

Condensed Consolidated Statements of Comprehensive Income (Unaudited)

	Three Months Ended March 31,
(In thousands, except per share amounts)	2023		2022
Revenues:
Net premiums written	$	205,900	$	199,731
Decrease in unearned premiums	5,358		15,599
Net premiums earned	211,258		215,330
Net investment income	43,236		24,680
Realized investment losses, net	(488)		(7,352)
(Loss) income from other invested assets	(2,702)		24,705
Other income	4,942		7,248
Total revenues	256,246		264,611
Losses and expenses:
(Benefit) provision for losses and LAE	(180)		(106,858)
Other underwriting and operating expenses	48,195		40,796
Interest expense	6,936		2,226
Total losses and expenses	54,951		(63,836)
Income before income taxes	201,295		328,447
Income tax expense	30,468		54,280
Net income	$	170,827	$	274,167
Earnings per share:
Basic	$	1.60	$	2.53
Diluted	1.59		2.52
Weighted average shares outstanding:
Basic	106,943		108,166
Diluted	107,585		108,590
Net income	$	170,827	$	274,167
Other comprehensive income (loss):
Change in unrealized appreciation (depreciation) of investments, net of tax expense (benefit) of $9,428 and ($35,897) in the three months ended March 31, 2023 and 2022	58,753		(203,006)
Total other comprehensive income (loss)	58,753		(203,006)
Comprehensive income	$	229,580	$	71,161

See accompanying notes to condensed consolidated financial statements.

2

Essent Group Ltd. and Subsidiaries

Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited)

	Three Months Ended March 31,
(In thousands)	2023		2022
Common Shares
Balance, beginning of period	$	1,615	$	1,641
Issuance of management incentive shares	8		7
Cancellation of treasury stock	(8)		(26)
Balance, end of period	1,615		1,622
Additional Paid-In Capital
Balance, beginning of period	1,350,377		1,428,952
Dividends and dividend equivalents declared	403		227
Issuance of management incentive shares	(8)		(7)
Stock-based compensation expense	5,106		4,807
Cancellation of treasury stock	(21,271)		(75,396)
Balance, end of period	1,334,607		1,358,583
Accumulated Other Comprehensive (Loss) Income
Balance, beginning of period	(382,790)		50,707
Other comprehensive income (loss)	58,753		(203,006)
Balance, end of period	(324,037)		(152,299)
Retained Earnings
Balance, beginning of period	3,493,107		2,754,814
Net income	170,827		274,167
Dividends and dividend equivalents declared	(27,178)		(21,819)
Balance, end of period	3,636,756		3,007,162
Treasury Stock
Balance, beginning of period	—		—
Treasury stock acquired	(21,279)		(75,422)
Cancellation of treasury stock	21,279		75,422
Balance, end of period	—		—
Total Stockholders' Equity	$	4,648,941	$	4,215,068

See accompanying notes to condensed consolidated financial statements.

3

Essent Group Ltd. and Subsidiaries

Condensed Consolidated Statements of Cash Flows (Unaudited)

	Three Months Ended March 31,
(In thousands)	2023		2022
Operating Activities
Net income	$	170,827	$	274,167
Adjustments to reconcile net income to net cash provided by operating activities:
Loss on the sale of investments, net	488		7,352
Loss (income) from other invested assets	2,702		(24,705)
Distribution of income from other invested assets	851		4,452
Depreciation and amortization	698		755
Stock-based compensation expense	5,106		4,807
Amortization of premium on investment securities	3,203		7,123
Deferred income tax provision	16,878		22,162
Change in:
Accrued investment income	(3,734)		3,313
Accounts receivable	(2,602)		1,009
Deferred policy acquisition costs	399		1,030
Other assets	(4,061)		4,910
Reserve for losses and LAE	(442)		(114,373)
Unearned premium reserve	(5,358)		(15,599)
Other accrued liabilities	(166)		4,226
Net cash provided by operating activities	184,789		180,629
Investing Activities
Net change in short-term investments	(95,725)		(204,276)
Purchase of investments available for sale	(798,280)		(281,565)
Proceeds from maturity of investments available for sale	412,441		54,035
Proceeds from sales of investments available for sale	333,513		493,211
Purchase of other invested assets	(1,945)		(21,796)
Return of investment from other invested assets	1,044		—
Purchase of property and equipment	(390)		(716)
Net cash (used in) provided by investing activities	(149,342)		38,893
Financing Activities
Treasury stock acquired	(21,279)		(75,422)
Payment of issuance costs for credit facility	—		(154)
Dividends paid	(26,775)		(21,592)
Net cash used in financing activities	(48,054)		(97,168)
Net (decrease) increase in cash	(12,607)		122,354
Cash at beginning of year	81,240		81,491
Cash at end of period	$	68,633	$	203,845
Supplemental Disclosure of Cash Flow Information
Income tax payments	$	—	$	—
Interest payments	(6,402)		(1,886)
Noncash Transactions
Lease liabilities arising from obtaining right-of-use assets	$	87	$	9,174

See accompanying notes to condensed consolidated financial statements.

4

Essent Group Ltd. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited)

In these notes to condensed consolidated financial statements, “Essent”, “Company”, “we”, “us”, and “our” refer to Essent Group Ltd. and its subsidiaries, unless the context otherwise requires.

Note 1. Nature of Operations and Basis of Presentation

Essent Group Ltd. (“Essent Group”) is a Bermuda-based holding company, which, through its wholly-owned subsidiaries, offers private mortgage insurance and reinsurance for mortgages secured by residential properties located in the United States. Mortgage insurance facilitates the sale of low down payment (generally less than 20%) mortgage loans into the secondary mortgage market, primarily to two government-sponsored enterprises (“GSEs”), Fannie Mae and Freddie Mac.

The primary mortgage insurance operations are conducted through Essent Guaranty, Inc. (“Essent Guaranty”), which is domiciled in the state of Pennsylvania. Essent Guaranty is headquartered in Radnor, Pennsylvania and maintains an operations center in Winston-Salem, North Carolina. Essent Guaranty is approved as a qualified mortgage insurer by the GSEs and is licensed to write mortgage insurance in all 50 states and the District of Columbia.

Essent Guaranty reinsures new insurance written ("NIW") to Essent Reinsurance Ltd. (“Essent Re”), an affiliated Bermuda domiciled Class 3A Insurer licensed pursuant to Section 4 of the Bermuda Insurance Act 1978 that provides insurance and reinsurance coverage of mortgage credit risk. In April 2021, Essent Guaranty and Essent Re agreed to increase the quota share reinsurance coverage provided by Essent Re from 25% to 35% effective January 1, 2021. The quota share reinsurance coverage provided for Essent Guaranty’s NIW prior to January 1, 2021 will continue to be 25%, the quota share percentage in effect at the time NIW was first ceded. Essent Re also provides insurance and reinsurance to Freddie Mac and Fannie Mae. In 2016, Essent Re formed Essent Agency (Bermuda) Ltd., a wholly-owned subsidiary, which provides underwriting consulting services to third-party reinsurers. In accordance with certain state law requirements, Essent Guaranty also reinsures that portion of the risk that is in excess of 25% of the mortgage balance with respect to any loan insured prior to April 1, 2019, after consideration of other reinsurance, to Essent Guaranty of PA, Inc. (“Essent PA”), an affiliate domiciled in the state of Pennsylvania.

In addition to offering mortgage insurance, we provide contract underwriting services on a limited basis through CUW Solutions, LLC ("CUW Solutions"), a Delaware limited liability company, that provides, among other things, mortgage contract underwriting services to lenders and mortgage insurance underwriting services to affiliates. CUW Solutions is headquartered in Radnor, Pennsylvania and it maintains an operations center in Winston-Salem, North Carolina that is subleased from Essent Guaranty.

We have prepared the condensed consolidated financial statements included herein pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). We have condensed or omitted certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) pursuant to such rules and regulations. In the opinion of management, the statements include all adjustments (which include normal recurring adjustments) required for a fair statement of financial position, results of operations and cash flows for the interim periods presented. These statements should be read in conjunction with the consolidated financial statements and notes thereto, including Note 1 and Note 2 to the consolidated financial statements, included in our Annual Report on Form 10-K for the year ended December 31, 2022, which discloses the principles of consolidation and a summary of significant accounting policies. The results of operations for the interim periods are not necessarily indicative of the results for the full year. We evaluated the need to recognize or disclose events that occurred subsequent to March 31, 2023 prior to the issuance of these condensed consolidated financial statements.

Note 2. Recently Issued Accounting Standards

Accounting Standards Not Yet Adopted

    In March 2020, the Financial Accounting Standards Board ("FASB") issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments in this update provide temporary optional guidance to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform. It provides optional expedients and exceptions for applying generally accepted accounting principles to contract, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. This standard may be elected and applied prospectively over time from March 12, 2020 through December 31, 2024, as amended by ASU

5

Essent Group Ltd. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited)

2022-06, as reference rate reform activities occur. The adoption of, and future elections under, this ASU are not expected to have a material impact on our consolidated financial statements as the ASU will ease, if warranted, the requirements for accounting for the future effects of the rate reform. We continue to monitor the impact the discontinuance of LIBOR or another reference rate will have on our contracts and other transactions.

In June 2022, the FASB issued ASU No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. This update clarifies the guidance in ASC 820 on the fair value measurement of an equity security that is subject to a contractual sale restriction and requires specific disclosures related to such an equity security. The update clarifies that a contractual sale restriction prohibiting the sale of an equity security is a characteristic of the reporting entity holding the equity security and is not included in the equity security's unit of account. Accordingly, an entity should not consider the contractual sale restriction when measuring the equity security’s fair value. The update also requires specific disclosures related to equity securities that are subject to contractual sale restrictions, including (1) the fair value of such equity securities reflected in the balance sheet, (2) the nature and remaining duration of the corresponding restrictions, and (3) any circumstances that could cause a lapse in the restrictions. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years, with early adoption permitted. The adoption of this ASU is not expected to have a material effect on the Company's consolidated operating results or financial position.

Note 3. Investments

Investments available for sale consist of the following:

March 31, 2023 (In thousands)	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value
U.S. Treasury securities	$	497,267	$	843	$	(22,326)	$	475,784
U.S. agency securities	12,696		8		(14)		12,690
U.S. agency mortgage-backed securities	950,645		1,286		(101,807)		850,124
Municipal debt securities (1)	650,470		5,489		(46,949)		609,010
Non-U.S. government securities	69,606		—		(6,588)		63,018
Corporate debt securities (2)	1,575,643		3,040		(116,087)		1,462,596
Residential and commercial mortgage securities	601,606		208		(59,801)		542,013
Asset-backed securities	680,460		314		(32,665)		648,109
Money market funds	286,692		—		—		286,692
Total investments available for sale	$	5,325,085	$	11,188	$	(386,237)	$	4,950,036

December 31, 2022 (In thousands)	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value
U.S. Treasury securities	$	584,173	$	341	$	(28,076)	$	556,438
U.S. agency securities	49,059		7		(8)		49,058
U.S. agency mortgage-backed securities	898,675		258		(115,190)		783,743
Municipal debt securities (1)	661,934		2,010		(61,254)		602,690
Non-U.S. government securities	69,651		—		(7,252)		62,399
Corporate debt securities (2)	1,546,513		1,195		(133,387)		1,414,321
Residential and commercial mortgage securities	577,915		390		(66,481)		511,824
Asset-backed securities	660,345		72		(35,856)		624,561
Money market funds	136,591		—		—		136,591
Total investments available for sale	$	5,184,856	$	4,273	$	(447,504)	$	4,741,625

6

Essent Group Ltd. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited)

	March 31,		December 31,
(1) The following table summarizes municipal debt securities as of :	2023		2022
Special revenue bonds	81.4	%	79.0	%
General obligation bonds	18.5		20.9
Certificate of participation bonds	—		—
Tax allocation bonds	0.1		0.1
Total	100.0	%	100.0	%

	March 31,		December 31,
(2) The following table summarizes corporate debt securities as of :	2023		2022
Financial	40.8	%	40.5	%
Consumer, non-cyclical	18.5		17.9
Consumer, cyclical	7.2		6.8
Industrial	6.7		6.8
Utilities	5.7		6.1
Communications	8.6		8.4
Technology	4.8		4.9
Energy	5.5		6.4
Basic Materials	2.1		2.1
Government	0.1		0.1
Total	100.0	%	100.0	%

7

Essent Group Ltd. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited)

The amortized cost and fair value of investments available for sale at March 31, 2023, by contractual maturity, are shown below. Expected maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Because most U.S. agency mortgage-backed securities, residential and commercial mortgage securities and asset-backed securities provide for periodic payments throughout their lives, they are listed below in separate categories.

(In thousands)	Amortized Cost		Fair Value
U.S. Treasury securities:
Due in 1 year	$	130,959	$	129,312
Due after 1 but within 5 years	313,584		297,672
Due after 5 but within 10 years	38,335		34,655
Due after 10 years	14,389		14,145
Subtotal	497,267		475,784
U.S. agency securities:
Due in 1 year	11,125		11,111
Due after 1 but within 5 years	1,571		1,579
Subtotal	12,696		12,690
Municipal debt securities:
Due in 1 year	6,006		5,977
Due after 1 but within 5 years	88,888		86,924
Due after 5 but within 10 years	175,352		167,037
Due after 10 years	380,224		349,072
Subtotal	650,470		609,010
Non-U.S. government securities:
Due in 1 year	10,020		10,012
Due after 1 but within 5 years	33,759		32,824
Due after 5 but within 10 years	5,532		4,512
Due after 10 years	20,295		15,670
Subtotal	69,606		63,018
Corporate debt securities:
Due in 1 year	241,103		238,178
Due after 1 but within 5 years	635,267		605,227
Due after 5 but within 10 years	484,388		433,797
Due after 10 years	214,885		185,394
Subtotal	1,575,643		1,462,596
U.S. agency mortgage-backed securities	950,645		850,124
Residential and commercial mortgage securities	601,606		542,013
Asset-backed securities	680,460		648,109
Money market funds	286,692		286,692
Total investments available for sale	$	5,325,085	$	4,950,036

8

Essent Group Ltd. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited)

The components of realized investment (losses) gains, net on the condensed consolidated statements of comprehensive income were as follows:

	Three Months Ended March 31,
(In thousands)	2023		2022
Realized gross gains	$	869	$	12,576
Realized gross losses	1,357		13,091
Impairment loss	—		6,837

The fair value of investments available for sale in an unrealized loss position and the related unrealized losses for which no allowance for credit loss has been recorded were as follows:

	Less than 12 months				12 months or more				Total
March 31, 2023 (In thousands)	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses
U.S. Treasury securities	$	184,036	$	(2,069)	$	256,893	$	(20,257)	$	440,929	$	(22,326)
U.S. agency securities	11,111		(14)		—		—		11,111		(14)
U.S. agency mortgage-backed securities	144,039		(3,586)		643,734		(98,221)		787,773		(101,807)
Municipal debt securities	150,068		(2,840)		244,856		(44,109)		394,924		(46,949)
Non-U.S. government securities	36,274		(472)		26,744		(6,116)		63,018		(6,588)
Corporate debt securities	467,974		(11,248)		774,083		(104,839)		1,242,057		(116,087)
Residential and commercial mortgage securities	136,012		(7,065)		395,814		(52,736)		531,826		(59,801)
Asset-backed securities	168,303		(4,755)		423,814		(27,910)		592,117		(32,665)
Total	$	1,297,817	$	(32,049)	$	2,765,938	$	(354,188)	$	4,063,755	$	(386,237)

	Less than 12 months				12 months or more				Total
December 31, 2022 (In thousands)	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses
U.S. Treasury securities	$	321,848	$	(12,381)	$	169,795	$	(15,695)	$	491,643	$	(28,076)
U.S. agency securities	7,117		(8)		—		—		7,117		(8)
U.S. agency mortgage-backed securities	351,310		(34,193)		415,743		(80,997)		767,053		(115,190)
Municipal debt securities	335,784		(41,620)		64,766		(19,634)		400,550		(61,254)
Non-U.S. government securities	48,071		(2,914)		14,328		(4,338)		62,399		(7,252)
Corporate debt securities	811,217		(69,415)		421,307		(63,972)		1,232,524		(133,387)
Residential and commercial mortgage securities	265,934		(22,628)		242,366		(43,853)		508,300		(66,481)
Asset-backed securities	333,080		(15,454)		258,572		(20,402)		591,652		(35,856)
Total	$	2,474,361	$	(198,613)	$	1,586,877	$	(248,891)	$	4,061,238	$	(447,504)

At March 31, 2023 and December 31, 2022, we held 2,526 and 2,578 individual investment securities, respectively, that were in an unrealized loss position. We assess our intent to sell these securities and whether we will be required to sell these securities before the recovery of their amortized cost basis when determining whether to record an impairment on the securities in an unrealized loss position. In assessing whether the decline in the fair value at March 31, 2023 of any of these securities resulted from a credit loss or other factors, we made inquiries of our investment managers to determine that each issuer was current on its scheduled interest and principal payments. We reviewed the credit rating of these securities noting that approximately 98% of the securities at March 31, 2023 had investment-grade ratings. We concluded that gross unrealized losses noted above were primarily associated with the changes in interest rates subsequent to purchase rather than due to credit

9

Essent Group Ltd. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited)

impairment. There were no impairments in the three months ended March 31, 2023. We recorded impairments of $6.8 million due to our intent to sell securities in an unrealized loss position in the three months ended March 31, 2022.

The Company's other invested assets at March 31, 2023 and December 31, 2022 totaled $255.3 million and $257.9 million, respectively. Other invested assets are principally comprised of limited partnership interests which are generally accounted for under the equity method or fair value using net asset value (or its equivalent) as a practical expedient. Our proportionate share of earnings or losses or changes in fair value are reported in income from other invested assets on the condensed consolidated statements of comprehensive income. For entities accounted for under the equity method that follow industry-specific guidance for investment companies, our proportionate share of earnings or losses includes changes in the fair value of the underlying assets of these entities. Due to the timing of receiving financial information from these partnerships, the results are generally reported on a one month or quarter lag.

Other invested assets that are accounted for at fair value using the net asset value (or its equivalent) as a practical expedient totaled $163.1 million as of March 31, 2023. The majority of these investments were in limited partnerships invested in real estate or consumer credit. At March 31, 2023, maximum future funding commitments were $49.0 million. For limited partnership investments that have a contractual expiration date, we expect the liquidation of the underlying assets to occur over the next one to eight years. For certain of these investments, the Company does not have the contractual option to redeem but receives distributions based on the liquidation of the underlying assets. In addition, the Company generally does not have the ability to sell or transfer these investments without the consent from the general partner of individual limited partnerships.

The fair value of investments deposited with insurance regulatory authorities to meet statutory requirements was $9.2 million at March 31, 2023 and $9.1 million at December 31, 2022. In connection with its insurance and reinsurance activities, Essent Re is required to maintain assets in trusts for the benefit of its contractual counterparties. The fair value of the investments on deposit in these trusts was $671.8 million at March 31, 2023 and $972.4 million at December 31, 2022. Essent Guaranty is required to maintain assets on deposit in connection with its fully collateralized reinsurance agreements (see Note 4). The fair value of the assets on deposit was $8.7 million at March 31, 2023 and $8.6 million at December 31, 2022. Essent Guaranty is also required to maintain assets on deposit for the benefit of the sponsor of a fixed income investment commitment. The fair value of the assets on deposit was $9.1 million at March 31, 2023 and $9.1 million at December 31, 2022.

Net investment income consists of: 

	Three Months Ended March 31,
(In thousands)	2023		2022
Fixed maturities	$	43,473	$	26,223
Short-term investments	1,721		44
Gross investment income	45,194		26,267
Investment expenses	(1,958)		(1,587)
Net investment income	$	43,236	$	24,680

Note 4. Reinsurance

In the ordinary course of business, our insurance subsidiaries may use reinsurance to provide protection against adverse loss experience and to expand our capital sources. Reinsurance recoverables are recorded as assets and included in other assets on our condensed consolidated balance sheets, predicated on a reinsurer's ability to meet their obligations under the reinsurance agreements. If the reinsurers are unable to satisfy their obligations under the agreements, our insurance subsidiaries would be liable for such defaulted amounts.

10

Essent Group Ltd. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited)

The effect of reinsurance on net premiums written and earned is as follows:

	Three Months Ended  March 31,
(In thousands)	2023		2022
Net premiums written:
Direct	$	239,491	$	220,254
Ceded (1)	(33,591)		(20,523)
Net premiums written	$	205,900	$	199,731
Net premiums earned:
Direct	$	244,849	$	235,853
Ceded (1)	(33,591)		(20,523)
Net premiums earned	$	211,258	$	215,330

(1)Net of profit commission.

Quota Share Reinsurance

    Essent Guaranty has entered into quota share reinsurance agreements with a panels of third-party reinsurers ("QSR" agreements). Each of the third-party reinsurers has an insurer financial strength rating of A- or better by S&P Global Ratings, A.M. Best or both. Under each QSR agreement, Essent Guaranty will cede premiums earned on all eligible policies written during a specified period, in exchange for reimbursement of ceded claims and claims expenses on covered policies, a specified ceding commission, and a profit commission that varies directly and inversely with ceded claims. Essent Guaranty has certain termination rights under each QSR agreement, including the option to terminate each QSR agreement subject to a termination fee.

The following tables summarizes Essent Guaranty's quota share reinsurance agreements as of March 31, 2023:

QSR Agreement	Coverage Period	Ceding Percentage	Ceding Commission	Profit Commission
QSR-2019	September 1, 2019-December 31, 2020	(1)	20%	63%	(2)
QSR-2022	January 1, 2022-December 31, 2022	20%	20%	62%
QSR-2023	January 1, 2023-December 31, 2023	17.5%	20%	58%

_______________________________________________________________________________

(1)Under QSR-2019, Essent Guaranty cedes 40% of premiums on singles policies and 20% on all other policies.

(2)The original profit commission on QSR-2019 was up to 60%; however because Essent Guaranty did not exercise its option to terminate the QSR Agreement on December 31, 2021, the maximum profit commission that Essent Guaranty could earn increased to 63% in 2022 and thereafter.

Total RIF ceded under the QSR agreements was $7.3 billion as of March 31, 2023.

Excess of Loss Reinsurance

Essent Guaranty has entered into fully collateralized reinsurance agreements ("Radnor Re Transactions") with unaffiliated special purpose insurers domiciled in Bermuda. For the reinsurance coverage periods, Essent Guaranty and its affiliates retain the first layer of the respective aggregate losses, and a Radnor Re special purpose insurer will then provide second layer coverage up to the outstanding reinsurance coverage amount. Essent Guaranty and its affiliates retain losses in excess of the outstanding reinsurance coverage amount. The reinsurance premium due to each Radnor Re special purpose insurer is calculated by multiplying the outstanding reinsurance coverage amount at the beginning of a period by a coupon rate, which is the sum of one-month LIBOR or SOFR plus a risk margin, and then subtracting actual investment income collected on the assets in the related reinsurance trust during that period. The aggregate excess of loss reinsurance coverage decreases over a ten-year period as the underlying covered mortgages amortize. Essent Guaranty has rights to terminate the Radnor Re

11

Essent Group Ltd. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited)

Transactions. The Radnor Re entities collateralized the coverage by issuing mortgage insurance-linked notes ("ILNs") in an aggregate amount equal to the initial coverage to unaffiliated investors. The notes have ten-year legal maturities and are non-recourse to any assets of Essent Guaranty or its affiliates. The proceeds of the notes were deposited into reinsurance trusts for the benefit of Essent Guaranty and will be the source of reinsurance claim payments to Essent Guaranty and principal repayments on the ILNs.

Essent Guaranty has also entered into reinsurance agreements with panels of reinsurers that provide aggregate excess of loss coverage immediately above or pari-passu to the coverage provided by the Radnor Re Transactions. The aggregate excess of loss reinsurance coverage decreases over a ten-year period as the underlying covered mortgages amortize. Essent Guaranty has rights to terminate these reinsurance agreements.

Essent Guaranty entered into a reinsurance agreement with a panel of reinsurers that provides excess of loss coverage on new insurance written from October 1, 2021 through December 31, 2022. For the reinsurance coverage period, Essent Guaranty and its affiliates retain the first layer of the respective aggregate losses, and the reinsurance panel will then provide second layer coverage up to the outstanding reinsurance coverage amount. Essent Guaranty and its affiliates retain losses in excess of the outstanding reinsurance coverage amount.

The following table summarizes Essent Guaranty's excess of loss reinsurance agreements as of March 31, 2023:

Vintage Year	Reinsurer	Effective Date	Optional Termination Date
2017	Panel of Reinsurers	November 1, 2018	October 1, 2023	(1)
2018	Radnor Re 2019-1 Ltd.	February 28, 2019	February 25, 2026
2018	Panel of Reinsurers	February 28, 2019	February 25, 2026
2019	Radnor Re 2020-1 Ltd.	January 30, 2020	January 25, 2027
2019	Panel of Reinsurers	January 30, 2020	January 25, 2027
2020 & 2021	Radnor Re 2021-1 Ltd.	June 23, 2021	June 26, 2028
2021	Radnor Re 2021-2 Ltd.	November 10, 2021	November 25, 2027
2021 & 2022	Panel of Reinsurers	June 1, 2022	January 1, 2030
2021 & 2022	Radnor Re 2022-1 Ltd.	September 21, 2022	September 25, 2028

(1) If the reinsurance agreement is not terminated at the optional termination date, the reinsurance premium increases by 50%.

The following table summarizes Essent Guaranty's excess of loss reinsurance coverages and retentions as of March 31, 2023:

(In thousands)					Remaining Reinsurance in Force
Vintage Year	Remaining Insurance in Force		Remaining Risk in Force		ILN		Other Reinsurance			Total		Remaining First Layer Retention
2017	5,511,131		1,450,432		—		70,895		(7)	70,895		421,003		(10)
2018	6,349,474		1,644,287		325,537		76,144		(8)	401,681		248,221
2019 (2)	7,859,217		2,029,598		395,889		43,991		(9)	439,880		214,485
2020 & 2021 (3)	38,168,321		9,652,777		414,005		—			414,005		278,909
2021 (4)	40,543,749		10,825,130		399,786		—			399,786		279,400
2021 & 2022 (5)	74,276,338		19,998,840		—		141,992			141,992		507,114
2021 & 2022 (6)	33,357,208		8,966,697		237,868		—			237,868		303,761
Total	$	206,065,438	$	54,567,761	$	1,773,085	$	333,022		$	2,106,107	$	2,025,706	(11)

(2) Reinsurance coverage on new insurance written from January 1, 2019 through August 31, 2019.

(3) Reinsurance coverage on new insurance written from August 1, 2020 through March 31, 2021.

(4) Reinsurance coverage on new insurance written from April 1, 2021 through September 30, 2021.

(5) Reinsurance coverage on new insurance written from October 1, 2021 through December 31, 2022.

12

Essent Group Ltd. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited)

(6) Reinsurance coverage on new insurance written from October 1, 2021 through July 31, 2022.

(7) Coverage provided immediately above the coverage provided by Radnor Re 2018-1 Ltd.

(8) Coverage provided pari-passu to the coverage provided by Radnor Re 2019-1 Ltd.

(9) Coverage provided pari-passu to the coverage provided by Radnor Re 2020-1 Ltd.

(10) The original and remaining first layer retention is associated with reinsurance provided by a panel of reinsurers. Amounts reported in prior periods reflected the retention associated with an ILN that is no longer outstanding as of March 31, 2023.

(11) The total remaining first layer retention differs from the sum of the individual reinsurance transactions as a result of overlapping coverage between certain transactions.

    Based on the level of delinquencies reported to us, the ILN transactions entered into prior to March 31, 2020 became subject to a "trigger event" as of June 25, 2020. The amortization of principal of the notes issued by the unaffiliated special purpose insurers in connection with those ILN transactions is suspended and the aggregate excess of loss reinsurance coverage will not amortize during the continuation of a trigger event. Radnor Re 2020-1 was no longer subject to a trigger event as of July 25, 2022.

The amount of monthly reinsurance premiums ceded to the Radnor Re entities will fluctuate due to changes in one-month LIBOR or SOFR and changes in money market rates that affect investment income collected on the assets in the reinsurance trusts. As the reinsurance premium will vary based on changes in these rates, we concluded that the Radnor Re Transactions contain embedded derivatives that will be accounted for separately like freestanding derivatives. The change in the fair value of the embedded derivatives is reported in earnings and included in other income.

In connection with the Radnor Re Transactions, we concluded that the risk transfer requirements for reinsurance accounting were met as each Radnor Re entity is assuming significant insurance risk and a reasonable possibility of a significant loss. In addition, we assessed whether each Radnor Re entity was a variable interest entity ("VIE") and the appropriate accounting for the Radnor Re entities if they were VIEs. A VIE is a legal entity that does not have sufficient equity at risk to finance its activities without additional subordinated financial support or is structured such that equity investors lack the ability to make significant decisions relating to the entity’s operations through voting rights or do not substantively participate in the gains and losses of the entity. A VIE is consolidated by its primary beneficiary. The primary beneficiary is the entity that has both (1) the power to direct the activities of the VIE that most significantly affect the entity’s economic performance and (2) the obligation to absorb losses or the right to receive benefits that could be potentially significant to the VIE. While also considering these factors, the consolidation conclusion depends on the breadth of the decision-making ability and ability to influence activities that significantly affect the economic performance of the VIE. We concluded that the Radnor Re entities are VIEs. However, given that Essent Guaranty (1) does not have the unilateral power to direct the activities that most significantly affect their economic performance and (2) does not have the obligation to absorb losses or the right to receive benefits that could be potentially significant to these entities, the Radnor Re entities are not consolidated in these financial statements.

The following table presents total assets of each Radnor Re special purpose insurer as well as our maximum exposure to loss associated with each Radnor Re entity, representing the fair value of the embedded derivatives, using observable inputs in active markets (Level 2), included in other assets (other accrued liabilities) on our condensed consolidated balance sheet and the estimated net present value of investment earnings on the assets in the reinsurance trusts, each as of March 31, 2023:

			Maximum Exposure to Loss
(In thousands)	Total VIE Assets		On - Balance Sheet		Off - Balance Sheet		Total
Radnor Re 2019-1 Ltd.	325,537		(2,218)		90		(2,128)
Radnor Re 2020-1 Ltd.	395,889		(1,286)		158		(1,128)
Radnor Re 2021-1 Ltd.	414,005		(4,657)		98		(4,559)
Radnor Re 2021-2 Ltd.	$	399,786	$	(3,849)	$	95	$	(3,754)
Radnor Re 2022-1 Ltd.	$	237,868	$	695	$	78	$	773
Total	$	1,773,085	$	(11,315)	$	519	$	(10,796)

13

Essent Group Ltd. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited)

Note 5. Reserve for Losses and Loss Adjustment Expenses

The following table provides a reconciliation of the beginning and ending reserve balances for losses and loss adjustment expenses (“LAE”) for the three months ended March 31:

(In thousands)	2023		2022
Reserve for losses and LAE at beginning of period	$	216,464	$	407,445
Less: Reinsurance recoverables	14,618		25,940
Net reserve for losses and LAE at beginning of period	201,846		381,505
Add provision for losses and LAE, net of reinsurance, occurring in:
Current period	32,694		24,369
Prior years	(32,874)		(131,227)
Net incurred losses and LAE during the current period	(180)		(106,858)
Deduct payments for losses and LAE, net of reinsurance, occurring in:
Current period	—		1
Prior years	2,001		909
Net loss and LAE payments during the current period	2,001		910
Net reserve for losses and LAE at end of period	199,665		273,737
Plus: Reinsurance recoverables	16,357		19,335
Reserve for losses and LAE at end of period	$	216,022	$	293,072

For the three months ended March 31, 2023, $2.0 million was paid for incurred claims and claim adjustment expenses attributable to insured events of prior years. There has been a $32.9 million favorable prior year development during the three months ended March 31, 2023. Reserves remaining as of March 31, 2023 for prior years are $167.0 million as a result of re-estimation of unpaid losses and loss adjustment expenses. For the three months ended March 31, 2022, $0.9 million was paid for incurred claims and claim adjustment expenses attributable to insured events of prior years. There was a $131.2 million favorable prior year development during the three months ended March 31, 2022. Reserves remaining as of March 31, 2022 for prior years were $249.4 million as a result of re-estimation of unpaid losses and loss adjustment expenses. In both periods, the favorable prior years' loss development was the result of a re-estimation of amounts ultimately to be paid on prior year defaults in the default inventory, including the impact of previously identified defaults that cured. Original estimates are increased or decreased as additional information becomes known regarding individual claims.

Due to business restrictions, stay-at-home orders and travel restrictions initially implemented in March 2020 as a result of COVID-19, unemployment in the United States increased significantly in the second quarter of 2020, declining during the second half of 2020 through 2022. As unemployment is one of the most common reasons for borrowers to default on their mortgage, the increase in unemployment has increased the number of delinquencies on the mortgages that we insure and has the potential to increase claim frequencies on defaults.

In response to the COVID-19 pandemic, the United States government enacted a number of policies to provide fiscal stimulus to the economy and relief to those affected by this global disaster. Specifically, mortgage forbearance programs and foreclosure moratoriums were instituted by Federal legislation along with actions taken by the Federal Housing Finance Agency (“FHFA”), Fannie Mae and Freddie Mac (collectively the “GSEs”). The mortgage forbearance plans provide for eligible homeowners who were adversely impacted by COVID-19 to temporarily reduce or suspend their mortgage payments for up to 18 months for loans in an active COVID-19-related forbearance program as of February 28, 2021. For borrowers that have the ability to begin to pay their mortgage at the end of the forbearance period, we expect that mortgage servicers will work with them to modify their loans at which time the mortgage will be removed from delinquency status. We believe that the forbearance process could have a favorable effect on the frequency of claims that we ultimately pay.

The defaulted loans reported to us in the second and third quarters of 2020 had reached the end of their forbearance periods as of March 31, 2022. During the first quarter of 2022, the Early COVID Defaults cured at elevated levels, and the cumulative cure rate for the Early COVID Defaults at March 31, 2022 exceeded our initial estimated cure rate implied by our estimate of ultimate loss for these defaults established at the onset of the pandemic. Based on cure activity through March 31, 2022 and our expectations for future cure activity, as of March 31, 2022, we lowered our estimate of ultimate loss for the Early

14

Essent Group Ltd. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited)

COVID Defaults from 7% to 4% of the initial risk in force. During the three months ended June 30, 2022, Early COVID Defaults cured at levels that exceeded our estimate as of March 31, 2022, and we further lowered our estimate of loss for these defaults as of June 30, 2022 to 2% of the initial risk in force. These revisions to our estimate of ultimate loss for the Early COVID Defaults resulted in a benefit recorded to the provision for losses of $164.1 million for the year ended December 31, 2022. Due to the level of Early COVID Defaults remaining in the default inventory, beginning in the third quarter of 2022, we resumed reserving for the Early COVID Defaults using our normal reserve methodology. The transition of defaults to foreclosure or claim has not returned to pre-pandemic levels. As a result, the level of defaults in the default inventory that have missed twelve or more payments is above pre-pandemic levels.

The economy in the United States is currently experiencing elevated levels of consumer price inflation. The Federal Reserve has increased the target federal funds rate several times during 2022 and 2023 in an effort to reduce consumer price inflation. These rate increases have resulted in higher mortgage interest rates which may lower home sale activity and affect the options available to delinquent borrowers. It is reasonably possible that our estimate of losses could change in the near term as a result of changes in the economic environment, the impact of elevated levels of consumer price inflation on home sale activity, housing inventory, and home prices. The impact on our reserves in future periods will be dependent upon the amount of delinquent notices received from loan servicers and our expectations for the amount of ultimate losses on these delinquencies.

Note 6. Debt Obligations

Credit Facility

Essent Group and its subsidiaries, Essent Irish Intermediate Holdings Limited and Essent US Holdings, Inc. (collectively, the "Borrowers"), are parties to a five-year secured credit facility with a committed capacity of $825 million (the Credit Facility"). The Credit Facility also provides for up to $175 million aggregate principal amount of uncommitted incremental term loan and/or revolving credit facilities that may be exercised at the Borrowers’ option so long as the Borrowers receive commitments from the lenders. Borrowings under the Credit Facility may be used for working capital and general corporate purposes, including, without limitation, capital contributions to Essent’s insurance and reinsurance subsidiaries. Borrowings accrue interest at a floating rate tied to a standard short-term borrowing index, selected at the Company’s option, plus an applicable margin. A commitment fee is due quarterly on the average daily amount of the undrawn revolving commitment. The applicable margin and the commitment fee are based on the senior unsecured debt rating or long-term issuer rating of Essent Group to the extent available, or the insurer financial strength rating of Essent Guaranty. The annual commitment fee rate at March 31, 2023 was 0.25%. The obligations under the Credit Facility are secured by certain assets of the Borrowers, excluding the stock and assets of its insurance and reinsurance subsidiaries. The Credit Facility contains several covenants, including financial covenants relating to minimum net worth, capital and liquidity levels, maximum debt to capitalization level and Essent Guaranty's compliance with the PMIERs (see Note 14). The borrowings under the Credit Facility contractually mature on December 10, 2026. As of March 31, 2023, the Company was in compliance with the covenants and $425 million had been borrowed under the term loan portion of the Credit Facility with a weighted average interest rate of 6.52%. As of December 31, 2022, $425 million had been borrowed with a weighted average interest rate of 6.02%.

Note 7. Commitments and Contingencies

Obligations under Guarantees

Under the terms of CUW Solutions' contract underwriting agreements with lenders and subject to contractual limitations on liability, we agree to indemnify certain lenders against losses incurred in the event that we make an error in determining whether loans processed meet specified underwriting criteria, to the extent that such error materially restricts or impairs the salability of such loan, results in a material reduction in the value of such loan or results in the lender repurchasing the loan. The indemnification may be in the form of monetary or other remedies. No remedy payments were made in the three months ended March 31, 2023, and we paid less than $0.1 million related to remedies in the three months ended March 31, 2022. As of March 31, 2023, management believes any potential claims for indemnification related to contract underwriting services through March 31, 2023 are not material to our consolidated financial position or results of operations.

In addition to the indemnifications discussed above, in the normal course of business, we enter into agreements or other relationships with third parties pursuant to which we may be obligated under specified circumstances to indemnify the counterparties with respect to certain matters. Our contractual indemnification obligations typically arise in the context of agreements entered into by us to, among other things, purchase or sell services, finance our business and business transactions,

15

Essent Group Ltd. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited)

lease real property and license intellectual property. The agreements we enter into in the normal course of business generally require us to pay certain amounts to the other party associated with claims or losses if they result from our breach of the agreement, including the inaccuracy of representations or warranties. The agreements we enter into may also contain other indemnification provisions that obligate us to pay amounts upon the occurrence of certain events, such as the negligence or willful misconduct of our employees, infringement of third-party intellectual property rights or claims that performance of the agreement constitutes a violation of law. Generally, payment by us under an indemnification provision is conditioned upon the other party making a claim, and typically we can challenge the other party’s claims. Further, our indemnification obligations may be limited in time and/or amount, and in some instances, we may have recourse against third parties for certain payments made by us under an indemnification agreement or obligation. As of March 31, 2023, contingencies triggering material indemnification obligations or payments have not occurred historically and are not expected to occur. The nature of the indemnification provisions in the various types of agreements and relationships described above are believed to be low risk and pervasive, and we consider them to have a remote risk of loss or payment. We have not recorded any provisions on the condensed consolidated balance sheets related to indemnifications.

Note 8. Capital Stock

Our authorized share capital consists of 233.3 million shares of a single class of common shares. The common shares have no preemptive rights or other rights to subscribe for additional shares, and no rights of redemption, conversion or exchange. Under certain circumstances and subject to the provisions of Bermuda law and our bye-laws, we may be required to make an offer to repurchase shares held by members. The common shares rank pari passu with one another in all respects as to rights of payment and distribution. In general, holders of common shares will have one vote for each common share held by them and will be entitled to vote, on a non-cumulative basis, at all meetings of shareholders. In the event that a shareholder is considered a 9.5% Shareholder under our bye-laws, such shareholder's votes will be reduced by whatever amount is necessary so that after any such reduction the votes of such shareholder will not result in any other person being treated as a 9.5% Shareholder with respect to the vote on such matter. Under these provisions certain shareholders may have their voting rights limited to less than one vote per share, while other shareholders may have voting rights in excess of one vote per share.

Dividends

The following table presents the amounts declared and paid per common share each quarter:

Quarter Ended	2023		2022
March 31	$	0.25	$	0.20
June 30	—		0.21
September 30	—		0.22
December 31	—		0.23
Total dividends per common share declared and paid	$	0.25	$	0.86

In May 2023, the Board of Directors declared a quarterly cash dividend of $0.25 per common share payable on June 12, 2023 to shareholders of record on June 1, 2023.

Share Repurchase Plan

In May 2022, the Board of Directors approved a share repurchase plan that authorizes the Company to repurchase up to $250 million of its common shares in the open market by the end of 2023. Through March 31, 2023, the Company repurchased 431,904 common shares at a cost of $16.6 million under the 2022 plan, leaving $233.4 million remaining unused under the authorized repurchase plan as of March 31, 2023.

16

Essent Group Ltd. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited)

Note 9. Stock-Based Compensation

In 2013, Essent Group's Board of Directors adopted, and Essent Group's shareholders approved, the Essent Group Ltd. 2013 Long-Term Incentive Plan (the "2013 Plan"), which was effective upon completion of the initial public offering. The types of awards available under the 2013 Plan include nonvested shares, nonvested share units, non-qualified share options, incentive stock options, share appreciation rights, and other share-based or cash-based awards. Nonvested shares and nonvested share units granted under the 2013 Plan have rights to dividends, which entitle holders to the same dividend value per share as holders of common shares in the form of dividend equivalent units ("DEUs"). DEUs are subject to the same vesting and other terms and conditions as the corresponding nonvested shares and nonvested share units. DEUs vest when the underlying shares or share units vest and are forfeited if the underlying share or share units forfeit prior to vesting. The maximum number of shares and share units available for issuance is 7.5 million under the 2013 Plan. As of March 31, 2023, there were 2.0 million common shares available for future grant under the 2013 Plan.

The following table summarizes nonvested common share, nonvested common share unit and DEU activity for the three months ended March 31, 2023:

	Time and Performance- Based Share Awards			Time-Based Share Awards			Share Units			DEUs
(Shares in thousands)	Number of Shares	Weighted Average Grant Date Fair Value		Number of Shares	Weighted Average Grant Date Fair Value		Number of Share Units	Weighted Average Grant Date Fair Value		Dividend Equivalent Units	Weighted Average Grant Date Fair Value
Outstanding at beginning of year	647	$	20.99	138	$	45.94	350	$	45.51	37	$	40.86
Granted	300	12.66		76	43.51		436	38.41		11	37.88
Vested	(103)	51.52		(64)	56.65		(131)	49.16		(14)	40.31
Forfeited	—	—		—	—		(13)	39.25		—	40.57
Outstanding at March 31, 2023	844	$	14.29	150	$	44.40	642	$	40.07	34	$	40.15

In February 2023, certain members of senior management were granted nonvested common shares under the 2013 Plan that were subject to time-based and performance-based vesting. The time-based share awards granted in February 2023 vest in three equal installments commencing on March 1 of the year following the grant year. The performance-based share awards granted in February 2023 vest based upon our compounded annual book value per share growth percentage and relative total shareholder return during a three-year performance period that commenced on January 1, 2023 and vest on March 1, 2026. Shares were issued at the maximum 200% of target. The portion of these nonvested performance-based share awards that will be earned is as follows:

		Relative Total Shareholder Return vs. S&P 1500 Financial Services Index
		≤25th percentile		50th percentile "Target"		≥75th percentile
Three-Year Book Value Per Share CAGR	10% "Target"	100	%	150	%	200	%
	9%	75	%	125	%	175	%
	8%	50	%	100	%	150	%
	6%	25	%	75	%	125	%
	5%	0	%	50	%	100	%

In the event that the compounded annual book value per share growth or the relative total shareholder return falls between the performance levels shown above, the nonvested common shares earned will be determined on a straight-line basis between the respective levels shown.

17

Essent Group Ltd. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited)

In January 2023, nonvested common share units were issued to all vice president and staff level employees and are subject to time-based vesting in three equal installments on January 6, 2024, 2025 and 2026. In connection with our incentive program covering bonus awards for performance year 2022, in February 2023, time-based share units were issued to certain employees that vest in three equal installments on March 1, 2024, 2025 and 2026.

Quoted market prices are used for the valuation of common shares granted that do not contain a market condition under ASC 718. The performance-based share awards granted in February 2021 contain a market condition and were valued based on analysis provided by a third-party valuation firm using a risk neutral simulation taking into effect the vesting conditions of the grant.

In February 2021, the performance-based share awards granted in 2019 and 2020 to certain members of senior management were amended to provide that such awards will no longer be subject to the achievement of the compounded annual book value per share growth metrics and will be subject to only service-based vesting. As a result, the shares subject to the amended 2019 and 2020 awards vested on March 1, 2022 and March 1, 2023, respectively.

The total fair value on the vesting date of nonvested shares, share units or DEUs that vested was $13.2 million and $16.3 million for the three months ended March 31, 2023 and 2022, respectively. As of March 31, 2023, there was $34.0 million of total unrecognized compensation expense related to nonvested shares or share units outstanding at March 31, 2023 and we expect to recognize the expense over a weighted average period of 2.5 years.

Employees have the option to tender shares to Essent Group to pay the minimum employee statutory withholding taxes associated with shares upon vesting. Common shares tendered by employees to pay employee withholding taxes totaled 111,820 in the three months ended March 31, 2023. The tendered shares were recorded at cost and included in treasury stock. All treasury stock has been cancelled as of March 31, 2023.

Compensation expense, net of forfeitures, and related tax effects recognized in connection with nonvested shares was as follows:

	Three Months Ended March 31,
(In thousands)	2023		2022
Compensation expense	$	5,106	$	4,807
Income tax benefit	1,018		957

Note 10. Dividends Restrictions

Our U.S. insurance subsidiaries are subject to certain capital and dividend rules and regulations as prescribed by jurisdictions in which they are authorized to operate. Under the insurance laws of the Commonwealth of Pennsylvania, Essent Guaranty and Essent PA may pay dividends during any 12-month period in an amount equal to the greater of (i) 10% of the preceding year-end statutory policyholders' surplus or (ii) the preceding year's statutory net income. The Pennsylvania statute also specifies that dividends and other distributions can be paid out of positive unassigned surplus without prior approval. At March 31, 2023, Essent Guaranty had unassigned surplus of approximately $286.8 million and Essent PA had unassigned surplus of approximately $14.1 million. In three months ended March 31, 2023 and 2022, Essent Guaranty paid dividends of $90 million and $100 million, respectively, to its parent, Essent US Holdings, Inc. Essent PA did not pay a dividend in the three months ended March 31, 2023 or 2022. As of March 31, 2023, Essent Guaranty and Essent PA could pay additional ordinary dividends in 2023 of $286.8 million and $5.3 million, respectively.

Essent Re is subject to certain dividend restrictions as prescribed by the Bermuda Monetary Authority and under certain agreements with counterparties. In connection with the quota share reinsurance agreement with Essent Guaranty, Essent Re has agreed to maintain a minimum total equity of $100 million. As of March 31, 2023, Essent Re had total equity of $1.6 billion.

At March 31, 2023, our insurance subsidiaries were in compliance with these rules, regulations and agreements.

18

Essent Group Ltd. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited)

Note 11. Earnings per Share (EPS)

The following table reconciles the net income and the weighted average common shares outstanding used in the computations of basic and diluted earnings per common share:

	Three Months Ended  March 31,
(In thousands, except per share amounts)	2023		2022
Net income	$	170,827	$	274,167
Basic weighted average shares outstanding	106,943		108,166
Dilutive effect of nonvested shares	642		424
Diluted weighted average shares outstanding	107,585		108,590
Basic earnings per share	$	1.60	$	2.53
Diluted earnings per share	$	1.59	$	2.52

There were 111,870 and 81,036 antidilutive shares for the three months ended March 31, 2023 and 2022.

Nonvested performance-based share awards are considered contingently issuable for purposes of the EPS calculation. The 2023, 2022 and 2021 performance-based share awards vest based upon our compounded annual book value per share growth percentage and relative total shareholder return during a three-year performance period. The performance-based share awards granted in years before 2021 vest based upon our compounded annual book value per share growth percentage during a three-year performance period. The following table summarizes the performance-based shares issuable if the reporting date was the end of the contingency period.

	2023 Performance-Based Grants		2022 Performance-Based Grants		2021 Performance-Based Grants		2020 Performance-Based Grants
Reporting Date	Percent Issuable Relative to Target	As a Percent of Shares Issued	Percent Issuable Relative to Target	As a Percent of Shares Issued	Percent Issuable Relative to Target	As a Percent of Shares Issued	Percent Issuable Relative to Target and Shares Issued
March 31, 2023	200%	100%	170%	85%	100%	50%
March 31, 2022			122%	61%	100%	50%	100%

19

Essent Group Ltd. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited)

Note 12. Accumulated Other Comprehensive Income (Loss)

The following table presents the rollforward of accumulated other comprehensive loss for the three months ended March 31, 2023 and 2022: 

	Three Months Ended March 31,
	2023						2022
(In thousands)	Before Tax		Tax Effect		Net of Tax		Before Tax		Tax Effect		Net of Tax
Balance at beginning of year	$	(443,230)	$	60,440	$	(382,790)	$	65,280	$	(14,573)	$	50,707
Other comprehensive income (loss):
Unrealized holding gains (losses) on investments:
Unrealized holding gains (losses) arising during the period	67,693		(9,476)		58,217		(246,255)		34,830		(211,425)
Less: Reclassification adjustment for losses included in net income (1)	488		48		536		7,352		1,067		8,419
Net unrealized gains (losses) on investments	68,181		(9,428)		58,753		(238,903)		35,897		(203,006)
Other comprehensive income (loss)	68,181		(9,428)		58,753		(238,903)		35,897		(203,006)
Balance at end of period	$	(375,049)	$	51,012	$	(324,037)	$	(173,623)	$	21,324	$	(152,299)

(1)Included in net realized investment losses on our condensed consolidated statements of comprehensive income.

Note 13. Fair Value of Financial Instruments

We carry certain of our financial instruments at fair value. We define fair value as the current amount that would be exchanged to sell an asset or transfer a liability, other than in a forced liquidation.

Fair Value Hierarchy

ASC No. 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. The level within the fair value hierarchy to measure the financial instrument shall be determined based on the lowest level input that is significant to the fair value measurement. The three levels of the fair value hierarchy are as follows:

•Level 1 — Quoted prices for identical instruments in active markets accessible at the measurement date.

•Level 2 — Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and valuations in which all significant inputs are observable in active markets. Inputs are observable for substantially the full term of the financial instrument.

•Level 3 — Valuations derived from one or more significant inputs that are unobservable.

Determination of Fair Value

When available, we generally use quoted market prices to determine fair value and classify the financial instrument in Level 1. In cases where quoted market prices for similar financial instruments are available, we utilize these inputs for valuation techniques and classify the financial instrument in Level 2. In cases where quoted market prices are not available, fair values are based on estimates using discounted cash flows, present value or other valuation techniques. Those techniques are significantly affected by the assumptions used, including the discount rates and estimates of future cash flows and we classify the financial instrument in Level 3. Accordingly, the fair value estimates may not be realized in an immediate settlement of the instrument.

20

Essent Group Ltd. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited)

We used the following methods and assumptions in estimating fair values of financial instruments:

•Investments available for sale — Investments available for sale are valued using quoted market prices in active markets, when available, and those investments are classified as Level 1 of the fair value hierarchy. Level 1 investments available for sale include investments such as U.S. Treasury securities and money market funds. Investments available for sale are classified as Level 2 of the fair value hierarchy if quoted market prices are not available and fair values are estimated using quoted prices of similar securities or recently executed transactions for the securities. U.S. agency securities, U.S. agency mortgage-backed securities, municipal debt securities, non-U.S. government securities, corporate debt securities, residential and commercial mortgage securities and asset-backed securities are classified as Level 2 investments.

We use independent pricing sources to determine the fair value of securities available for sale in Level 1 and Level 2 of the fair value hierarchy. We use one primary pricing service to provide individual security pricing based on observable market data and receive one quote per security. To ensure securities are appropriately classified in the fair value hierarchy, we review the pricing techniques and methodologies of the independent pricing service and believe that their policies adequately consider market activity, either based on specific transactions for the issue valued or based on modeling of securities with similar credit quality, duration, yield and structure that were recently traded. U.S. agency securities, U.S. agency mortgage-backed securities, municipal debt securities, non-U.S. government securities and corporate debt securities are valued by our primary vendor using recently executed transactions and proprietary models based on observable inputs, such as interest rate spreads, yield curves and credit risk. Residential and commercial mortgage securities and asset-backed securities are valued by our primary vendor using proprietary models based on observable inputs, such as interest rate spreads, prepayment speeds and credit risk. As part of our evaluation of investment prices provided by our primary pricing service, we obtained and reviewed their pricing methodologies which include a description of how each security type is evaluated and priced. We review the reasonableness of prices received from our primary pricing service by comparison to prices obtained from additional pricing sources. We have not made any adjustments to the prices obtained from our primary pricing service.

21

Essent Group Ltd. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited)

Assets and Liabilities Measured at Fair Value

All assets measured at fair value are categorized in the table below based upon the lowest level of significant input to the valuations. All fair value measurements at the reporting date were on a recurring basis.

March 31, 2023 (In thousands)	Quoted Prices in Active  Markets for Identical Instruments (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
Recurring fair value measurements
Financial Assets:
U.S. Treasury securities	$	475,784	$	—	$	—	$	475,784
U.S. agency securities	—		12,690		—		12,690
U.S. agency mortgage-backed securities	—		850,124		—		850,124
Municipal debt securities	—		609,010		—		609,010
Non-U.S. government securities	—		63,018		—		63,018
Corporate debt securities	—		1,462,596		—		1,462,596
Residential and commercial mortgage securities	—		542,013		—		542,013
Asset-backed securities	—		648,109		—		648,109
Money market funds	286,692		—		—		286,692
Total assets at fair value (1) (2)	$	762,476	$	4,187,560	$	—	$	4,950,036

December 31, 2022 (In thousands)	Quoted Prices in Active  Markets for Identical Instruments (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
Recurring fair value measurements
Financial Assets:
U.S. Treasury securities	$	556,438	$	—	$	—	$	556,438
U.S. agency securities	—		49,058		—		49,058
U.S. agency mortgage-backed securities	—		783,743		—		783,743
Municipal debt securities	—		602,690		—		602,690
Non-U.S. government securities	—		62,399		—		62,399
Corporate debt securities	—		1,414,321		—		1,414,321
Residential and commercial mortgage securities	—		511,824		—		511,824
Asset-backed securities	—		624,561		—		624,561
Money market funds	136,591		—		—		136,591
Total assets at fair value (1)	$	693,029	$	4,048,596	$	—	$	4,741,625

(1)Does not include the fair value of embedded derivatives, which we have accounted for separately as freestanding derivatives and included in other assets or other accrued liabilities in our condensed consolidated balance sheet. See Note 4 for more information.

(2)Does not include certain other invested assets that are measured at fair value using the net asset value per share (or its equivalent) as a practical expedient, as applicable accounting standards do not provide for classification within the fair value hierarchy.

22

Essent Group Ltd. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited)

Note 14. Statutory Accounting

Our U.S. insurance subsidiaries prepare statutory-basis financial statements in accordance with the accounting practices prescribed or permitted by their respective state’s department of insurance, which is a comprehensive basis of accounting other than GAAP. We did not use any prescribed or permitted statutory accounting practices (individually or in the aggregate) that resulted in reported statutory surplus or capital that was significantly different from the statutory surplus or capital that would have been reported had National Association of Insurance Commissioners’ statutory accounting practices been followed. The following table presents Essent Guaranty’s and Essent PA’s statutory net income, statutory surplus and contingency reserve liability as of and for the three months ended March 31:

(In thousands)	2023		2022
Essent Guaranty
Statutory net income	$	123,936	$	200,277
Statutory surplus	992,134		1,081,986
Contingency reserve liability	2,105,708		1,862,482
Essent PA
Statutory net (loss) income	$	(112)	$	859
Statutory surplus	53,138		56,910
Contingency reserve liability	56,101		57,461

Net income determined in accordance with statutory accounting practices differs from GAAP. In 2023 and 2022, the more significant differences between net income determined under statutory accounting practices and GAAP for Essent Guaranty and Essent PA relate to policy acquisition costs and income taxes. Under statutory accounting practices, policy acquisition costs are expensed as incurred while such costs are capitalized and amortized to expense over the life of the policy under GAAP. We are eligible for a tax deduction, subject to certain limitations for amounts required by state law or regulation to be set aside in statutory contingency reserves when we purchase non-interest-bearing United States Mortgage Guaranty Tax and Loss Bonds (“T&L Bonds”) issued by the Treasury Department. Under statutory accounting practices, this deduction reduces the tax provision recorded by Essent Guaranty and Essent PA and, as a result, increases statutory net income and surplus as compared to net income and equity determined in accordance with GAAP.

At March 31, 2023 and 2022, the statutory capital of our U.S. insurance subsidiaries, which is defined as the total of statutory surplus and contingency reserves, was in excess of the statutory capital necessary to satisfy their regulatory requirements.

Effective December 31, 2015, Fannie Mae and Freddie Mac, at the direction of the Federal Housing Finance Agency, implemented new coordinated Private Mortgage Insurer Eligibility Requirements, which we refer to as the "PMIERs." The PMIERs represent the standards by which private mortgage insurers are eligible to provide mortgage insurance on loans owned or guaranteed by Fannie Mae and Freddie Mac. The PMIERs include financial strength requirements incorporating a risk-based framework that require approved insurers to have a sufficient level of liquid assets from which to pay claims. The PMIERs also include enhanced operational performance expectations and define remedial actions that apply should an approved insurer fail to comply with these requirements. In 2018, the GSEs released revised PMIERs framework ("PMIERs 2.0") which became effective on March 31, 2019. As of March 31, 2023, Essent Guaranty, our GSE-approved mortgage insurance company, was in compliance with PMIERs 2.0.

Statement of Statutory Accounting Principles No. 58, Mortgage Guaranty Insurance, requires mortgage insurers to establish a special contingency reserve for statutory accounting purposes included in total liabilities equal to 50% of earned premium for that year. This reserve is required to be maintained for a period of 120 months to protect against the effects of adverse economic cycles. After 120 months, the reserve is released to unassigned funds. In the event an insurer’s loss ratio in any calendar year exceeds 35%, however, the insurer may, after regulatory approval, release from its contingency reserves an amount equal to the excess portion of such losses. During the three months ended March 31, 2023, Essent Guaranty increased its contingency reserve by $57.0 million and Essent PA decreased its contingency reserve by $0.6 million. During the three months ended March 31, 2023 and 2022, Essent Guaranty released contingency reserves of $9.8 million and $2.6 million,

23

Essent Group Ltd. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited)

respectively, and Essent PA released contingency reserves of $0.8 million and $0.2 million, respectively, to unassigned funds upon completion of the 120 month holding period.

Under The Insurance Act 1978, as amended, and related regulations of Bermuda (the "Insurance Act"), Essent Re is required to annually prepare statutory financial statements and a statutory financial return in accordance with the financial reporting provisions of the Insurance Act, which is a basis other than GAAP. The Insurance Act also requires that Essent Re maintain minimum share capital of $1 million and must ensure that the value of its general business assets exceeds the amount of its general business liabilities by an amount greater than the prescribed minimum solvency margins and enhanced capital requirement pertaining to its general business. At December 31, 2022, all such requirements were met.

Essent Re's statutory capital and surplus was $1.6 billion as of March 31, 2023 and $1.5 billion as of December 31, 2022. Essent Re's statutory net income was $72.6 million and $89.6 million for the three months ended March 31, 2023 and 2022, respectively. Statutory capital and surplus as of March 31, 2023 and December 31, 2022 and statutory net income in the three months ended March 31, 2023 and 2022 determined in accordance with statutory accounting practices were not significantly different than the amounts determined under GAAP.

24

Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion should be read together with the “Selected Financial Data” and our audited consolidated financial statements and related notes included in our Annual Report on Form 10-K as of and for the year ended December 31, 2022 as filed with the Securities and Exchange Commission and referred to herein as the “Annual Report,” and our condensed consolidated financial statements and related notes as of and for the three months ended March 31, 2023 included in Part I, Item 1 of this Quarterly Report on Form 10-Q, which we refer to as the “Quarterly Report.” In addition to historical information, this discussion contains forward-looking statements that involve risks, uncertainties and assumptions that could cause actual results to differ materially from management’s expectations. Factors that could cause such differences are discussed in the sections entitled “Special Note Regarding Forward-Looking Statements” in this Quarterly Report and Part I, Item 1A “Risk Factors” in our Annual Report and Part II, Item 1A “Risk Factors” in this Quarterly Report. We are not undertaking any obligation to update any forward-looking statements or other statements we may make in the following discussion or elsewhere in this document even though these statements may be affected by events or circumstances occurring after the forward-looking statements or other statements were made.

Overview

We are an established private mortgage insurance company. Essent Guaranty, Inc., our wholly-owned insurance subsidiary which we refer to as "Essent Guaranty," is licensed to write coverage in all 50 states and the District of Columbia. The financial strength ratings of Essent Guaranty are A3 with a stable outlook by Moody’s Investors Service (“Moody's”), BBB+ with a stable outlook by S&P Global Ratings (“S&P”) and A (Excellent) with a stable outlook by A.M. Best.

Our holding company is domiciled in Bermuda and our U.S. insurance business is headquartered in Radnor, Pennsylvania. We operate an additional underwriting and service center in Winston-Salem, North Carolina. We have a highly experienced, talented team with 337 employees as of March 31, 2023. We generated new insurance written, or NIW, of approximately $12.9 billion and $12.8 billion for the three months ended March 31, 2023 and 2022, respectively. As of March 31, 2023, we had approximately $231.5 billion of insurance in force.

We also offer mortgage-related insurance and reinsurance through our wholly-owned Bermuda-based subsidiary, Essent Reinsurance Ltd., which we refer to as "Essent Re." As of March 31, 2023, Essent Re provided insurance or reinsurance relating to GSE risk share and other reinsurance transactions covering approximately $2.1 billion of risk. Essent Re also reinsures Essent Guaranty’s NIW under a quota share reinsurance agreement. In April 2021, Essent Guaranty and Essent Re agreed to increase the quota share reinsurance coverage of Essent Guaranty’s NIW provided by Essent Re from 25% to 35% effective January 1, 2021. The quota share reinsurance coverage provided by Essent Re for Essent Guaranty’s NIW prior to January 1, 2021 will continue to be 25%, the quota share percentage in effect at the time NIW was first ceded. The insurer financial strength ratings of Essent Re are BBB+ with a stable outlook by S&P and A (Excellent) with a stable outlook by A.M. Best

COVID-19

Due to the novel coronavirus disease 2019 ("COVID-19"), we experienced a significant increase in the amount of new defaults reported in 2020, especially during the second and third quarters of 2020. We segmented these two quarters’ 49,398 defaults as specifically COVID-19 related (“Early COVID Defaults”) and provided losses for these two cohorts differently as compared to our normal loss reserving methodology. The default-to-claim transition patterns of the Early COVID Defaults have been different than our historical defaults. We believe that the borrowers associated with the Early COVID Defaults have been able to take advantage of foreclosure moratoriums and mortgage forbearance programs instituted by Federal legislation along with actions taken by the Federal Housing Finance Agency (“FHFA”), Fannie Mae and Freddie Mac (collectively the “GSEs”) which has extend traditional default-to-claim timelines. As a result of these programs, along with Federal stimulus, these borrowers associated with the Early COVID Defaults have had more resources and an extended time period to address the issues that triggered the default, that we believe will result in a higher cure rate, and correspondingly lower claim payments than historical defaults.

    Over 90% of loans insured by Essent are federally backed by Fannie Mae or Freddie Mac. As a mortgage loan in forbearance is considered delinquent, we will provide loss reserves as loans in forbearance are reported to us as delinquent once the borrower has missed two consecutive payments. However, we believe providing borrowers time to recover from the adverse financial impact of the COVID-19 event may allow some families to be able to remain in their homes and avoid foreclosure.

As of March 31, 2023, approximately 99% of the Early COVID Defaults had cured. While this level of cure activity exceeded our initial expectations for the Early COVID Defaults, the transition of defaults to foreclosure or claim has not

25

returned to pre-pandemic levels. As a result, the level of defaults in the default inventory that have missed twelve or more payments is above pre-pandemic levels.

Current Economic Developments

The economy in the United States is currently experiencing elevated levels of consumer price inflation. The Federal Reserve has increased the target federal funds rate several times during 2022 and 2023 in an effort to reduce consumer price inflation. These rate increases have resulted in higher mortgage interest rates which may lower home sale activity and affect the options available to delinquent borrowers. The impact on our reserves in future periods will be dependent upon the amount of delinquent notices received from loan servicers and our expectations for the amount of ultimate losses on these delinquencies. As noted in “— Liquidity and Capital Resources,” Essent had substantial liquidity and had Available Assets in excess of Minimum Required Assets under PMIERs 2.0 as of March 31, 2023. Future increases in defaults may result in an increase in our provisions for loss and loss adjustment expenses compared to prior periods, reduced profit commission under our quota share reinsurance agreements with panels of third-party reinsurers ("the QSR Agreements") and an increase in our Minimum Required Assets.

Legislative and Regulatory Developments

Our results are significantly impacted by, and our future success may be affected by, legislative and regulatory developments affecting the housing finance industry. See Part I, Item 1 “Business—Regulation” and Part II, Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Legislative and Regulatory Developments” in our Annual Report for a discussion of the laws and regulations to which we are subject as well as legislative and regulatory developments affecting the housing finance industry.

    The U.S. Internal Revenue Service and Department of the Treasury published both final and newly proposed regulations in January 2021 relating to the tax treatment of passive foreign investment companies ("PFICs"). The final regulations provide guidance on various PFIC rules, including changes resulting from the 2017 Tax Cuts and Jobs Act. In addition, the Company is evaluating the potential impact of the newly proposed PFIC regulations to its shareholders and business operations. The newly proposed regulations, among other provisions, set a limit on the amount of assets that may be deemed “non-passive assets” within the PFIC asset test of a foreign holding company.

On August 16, 2022, the “Inflation Reduction Act of 2022” (“IRA”), was enacted, which, among other things, provides for a corporate alternative minimum tax and an excise tax on corporate stock repurchases. Based on our current analysis of the provisions, we do not expect the IRA to have a material impact on our financial position or results of operations. As the IRS issues additional guidance related to the IRA, we will evaluate any potential impact to our consolidated financial statements.

The SEC issued a proposed rule in January 2023 that, among other things, prohibits certain participants in an asset-backed security, including a synthetic asset-backed security (synthetic ABS), from engaging in transactions that would involve or result in any material conflict of interest with respect to any investor in a transaction arising out of such activity (conflicted transaction). The definition of conflicted transactions is broadly defined and synthetic ABS could be broadly interpreted to include mortgage insurance linked notes (“ILNs”). If this SEC proposal is adopted as proposed, it could affect or prohibit our ability to enter into reinsurance transactions using ILNs. We are assessing the potential impact of the rule on future ILN reinsurance transactions if the rule is adopted as proposed.

Factors Affecting Our Results of Operations

Net Premiums Written and Earned

Premiums associated with our U.S. mortgage insurance business are based on insurance in force, or IIF, during all or a portion of a period. A change in the average IIF during a period causes premiums to increase or decrease as compared to prior periods. Average net premium rates in effect during a given period will also cause premiums to differ when compared to earlier periods. IIF at the end of a reporting period is a function of the IIF at the beginning of such reporting period plus NIW less policy cancellations (including claims paid) during the period. As a result, premiums are generally influenced by:

•NIW, which is the aggregate principal amount of the new mortgages that are insured during a period. Many factors affect NIW, including, among others, the volume of low down payment home mortgage originations, the competition to provide credit enhancement on those mortgages, the number of customers who have approved us to provide mortgage insurance and changes in our NIW from certain customers;

26

•Cancellations of our insurance policies, which are impacted by payments on mortgages, home price appreciation, or refinancings, which in turn are affected by mortgage interest rates. Cancellations are also impacted by the levels of claim payments and rescissions;

•Premium rates, which represent the amount of the premium due as a percentage of IIF. Premium rates are based on the risk characteristics of the loans insured, the percentage of coverage on the loans, competition from other mortgage insurers and general industry conditions; and

•Premiums ceded or assumed under reinsurance arrangements. See Note 4 to our condensed consolidated financial statements.

Premiums are paid either on a monthly installment basis (“monthly premiums”), in a single payment at origination (“single premiums”), or in some cases as an annual premium. For monthly premiums, we receive a monthly premium payment which is recorded as net premiums earned in the month the coverage is provided. Monthly premium payments are based on the original mortgage amount rather than the amortized loan balance. Net premiums written may be in excess of net premiums earned due to single premium policies. For single premiums, we receive a single premium payment at origination, which is recorded as “unearned premium” and earned over the estimated life of the policy, which ranges from 36 to 156 months depending on the term of the underlying mortgage and loan-to-value ratio at date of origination. If single premium policies are cancelled due to repayment of the underlying loan and the premium is non-refundable, the remaining unearned premium balance is immediately recognized as earned premium revenue. Substantially all of our single premium policies in force as of March 31, 2023 were non-refundable. Premiums collected on annual policies are recognized as net premiums earned on a straight-line basis over the year of coverage. For the three months ended March 31, 2023 and 2022, monthly premium policies comprised 96% and 98% of our NIW, respectively.

Premiums associated with our GSE and other risk share transactions are based on the level of risk in force and premium rates on the transactions.

Persistency and Business Mix

The percentage of IIF that remains on our books after any 12-month period is defined as our persistency rate. Because our insurance premiums are earned over the life of a policy, higher persistency rates can have a significant impact on our profitability. The persistency rate on our portfolio was 84.4% at March 31, 2023. Generally, higher prepayment speeds lead to lower persistency.

 Prepayment speeds and the relative mix of business between single premium policies and monthly premium policies also impact our profitability. Our premium rates include certain assumptions regarding repayment or prepayment speeds of the mortgages. Because premiums are paid at origination on single premium policies, assuming all other factors remain constant, if loans are prepaid earlier than expected, our profitability on these loans is likely to increase and, if loans are repaid slower than expected, our profitability on these loans is likely to decrease. By contrast, if monthly premium loans are repaid earlier than anticipated, our premium earned with respect to those loans and therefore our profitability declines. Currently, the expected return on single premium policies is less than the expected return on monthly policies.

Net Investment Income

Our investment portfolio was predominantly comprised of investment-grade fixed income securities and money market funds as of March 31, 2023. The principal factors that influence investment income are the size of the investment portfolio and the yield on individual securities. As measured by amortized cost (which excludes changes in fair market value, such as from changes in interest rates), the size of our investment portfolio is mainly a function of increases in capital and cash generated from or used in operations which is impacted by net premiums received, investment earnings, net claim payments and expenses. Realized gains and losses are a function of the difference between the amount received on the sale of a security and the security’s amortized cost, as well as any provision for credit losses or impairments recognized in earnings. The amount received on the sale of fixed income securities is affected by the coupon rate of the security compared to the yield of comparable securities at the time of sale.

Income from Other Invested Assets

As part of our overall investment strategy, we also allocate a relatively small percentage of our portfolio to limited partnership investments in real estate, consumer credit and traditional venture capital and private equity investments. The

27

results of these investing activities are reported in income from other invested assets. These investments are generally accounted for under the equity method or fair value using net asset value (or its equivalent) as a practical expedient. For entities accounted for under the equity method that follow industry-specific guidance for investment companies, our proportionate share of earnings or losses includes changes in the fair value of the underlying assets of these entities. Fluctuations in the fair value of these entities may increase the volatility of the Company’s reported results of operations.

Other Income

Other income includes revenues associated with contract underwriting services and underwriting consulting services to third-party reinsurers. The level of contract underwriting revenue is dependent upon the number of customers who have engaged us for this service and the number of loans underwritten for these customers. Revenue from underwriting consulting services to third-party reinsurers is dependent upon the number of customers who have engaged us for this service and the level of premiums associated with the transactions underwritten for these customers.

In connection with the acquisition of our mortgage insurance platform, we entered into a services agreement with Triad Guaranty Inc. and its wholly-owned subsidiary, Triad Guaranty Insurance Corporation, which we refer to collectively as “Triad,” to provide certain information technology maintenance and development and customer support-related services. In return for these services, we receive a flat monthly fee which is recorded in other income. During 2022, Triad exercised its one year renewal option extending the services agreement through November 2023.

    As more fully described in Note 4 to our condensed consolidated financial statements, the premiums ceded under certain reinsurance contracts with unaffiliated third parties varies based on changes in market interest rates. Under GAAP, these contracts contain embedded derivatives that are accounted for separately as freestanding derivatives. The change in the fair value of the embedded derivatives is reported in earnings and included in other income.

Provision for Losses and Loss Adjustment Expenses

The provision for losses and loss adjustment expenses reflects the current expense that is recorded within a particular period to reflect actual and estimated loss payments that we believe will ultimately be made as a result of insured loans that are in default.

Losses incurred are generally affected by:

•the overall state of the economy, which broadly affects the likelihood that borrowers may default on their loans and have the ability to cure such defaults;

•changes in housing values, which affect our ability to mitigate our losses through the sale of properties with loans in default as well as borrower willingness to continue to make mortgage payments when the value of the home is below or perceived to be below the mortgage balance;

•the product mix of IIF, with loans having higher risk characteristics generally resulting in higher defaults and claims;

•the size of loans insured, with higher average loan amounts tending to increase losses incurred;

•the loan-to-value ratio, with higher average loan-to-value ratios tending to increase losses incurred;

•the percentage of coverage on insured loans, with deeper average coverage tending to increase losses incurred;

•credit quality of borrowers, including higher debt-to-income ratios and lower FICO scores, which tend to increase incurred losses;

•the level and amount of reinsurance coverage maintained with third parties;

•the rate at which we rescind policies. Because of tighter underwriting standards generally in the mortgage lending industry and terms set forth in our master policy, we expect that our level of rescission activity will be lower than rescission activity seen in the mortgage insurance industry for vintages originated prior to the financial crisis; and

•the distribution of claims over the life of a book. As of March 31, 2023, 61% of our IIF relates to business written since January 1, 2021 and was less than three years old. As a result, based on historical industry performance, we

28

expect the number of defaults and claims we experience, as well as our provision for losses and loss adjustment expenses ("LAE"), to increase as our portfolio seasons. See “— Mortgage Insurance Earnings and Cash Flow Cycle” below.

We establish loss reserves for delinquent loans when we are notified that a borrower has missed at least two consecutive monthly payments (“Case Reserves”), as well as estimated reserves for defaults that may have occurred but not yet been reported to us (“IBNR Reserves”). We also establish reserves for the associated loss adjustment expenses, consisting of the estimated cost of the claims administration process, including legal and other fees. Using both internal and external information, we establish our reserves based on the likelihood that a default will reach claim status and estimated claim severity. See Part II, Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies” included in our Annual Report for further information.

Based upon our experience and industry data, claims incidence for mortgage insurance is generally highest in the third through sixth years after loan origination. Claims incidence for defaults associated with COVID-19 may not follow this pattern. As of March 31, 2023, 61% of our IIF relates to business written since January 1, 2021 and was less than three years old. Although the claims experience on new insurance written by us to date has been favorable, we expect incurred losses and claims to increase as a greater amount of this book of insurance reaches its anticipated period of highest claim frequency. The actual default rate and the average reserve per default that we experience as our portfolio matures is difficult to predict and is dependent on the specific characteristics of our current in-force book (including the credit score of the borrower, the loan-to-value ratio of the mortgage, geographic concentrations, etc.), as well as the profile of new business we write in the future. In addition, the default rate and the average reserve per default will be affected by future macroeconomic factors such as housing prices, interest rates and employment.

Due to business restrictions, stay-at-home orders and travel restrictions initially implemented in March 2020 as a result of COVID-19, unemployment in the United States increased significantly in the second quarter of 2020, declining during the second half of 2020 through 2022. As unemployment is one of the most common reasons for borrowers to default on their mortgage, the increase in unemployment has increased the number of delinquencies on the mortgages we insure, and has the potential to increase claim frequencies on defaults. As a result, we received 36,784 defaults in the three months ended June 30, 2020 and 12,614 defaults in the three months ended September 30, 2020, which resulted in a significant increase in our default rate from 0.83% at March 31, 2020 to 4.54% at September 30, 2020.

In response to the COVID-19 pandemic, the United States government enacted a number of policies to provide fiscal stimulus to the economy and relief to those affected by this global disaster. Specifically, mortgage forbearance programs and foreclosure moratoriums were instituted by Federal legislation along with actions taken by FHFA and the GSEs. The mortgage forbearance plans permit these borrowers to temporarily reduce or suspend their mortgage payments for up to 18 months for loans in an active COVID-19-related forbearance program as of February 28, 2021. For borrowers that have the ability to begin to pay their mortgage at the end of the forbearance period, we expect that mortgage servicers will continue to work with them to modify their loans at which time the mortgage will be removed from delinquency status. We believe that the forbearance process could have a favorable effect on the frequency of claims that we ultimately pay. Based on the forbearance programs in place and the credit characteristics of the Early COVID Defaults, we believe that the ultimate number of Early COVID Defaults that result in claims will be less than our historical default-to-claim experience. Accordingly, we applied a lower reserve rate to the Early COVID Defaults than the rate used for defaults that had missed a comparable number of payments as of March 31, 2020 and in prior periods that did not have access to forbearance plans.

The defaulted loans reported to us in the second and third quarters of 2020 had reached the end of their forbearance periods as of March 31, 2022. During the first quarter of 2022, the Early COVID Defaults cured at elevated levels, and the cumulative cure rate for the Early COVID Defaults at March 31, 2022 exceeded our initial estimated cure rate implied by our estimate of ultimate loss for these defaults established at the onset of the pandemic. Based on cure activity through March 31, 2022 and our expectations for future cure activity, as of March 31, 2022, we lowered our estimate of ultimate loss for the Early COVID Defaults. During the three months ended June 30, 2022, Early COVID Defaults cured at levels that exceeded our estimate as of March 31, 2022, and we further lowered our estimate of loss for these defaults as of June 30, 2022 to 2% of the initial risk in force. These revisions to our estimate of ultimate loss for the Early COVID Defaults resulted in a benefit recorded to the provision for losses of $164.1 million for the year ended December 31, 2022. Due to the level of Early COVID Defaults remaining in the default inventory, beginning in the third quarter of 2022, we resumed reserving for the Early COVID Defaults using our normal reserve methodology. While the level of cure activity for the Early COVID Defaults exceeded our initial expectations, the transition of defaults to foreclosure or claim has not returned to pre-pandemic levels as of March 31, 2023. As a result, the level of defaults in the default inventory that have missed twelve or more payments is above pre-pandemic levels.

29

The economy in the United States is currently experiencing elevated levels of consumer price inflation. The Federal Reserve has increased the target federal funds rate several times during 2022 and 2023 in an effort to reduce consumer price inflation. These rate increases have resulted in higher mortgage interest rates which may lower home sale activity and affect the options available to delinquent borrowers. It is reasonably possible that our estimate of losses could change in the near term as a result of changes in the economic environment, the impact of elevated levels of consumer price inflation on home sale activity, housing inventory, and home prices.

As more fully described in Note 4 to our condensed consolidated financial statements, at March 31, 2023, we had approximately $2.1 billion of excess of loss reinsurance covering NIW from January 1, 2017 to December 31, 2022 and a quota share reinsurance on portions of our NIW effective September 1, 2019 through December 31, 2020 and January 1, 2022 through December 31, 2023. The impact on our reserves in future periods will be dependent upon the amount of delinquent notices received from loan servicers, the performance of defaults and our expectations for the amount of ultimate losses on these delinquencies.

Third-Party Reinsurance

We use third-party reinsurance to provide protection against adverse loss experience and to expand our capital sources. When we enter into a reinsurance agreement, the reinsurer receives a premium and, in exchange, agrees to insure an agreed upon portion of incurred losses. These arrangements have the impact of reducing our earned premiums, but also reduce our risk in force ("RIF"), which provides capital relief, and may include capital relief under the PMIERs financial strength requirements. Our incurred losses are reduced by any incurred losses ceded in accordance with the reinsurance agreement. For additional information regarding reinsurance, see Note 4 to our condensed consolidated financial statements.

Other Underwriting and Operating Expenses

Our other underwriting and operating expenses include components that are substantially fixed, as well as expenses that generally increase or decrease in line with the level of NIW.

Our most significant expense is compensation and benefits for our employees, which represented 55% of other underwriting and operating expenses for the three months ended March 31, 2023, compared to 61% of other underwriting and operating expenses for the three months ended March 31, 2022. Compensation and benefits expense includes base and incentive cash compensation, stock compensation expense, benefits and payroll taxes.

Underwriting and other expenses include legal, consulting, other professional fees, premium taxes, travel, entertainment, marketing, licensing, supplies, hardware, software, rent, utilities, depreciation and amortization and other expenses. We anticipate that as we continue to add new customers and increase our IIF, our expenses will also continue to increase.

Interest Expense

Interest expense is incurred as a result of borrowings under our secured credit facility (the “Credit Facility”). Borrowings under the Credit Facility may be used for working capital and general corporate purposes, including, without limitation, capital contributions to Essent’s insurance and reinsurance subsidiaries. Borrowings accrue interest at a floating rate tied to a standard short-term borrowing index, selected at the Company’s option, plus an applicable margin.

Income Taxes

Income taxes are incurred based on the amount of earnings or losses generated in the jurisdictions in which we operate and the applicable tax rates and regulations in those jurisdictions. Our U.S. insurance subsidiaries are generally not subject to income taxes in most states in which we operate; however, our non-insurance subsidiaries are subject to state income taxes. In lieu of state income taxes, our insurance subsidiaries pay premium taxes that are recorded in other underwriting and operating expenses.

Essent Group Ltd. ("Essent Group") and its wholly-owned subsidiary, Essent Re, are domiciled in Bermuda, which does not have a corporate income tax. Under a quota share reinsurance agreement, Essent Re reinsures 25% of Essent Guaranty’s NIW through December 31, 2020 and 35% of Essent Guaranty’s NIW after December 31, 2020. Essent Re also provides insurance and reinsurance to Freddie Mac and Fannie Mae.

30

The amount of income tax expense or benefit recorded in future periods will be dependent on the jurisdictions in which we operate and the tax laws and regulations in effect.

Mortgage Insurance Earnings and Cash Flow Cycle

In general, the majority of any underwriting profit (premium revenue minus losses) that a book generates occurs in the early years of the book, with the largest portion of any underwriting profit realized in the first year. Subsequent years of a book generally result in modest underwriting profit or underwriting losses. This pattern generally occurs because relatively few of the claims that a book will ultimately experience typically occur in the first few years of the book, when premium revenue is highest, while subsequent years are affected by declining premium revenues, as the number of insured loans decreases (primarily due to loan prepayments), and by increasing losses.

Key Performance Indicators

Insurance In Force

As discussed above, premiums we collect and earn are generated based on our IIF, which is a function of our NIW and cancellations. The following table includes a summary of the change in our IIF for the three months ended March 31, 2023 and 2022 for our U.S. mortgage insurance portfolio. In addition, this table includes our RIF at the end of each period.

	Three Months Ended March 31,
(In thousands)	2023		2022
IIF, beginning of period	$	227,062,055	$	207,190,544
NIW - Flow	12,893,789		12,841,482
Cancellations	(8,418,429)		(13,189,030)
IIF, end of period	$	231,537,415	$	206,842,996
Average IIF during the period	$	228,885,174	$	206,631,135
RIF, end of period	$	51,469,312	$	45,261,164

The following is a summary of our IIF at March 31, 2023 by vintage:

($ in thousands)	$		%
2023 (through March 31)	12,813,737		5.5	%
2022	59,703,096		25.8	%
2021	69,593,624		30.1
2020	55,661,138		24.0
2019	14,135,010		6.1
2018	6,439,876		2.8
2017 and prior	13,190,936		5.7
	$	231,537,417	100.0	%

Average Net Premium Rate

Our average net premium rate is calculated by dividing net premiums earned for the U.S. mortgage insurance portfolio by average insurance in force for the period and is dependent on a number of factors, including: (1) the risk characteristics and average coverage on the mortgages we insure; (2) the mix of monthly premiums compared to single premiums in our portfolio; (3) cancellations of non-refundable single premiums during the period; (4) changes to our pricing for NIW; and (5) premiums ceded under third-party reinsurance agreements. The following table presents the average net premium rate for our U.S. mortgage insurance portfolio:

31

	Three Months Ended March 31,
	2023		2022
Base average premium rate	0.40	%	0.41	%
Single premium cancellations	—		0.02
Gross average premium rate	0.40		0.43
Ceded premiums	(0.06)		(0.04)
Net average premium rate	0.34	%	0.39	%

We anticipate that the continued use of third-party reinsurance along with changes to the level of future cancellations of non-refundable single premium policies and mix of IIF will reduce our average net premium rate in future periods.

Persistency Rate

The measure for assessing the impact of policy cancellations on IIF is our persistency rate, defined as the percentage of IIF that remains on our books after any twelve-month period. See additional discussion regarding the impact of the persistency rate on our performance in “— Factors Affecting Our Results of Operations — Persistency and Business Mix.”

Risk-to-Capital

The risk-to-capital ratio has historically been used as a measure of capital adequacy in the U.S. mortgage insurance industry and is calculated as a ratio of net risk in force to statutory capital. Net risk in force represents total risk in force net of reinsurance ceded and net of exposures on policies for which loss reserves have been established. Statutory capital for our U.S. insurance companies is computed based on accounting practices prescribed or permitted by the Pennsylvania Insurance Department. See additional discussion in “— Liquidity and Capital Resources — Insurance Company Capital.”

As of March 31, 2023, our combined net risk in force for our U.S. insurance companies was $33.0 billion and our combined statutory capital was $3.2 billion, resulting in a risk-to-capital ratio of 10.3 to 1. The amount of capital required varies in each jurisdiction in which we operate; however, generally, the maximum permitted risk-to-capital ratio is 25.0 to 1. State insurance regulators are currently examining their respective capital rules to determine whether, in light of the financial crisis, changes are needed to more accurately assess mortgage insurers’ ability to withstand stressful economic conditions. As a result, the capital metrics under which they assess and measure capital adequacy may change in the future. Independent of the state regulator and GSE capital requirements, management continually assesses the risk of our insurance portfolio and current market and economic conditions to determine the appropriate levels of capital to support our business.

32

Results of Operations

The following table sets forth our results of operations for the periods indicated:

Summary of Operations	Three Months Ended March 31,
(In thousands)	2023		2022
Revenues:
Net premiums written	$	205,900	$	199,731
Decrease in unearned premiums	5,358		15,599
Net premiums earned	211,258		215,330
Net investment income	43,236		24,680
Realized investment losses, net	(488)		(7,352)
(Loss) income from other invested assets	(2,702)		24,705
Other income	4,942		7,248
Total revenues	256,246		264,611
Losses and expenses:
(Benefit) provision for losses and LAE	(180)		(106,858)
Other underwriting and operating expenses	48,195		40,796
Interest expense	6,936		2,226
Total losses and expenses	54,951		(63,836)
Income before income taxes	201,295		328,447
Income tax expense	30,468		54,280
Net income	$	170,827	$	274,167

Three Months Ended March 31, 2023 Compared to the Three Months Ended March 31, 2022

For the three months ended March 31, 2023, we reported net income of $170.8 million, compared to net income of $274.2 million for the three months ended March 31, 2022. The decrease in our operating results in 2023 over the same period in 2022 was primarily due to increases in the provision for losses and LAE, and other operating and underwriting expenses, as well as a decrease in income from other invested assets, partially offset by an increase in net investment income and a decrease in income taxes.

Net Premiums Written and Earned

Net premiums earned decreased in the three months ended March 31, 2023 by 2%, compared to the three months ended March 31, 2022 primarily due to the decrease in the average net premium rate, partially offset by increase in our average IIF from $206.6 billion at March 31, 2022 to $228.9 billion at March 31, 2023. The average net premium rate was 0.34% and 0.39% for the three months ended March 31, 2023 and 2022, respectively. See "—Key Performance Indicators—Average Net Premium Rate" above. In the three months ended March 31, 2023, premiums earned on the cancellation of non-refundable single premium policies decreased to $1.8 million from $9.1 million in the three months ended March 31, 2022 as a result of a decrease in existing borrowers refinancing their mortgages 2023 compared to the same period in 2022. In the three months ended March 31, 2023, ceded premiums increased to $33.6 million from $20.5 million in the three months ended March 31, 2022 due to a reduction in loss reserves ceded under our QSR Agreement that reduced ceded premium as well as additional risk ceded under our QSR Agreements and new third-party reinsurance agreements entered in 2022.

Net premiums written increased by 3% in the three months ended March 31, 2023 compared to the three months ended March 31, 2022 primarily due to an increase in average IIF in the three months ended March 31, 2023 compared to the same period in 2022, partially offset by an increase in premiums ceded under third-party reinsurance agreements, changes in the mix of mortgages we insure and changes in our pricing.

In the three months ended March 31, 2023 and 2022, unearned premiums decreased by $5.4 million and $15.6 million, respectively. The change in unearned premiums was a result of net premiums written on single premium policies of $6.9

33

million and $4.1 million, respectively, which was offset by $12.3 million and $19.7 million, respectively, of unearned premium that was recognized in earnings during the periods.

Net Investment Income

Our net investment income was derived from the following sources for the periods indicated:

	Three Months Ended March 31,
(In thousands)	2023		2022
Fixed maturities	$	43,473	$	26,223
Short-term investments	1,721		44
Gross investment income	45,194		26,267
Investment expenses	(1,958)		(1,587)
Net investment income	$	43,236	$	24,680

The increase in net investment income for the three months ended March 31, 2023 as compared to the same period in 2022 was due to an increase in the pre-tax investment income yield and an increase in the weighted average balance of our investment portfolio. The pre-tax investment income yield increased from 2.1% in the three months ended March 31, 2022 to 3.4% in the three months ended March 31, 2023 primarily due to a general increase in investment yields due to rising interest rates. The pre-tax investment income yields are calculated based on amortized cost and exclude investment expenses. The average cash and investment portfolio balance increased to $5.3 billion for the three months ended March 31, 2023 from $5.0 billion for the three months ended March 31, 2022 primarily due to investing cash flows from operations. See “— Liquidity and Capital Resources” for further details of our investment portfolio.

Income from Other Invested Assets

Income from other invested assets for the three months ended March 31, 2023 was a loss of $2.7 million as compared to a gain of 24.7 million for the three months ended March 31, 2022. The decrease in income from other invested assets was primarily due to lower fair value adjustments recorded during the three months ended March 31, 2023 as compared to the same period in 2022.

Other Income

Other income for the three months ended March 31, 2023 was $4.9 million as compared to $7.2 million for the three months ended March 31, 2022. The decrease in other income for the three months ended March 31, 2023 as compared to the same period in 2022 was primarily due to changes in the fair value of the embedded derivatives contained in certain of our reinsurance agreements. In the three months ended March 31, 2023, we recorded an unfavorable decrease in the fair value of these embedded derivatives of $0.4 million compared to a favorable increase in the fair value of the embedded derivatives of $4.4 million in the three months ended March 31, 2022. Other income also includes Triad service fee income, contract underwriting revenues and underwriting consulting services to third-party reinsurers.

Provision for Losses and Loss Adjustment Expenses

The increase in the provision for losses and LAE in the three months ended March 31, 2023 as compared to the same periods in 2022 was primarily due to a decrease in the estimate of ultimate loss for Early COVID Defaults during the three months ended March 31, 2022 which resulted in a benefit recorded to the provision for losses of $101.2 million. In the three months ended March 31, 2023 we recorded a benefit to the provision for losses of $0.2 million primarily due to cure activity for defaults reported in prior years offset by a provision for losses recorded for current year defaults.

34

The following table presents a rollforward of insured loans in default for our U.S. mortgage insurance portfolio for the periods indicated: 

	Three Months Ended March 31,
	2023	2022
Beginning default inventory	13,433	16,963
Plus: new defaults	7,015	6,188
Less: cures	(7,574)	(8,167)
Less: claims paid	(94)	(55)
Less: rescissions and denials, net	(7)	(6)
Ending default inventory	12,773	14,923

The following table includes additional information about our loans in default as of the dates indicated for our U.S. mortgage insurance portfolio: 

	As of March 31,
	2023			2022
Case reserves (in thousands) (1)	$	199,108		$	270,292
Total reserves (in thousands) (1)	$	215,957		$	292,818
Ending default inventory	12,773			14,923
Average case reserve per default (in thousands)	$	15.6		$	18.1
Average total reserve per default (in thousands)	$	16.9		$	19.6
Default rate	1.57		%	1.93		%
Claims received included in ending default inventory	113			74

(1)The U.S. mortgage insurance portfolio reserves exclude reserves on GSE and other risk share risk in force at Essent Re of $0.1 million and $0.3 million as of March 31, 2023 and 2022, respectively.

The following table provides a reconciliation of the beginning and ending reserve balances for losses and LAE:

	Three Months Ended March 31,
(In thousands)	2023		2022
Reserve for losses and LAE at beginning of period	$	216,464	$	407,445
Less: Reinsurance recoverables	14,618		25,940
Net reserve for losses and LAE at beginning of period	201,846		381,505
Add provision for losses and LAE occurring in:
Current period	32,694		24,369
Prior years	(32,874)		(131,227)
Incurred losses and LAE during the current period	(180)		(106,858)
Deduct payments for losses and LAE occurring in:
Current period	—		1
Prior years	2,001		909
Loss and LAE payments during the current period	2,001		910
Net reserve for losses and LAE at end of period	199,665		273,737
Plus: Reinsurance recoverables	16,357		19,335
Reserve for losses and LAE at end of period	$	216,022	$	293,072

35

The following tables provide a detail of reserves and defaulted RIF by the number of missed payments and pending claims for our U.S. mortgage insurance portfolio:

	As of March 31, 2023
($ in thousands)	Number of Policies in Default	Percentage of Policies in Default		Amount of Reserves		Percentage of Reserves		Defaulted RIF		Reserves as a Percentage of Defaulted RIF
Missed payments:
Three payments or less	5,366	42	%	$	31,080	16	%	$	366,993	8	%
Four to eleven payments	5,106	40		78,125		39		363,299		22
Twelve or more payments	2,188	17		85,517		43		130,520		66
Pending claims	113	1		4,386		2		5,004		88
Total case reserves (1)	12,773	100	%	199,108		100	%	$	865,816	23
IBNR				14,933
LAE				1,916
Total reserves for losses and LAE (1)				$	215,957

(1)The U.S. mortgage insurance portfolio reserves exclude reserves on GSE and other risk share risk in force at Essent Re of $0.1 million as of March 31, 2023.

	As of March 31, 2022
($ in thousands)	Number of Policies in Default	Percentage of Policies in Default		Amount of Reserves		Percentage of Reserves		Defaulted RIF		Reserves as a Percentage of Defaulted RIF
Missed payments:
Three payments or less	4,338	29	%	$	21,348	8	%	$	269,069	8	%
Four to eleven payments	4,971	33		64,332		24		312,976		21
Twelve or more payments	5,540	37		181,859		67		347,926		52
Pending claims	74	1		2,753		1		3,341		82
Total case reserves (2)	14,923	100	%	270,292		100	%	$	933,312	29
IBNR				20,272
LAE				2,254
Total reserves for losses and LAE (2)				$	292,818

(2)The U.S. mortgage insurance portfolio reserves exclude reserves on GSE and other risk share risk in force at Essent Re of $0.3 million as of March 31, 2022.

During the three months ended March 31, 2023, the provision for losses and LAE was a benefit of $0.2 million, comprised of $32.9 million of favorable prior years’ loss development partially offset by a provision of $32.7 million for current year losses. During the three months ended March 31, 2022, the provision for losses and LAE was a benefit of $106.9 million, comprised of $131.2 million of favorable prior years’ loss development partially offset by a provision of $24.4 million for current year losses. In both periods, the prior years’ loss development was the result of a re-estimation of amounts ultimately to be paid on prior year defaults in the default inventory, including the impact of previously identified defaults that cured.

The following table includes additional information about our claims paid and claim severity for the periods indicated:

	Three Months Ended March 31,
($ in thousands)	2023			2022
Number of claims paid	94			55
Amount of claims paid	$	1,959		$	826
Claim severity	59		%	35		%

36

Other Underwriting and Operating Expenses

Following are the components of our other underwriting and operating expenses for the periods indicated:

	Three Months Ended March 31,
	2023				2022
($ in thousands)	$		%		$		%
Compensation and benefits	$	26,629	55	%	$	24,830	61	%
Premium taxes	4,653		10		3,968		10
Other	16,913		35		11,998		29
Total other underwriting and operating expenses	$	48,195	100	%	$	40,796	100	%
Number of employees at end of period			337				347

The significant factors contributing to the change in other underwriting and operating expenses are:

•Compensation and benefits increased in the three months ended March 31, 2023 as compared to the three months ended March 31, 2022 due to increased salaries and wages, increased incentive compensation, and increased stock compensation expense largely due to shares granted in 2023 and 2022. Compensation and benefits includes salaries, wages and bonus, stock compensation expense, benefits and payroll taxes.

•Premium taxes increased primarily due to an increase in our effective premium tax rate.

•Other expenses increased primarily as a result of increases in professional fees and software related expenses partially offset by an increase in ceding commission earned under the QSR Agreement. In the three months ended March 31, 2023, other expenses included approximately $3.4 million of transaction costs associated with the Company's announced title business acquisition. Other expenses include professional fees, travel, marketing, hardware, software, rent, depreciation and amortization and other facilities expenses.

Interest Expense

For each of the three months ended March 31, 2023 and 2022, we incurred interest expense of $6.9 million and $2.2 million, respectively. Interest expense increased due to an increase in the weighted average interest rate for borrowings outstanding. For the three months ended March 31, 2023, the borrowings under the Credit Facility had a weighted average interest rate of 6.28% as compared to 1.85% for the three months ended March 31, 2022. For the three months ended March 31, 2023 and March 31, 2022, the average amount outstanding under the Credit Facility was $425.0 million, respectively.

Income Taxes

Our subsidiaries in the United States file a consolidated U.S. Federal income tax return. Our income tax expense was $30.5 million and $54.3 million for the three months ended March 31, 2023 and 2022, respectively. The provision for income taxes for the three months ended March 31, 2023 was calculated using an estimated annual effective tax rate of 15.1% as compared to an estimated annual effective tax rate of 16.0% for the three months ended March 31, 2022. For the three months ended March 31, 2023, income tax expense includes $0.2 million of discrete tax benefit associated with realized and unrealized losses recognized during the period partially offset by excess tax deficits associated with the vesting of common shares and common share units. For the three months ended March 31, 2022, income tax expense includes $7.0 million of discrete tax expense associated with realized and unrealized gains recognized during the period. The tax effects of discrete items are recognized in the reporting period in which they occur and are not considered in determining the annual effective tax rate.

Liquidity and Capital Resources

Overview

Our sources of funds consist primarily of:

37

•our investment portfolio and interest income on the portfolio;

•net premiums that we will receive from our existing IIF as well as policies that we write in the future;

•borrowings under our Credit Facility; and

•issuance of capital shares.

Our obligations consist primarily of:

•claim payments under our policies;

•interest payments and repayment of borrowings under our Credit Facility;

•the other costs and operating expenses of our business;

•the repurchase of common shares under the share repurchase plan approved by our Board of Directors; and

•the payment of dividends on our common shares.

As of March 31, 2023, we had substantial liquidity with cash of $68.6 million, short-term investments of $347.8 million and fixed maturity investments of $4.6 billion. We also had $400 million available capacity under the revolving credit component of our Credit Facility, with $425 million of borrowings outstanding under our Credit Facility. Borrowings under the Credit Facility contractually mature on December 10, 2026. Holding company net cash and investments available for sale totaled $723.1 million at March 31, 2023. In addition, Essent Guaranty is a member of the Federal Home Loan Bank of Pittsburgh (the “FHLBank”) and has access to secured borrowing capacity with the FHLBank to provide Essent Guaranty with supplemental liquidity. Essent Guaranty had no outstanding borrowings with the FHLBank at March 31, 2023.

Management believes that the Company has sufficient liquidity available both at its holding companies and in its insurance and other operating subsidiaries to meet its operating cash needs and obligations and committed capital expenditures for the next 12 months.

While the Company and all of its subsidiaries are expected to have sufficient liquidity to meet all their expected obligations, additional capital may be required to meet any new capital requirements that are adopted by regulatory authorities or the GSEs, to respond to changes in the business or economic environment, to provide additional capital related to the growth of our risk in force in our mortgage insurance portfolio, or to fund new business initiatives. We regularly review potential investments and acquisitions, some of which may be material, that, if consummated, would expand our existing business or result in new lines of business, and at any given time we may be in discussions concerning possible transactions. In February 2023, we announced that Essent US Holdings, Inc. entered into an agreement to acquire the title insurance operations of a subsidiary of Finance of America Companies for $100 million. We continually evaluate opportunities based upon market conditions to further increase our financial flexibility through the issuance of equity or debt, or other options including reinsurance or credit risk transfer transactions. There can be no guarantee that any such opportunities will be available on acceptable terms or at all.

    At the operating subsidiary level, liquidity could be impacted by any one of the following factors:

•significant decline in the value of our investments;

•inability to sell investment assets to provide cash to fund operating needs;

•decline in expected revenues generated from operations;

•increase in expected claim payments related to our IIF; or

•increase in operating expenses.

Our U.S. insurance subsidiaries are subject to certain capital and dividend rules and regulations prescribed by jurisdictions in which they are authorized to operate and the GSEs. Under the insurance laws of the Commonwealth of Pennsylvania, the insurance subsidiaries may pay dividends during any twelve-month period in an amount equal to the greater

38

of (i) 10% of the preceding year-end statutory policyholders' surplus or (ii) the preceding year’s statutory net income. The Pennsylvania statute also requires that dividends and other distributions be paid out of positive unassigned surplus without prior approval. At March 31, 2023, Essent Guaranty had unassigned surplus of approximately $286.8 million and Essent PA had unassigned surplus of approximately $14.1 million. As of March 31, 2023, Essent Guaranty and Essent PA could pay additional ordinary dividends in 2023 of $286.8 million and $5.3 million, respectively. Essent Re is subject to certain dividend restrictions as prescribed by the Bermuda Monetary Authority and under certain agreements with counterparties. In connection with a quota share reinsurance agreement with Essent Guaranty, Essent Re has agreed to maintain a minimum total equity of $100 million. As of March 31, 2023, Essent Re had total equity of $1.6 billion. In connection with its insurance and reinsurance activities, Essent Re is required to maintain assets in trusts for the benefit of its contractual counterparties. See Note 3 to our condensed consolidated financial statements. At March 31, 2023, our insurance subsidiaries were in compliance with these rules, regulations and agreements.

Cash Flows

The following table summarizes our consolidated cash flows from operating, investing and financing activities:

	Three Months Ended March 31,
(In thousands)	2023		2022
Net cash provided by operating activities	$	184,789	$	180,629
Net cash (used in) provided by investing activities	(149,342)		38,893
Net cash used in financing activities	(48,054)		(97,168)
Net (decrease) increase in cash	$	(12,607)	$	122,354

Operating Activities

Cash flow provided by operating activities totaled $184.8 million for the three months ended March 31, 2023, as compared to $180.6 million for the three months ended March 31, 2022. The increase in cash flow provided by operating activities was primarily due to an increase in premiums collected.

Investing Activities

Cash flow used in investing activities totaled $149.3 million for three months ended March 31, 2023 compared to $38.9 million provided by investing activities for the three months ended March 31, 2022. Cash flow used in 2023 investing activities related to investing cash flows from operations. Cash flow provided by 2022 investing activities primarily related to proceeds from the sales of investments available for sale associated with targeted repositioning of components of our investment portfolio partially offset by a net increase in short-term investments and purchases of investments available for sale

Financing Activities

Cash flow used in financing activities totaled $48.1 million $97.2 million for the three months ended March 31, 2023 and 2022, respectively, primarily related to the quarterly cash dividends paid, repurchases of common stock under our share repurchase plans and treasury stock acquired from employees to satisfy tax withholding obligations.

Insurance Company Capital

We compute a risk-to-capital ratio for our U.S. insurance companies on a separate company statutory basis, as well as for our combined insurance operations. The risk-to-capital ratio is our net risk in force divided by our statutory capital. Our net risk in force represents risk in force net of reinsurance ceded, if any, and net of exposures on policies for which loss reserves have been established. Statutory capital consists primarily of statutory policyholders’ surplus (which increases as a result of statutory net income and decreases as a result of statutory net loss and dividends paid), plus the statutory contingency reserve. The statutory contingency reserve is reported as a liability on the statutory balance sheet. A mortgage insurance company is required to make annual contributions to the contingency reserve of 50% of net premiums earned. These contributions must generally be maintained for a period of ten years. However, with regulatory approval, a mortgage insurance company may make early withdrawals from the contingency reserve when incurred losses exceed 35% of net premiums earned in a calendar year.

39

During the three months ended March 31, 2023 and 2022, no capital contributions were made to our U.S. insurance subsidiaries and Essent Guaranty paid dividends to Essent US Holdings, Inc. of $90 million and $100 million, respectively.

    Essent Guaranty has entered into reinsurance agreements that provide excess of loss reinsurance coverage for new defaults on portfolios of mortgage insurance policies issued in 2017 through December 31, 2022. The aggregate excess of loss reinsurance coverages decrease over a ten-year period as the underlying covered mortgages amortize. Based on the level of delinquencies reported to us, the insurance-linked note transactions (the "ILNs") that Essent Guaranty has entered into prior to March 31, 2020 became subject to a "trigger event" as of June 25, 2020. The aggregate excess of loss reinsurance coverage will not amortize during the continuation of a trigger event. Radnor Re 2020-1 was no longer subject to a trigger event as of July 25, 2022.

Essent Guaranty has entered into a quota share reinsurance agreement with a panel of third-party reinsurers ("QSR" agreement"). Each of the third-party reinsurers has an insurer minimum financial strength rating of A- or better by S&P Global Ratings, A.M. Best or both. Under each QSR agreement, Essent Guaranty will cede premiums on a percentage of risk on all eligible policies written during a specified period, in exchange for reimbursement of ceded claims and claims expenses on covered policies, a specific ceding commission, as well as a profit commission that varies directly and inversely with ceded claims. These reinsurance coverages also reduces net risk in force and PMIERs Minimum Required Assets. See Note 4 to our condensed consolidated financial statements.

The following tables summarizes Essent Guaranty's QSR agreements as of March 31, 2023:

QSR Agreement	Eligible Policy Period	Ceding Percentage	Ceding Commission	Profit Commission
QSR-2019	September 1, 2019-December 31, 2020	(1)	20%	63%	(2)
QSR-2022	January 1, 2022-December 31, 2022	20%	20%	62%
QSR-2023	January 1, 2023-December 31, 2023	17.5%	20%	58%

_______________________________________________________________________________

(1)Under QSR-2019, Essent Guaranty cedes 40% of premiums on singles policies and 20% on all other policies.

(2)The initial profit commission on QSR-2019 was up to 60%. Since Essent Guaranty did not exercise its option to terminate this QSR agreement on December 31, 2021, the maximum profit commission that Essent Guaranty could earn increased to 63% in 2022 and thereafter.

Our combined risk-to-capital calculation for our U.S. insurance subsidiaries as of March 31, 2023 was as follows:

Combined statutory capital: ($ in thousands)
Policyholders’ surplus	$	2,161,810
Contingency reserves	1,045,292
Combined statutory capital	$	3,207,102
Combined net risk in force	$	33,038,825
Combined risk-to-capital ratio	10.3:1

For additional information regarding regulatory capital, see Note 14 to our condensed consolidated financial statements. Our combined statutory capital equals the sum of statutory capital of Essent Guaranty plus Essent PA, after eliminating the impact of intercompany transactions. The combined risk-to-capital ratio equals the sum of the net risk in force of Essent Guaranty and Essent PA divided by combined statutory capital. The information above has been derived from the annual and quarterly statements of our insurance subsidiaries, which have been prepared in conformity with accounting practices prescribed or permitted by the Pennsylvania Insurance Department and the National Association of Insurance Commissioners Accounting Practices and Procedures Manual. Such practices vary from accounting principles generally accepted in the United States.

Essent Re has entered into GSE and other risk share transactions, including insurance and reinsurance transactions with Freddie Mac and Fannie Mae. Under a quota share reinsurance agreement, Essent Re reinsures 25% of Essent Guaranty’s NIW through December 31, 2020 and 35% of Essent Guaranty’s NIW after December 31, 2020. During the three months ended March 31, 2023 and 2022, Essent Re paid no dividends to Essent Group and Essent Group made no capital contributions to Essent Re. As of March 31, 2023, Essent Re had total stockholders’ equity of $1.6 billion and net risk in force of $20.3 billion.

40

Financial Strength Ratings

The insurer financial strength rating of Essent Guaranty, our principal mortgage insurance subsidiary, is rated A3 with a stable outlook by Moody’s Investors Service (“Moody's”), BBB+ with a stable outlook by S&P and A (Excellent) with stable outlook by A.M. Best. The insurer financial strength rating of Essent Re is BBB+ with a stable outlook by S&P and A (Excellent) with stable outlook by A.M. Best.

Private Mortgage Insurer Eligibility Requirements

Effective December 31, 2015, Fannie Mae and Freddie Mac, at the direction of the FHFA, implemented new coordinated Private Mortgage Insurer Eligibility Requirements, which we refer to as the "PMIERs." The PMIERs represent the standards by which private mortgage insurers are eligible to provide mortgage insurance on loans owned or guaranteed by Fannie Mae and Freddie Mac. The PMIERs include financial strength requirements incorporating a risk-based framework that require approved insurers to have a sufficient level of liquid assets from which to pay claims. This risk-based framework provides that an insurer must hold a substantially higher level of required assets for insured loans that are in default compared to a performing loan. The PMIERs also include enhanced operational performance expectations and define remedial actions that apply should an approved insurer fail to comply with these requirements. In 2018, the GSEs released revised PMIERs framework ("PMIERs 2.0") which became effective on March 31, 2019. As of March 31, 2023, Essent Guaranty, our GSE-approved mortgage insurance company, was in compliance with PMIERs 2.0. As of March 31, 2023, Essent Guaranty's Available Assets were $3.23 billion or 168% of its Minimum Required Assets of $1.92 billion based on our interpretation of PMIERs 2.0.

Under PMIERs guidance issued by the GSEs effective June 30, 2020, Essent will apply a 0.30 multiplier to the risk-based required asset amount factor for each insured loan in default backed by a property located in a Federal Emergency Management Agency (“FEMA”) Declared Major Disaster Area eligible for Individual Assistance and that either 1) is subject to a forbearance plan granted in response to a FEMA Declared Major Disaster, the terms of which are materially consistent with terms of forbearance plans, repayment plans or loan modification trial period offered by Fannie Mae or Freddie Mac, or 2) has an initial missed payment occurring up to either (i) 30 days prior to the first day of the incident period specified in the FEMA Major Disaster Declaration or (ii) 90 days following the last day of the incident period specified in the FEMA Major Disaster Declaration, not to exceed 180 days from the first day of the incident period specified in the FEMA Major Disaster Declaration. In the case of the foregoing, the 0.30 multiplier shall be applied to the risk-based required asset amount factor for a non-performing primary mortgage guaranty insurance loan for no longer than three calendar months beginning with the month the loan becomes a non-performing primary mortgage guaranty insurance loan by reaching two missed monthly payments absent a forbearance plan described in 1) above. Further, under temporary provisions provided by the PMIERs guidance, Essent will apply a 0.30 multiplier to the risk-based required asset amount factor for each insured loan in default backed by a property that has an initial missed payment occurring on or after March 1, 2020 and prior to April 1, 2021 (COVID-19 Crisis Period). The 0.30 multiplier will be applicable for insured loans in default 1) subject to a forbearance plan granted in response to a financial hardship related to COVID-19 (which shall be assumed to be the case for any loan that has an initial missed payment occurring during the COVID-19 Crisis Period and is subject to a forbearance plan, repayment plan or loan modification trial period), the terms of which are materially consistent with terms offered by Fannie Mae or Freddie Mac or 2) for no longer than three calendar months beginning with the month the loan becomes a non-performing primary mortgage guaranty insurance loan by reaching two missed monthly payments.

Financial Condition

Stockholders’ Equity

As of March 31, 2023, stockholders’ equity was $4.65 billion, compared to $4.46 billion as of December 31, 2022. Stockholders' equity increased primarily due to net income generated in 2023 and a decrease in accumulated other comprehensive loss related to a decrease in our net unrealized investment losses, partially offset by dividends paid and the repurchase of common shares under our share repurchase plan.

Investments

As of March 31, 2023, investments totaled $5.2 billion compared to $5.0 billion as of December 31, 2022. In addition, our total cash was $68.6 million as of March 31, 2023, compared to $81.2 million as of December 31, 2022. The increase in investments was primarily due to investing net cash flows from operations during the three months ended March 31, 2023 and a decrease in our net unrealized investment losses.

41

Investments Available for Sale by Asset Class

Asset Class	March 31, 2023				December 31, 2022
($ in thousands)	Fair Value		Percent		Fair Value		Percent
U.S. Treasury securities	$	475,784	9.6	%	$	556,438	11.7	%
U.S. agency securities	12,690		0.3		49,058		1.0
U.S. agency mortgage-backed securities	850,124		17.2		783,743		16.5
Municipal debt securities(1)	609,010		12.3		602,690		12.8
Non-U.S. government securities	63,018		1.3		62,399		1.3
Corporate debt securities(2)	1,462,596		29.5		1,414,321		29.8
Residential and commercial mortgage securities	542,013		10.9		511,824		10.8
Asset-backed securities	648,109		13.1		624,561		13.2
Money market funds	286,692		5.8		136,591		2.9
Total Investments Available for Sale	$	4,950,036	100.0	%	$	4,741,625	100.0	%

	March 31,		December 31,
(1) The following table summarizes municipal debt securities as of :	2023		2022
Special revenue bonds	81.4	%	79.0	%
General obligation bonds	18.5		20.9
Tax allocation bonds	0.1		0.1
Total	100.0	%	100.0	%

	March 31,		December 31,
(2) The following table summarizes corporate debt securities as of :	2023		2022
Financial	40.8	%	40.5	%
Consumer, non-cyclical	18.5		17.9
Consumer, cyclical	7.2		6.8
Industrial	6.7		6.8
Utilities	5.7		6.1
Communications	8.6		8.4
Technology	4.8		4.9
Energy	5.5		6.4
Basic Materials	2.1		2.1
Government	0.1		0.1
Total	100.0	%	100.0	%

42

Investments Available for Sale by Rating

Rating (1)	March 31, 2023				December 31, 2022
($ in thousands)	Fair Value		Percent		Fair Value		Percent
Aaa	$	2,152,791	46.1	%	$	2,122,599	46.2	%
Aa1	106,131		2.3		111,262		2.4
Aa2	329,046		7.1		325,241		7.1
Aa3	233,021		5.0		232,500		5.0
A1	407,348		8.7		396,095		8.6
A2	388,296		8.3		410,163		8.9
A3	281,073		6.0		268,928		5.8
Baa1	246,921		5.3		236,793		5.1
Baa2	245,523		5.3		221,308		4.8
Baa3	175,828		3.8		187,117		4.1
Below Baa3	97,366		2.1		93,028		2.0
Total (2)	$	4,663,344	100.0	%	$	4,605,034	100.0	%

(1)Based on ratings issued by Moody’s, if available. S&P or Fitch Ratings ("Fitch") rating utilized if Moody’s not available.

(2)Excludes $286,692 and $136,591 of money market funds at March 31, 2023 and December 31, 2022, respectively.

Investments Available for Sale by Effective Duration

Effective Duration	March 31, 2023				December 31, 2022
($ in thousands)	Fair Value		Percent		Fair Value		Percent
< 1 Year	$	1,297,860	26.2	%	$	1,245,839	26.3	%
1 to < 2 Years	517,407		10.5		534,038		11.3
2 to < 3 Years	416,003		8.4		511,701		10.8
3 to < 4 Years	586,055		11.8		525,683		11.1
4 to < 5 Years	438,784		8.9		400,540		8.4
5 or more Years	1,693,927		34.2		1,523,824		32.1
Total Investments Available for Sale	$	4,950,036	100.0	%	$	4,741,625	100.0	%

43

Top Ten Investments Available for Sale Holdings

	March 31, 2023
Rank ($ in thousands)	Security	Fair Value			Amortized Cost		Unrealized Gain (Loss)(1)		Credit Rating(2)
1	US Treasury 2.875% 06/15/2025	$	40,295		$	40,949	$	(654)	Aaa
2	US Treasury 1.500% 08/15/2026	31,556			34,385		(2,829)		Aaa
3	Freddie Mac 5.500% 11/01/2052	29,946			30,205		(259)		Aaa
4	US Treasury 0.250% 05/31/2025	23,629			25,588		(1,959)		Aaa
5	US Treasury 2.500% 01/31/2024	20,019			20,391		(372)		Aaa
6	US Treasury 2.625% 06/30/2023	19,651			19,743		(92)		Aaa
7	US Treasury 2.000% 04/30/2024	19,517			19,580		(63)		Aaa
8	US Treasury 0.875% 06/30/2026	17,918			19,641		(1,723)		Aaa
9	US Treasury 0.125% 10/15/2023	17,195			17,619		(424)		Aaa
10	US Treasury 5.250% 11/15/2028	16,477			17,671		(1,194)		Aaa
Total		$	236,203		$	245,772	$	(9,569)
Percent of Investments Available for Sale		4.8		%

(1)As of March 31, 2023, for securities in an unrealized loss position, management believes the declines in fair value are principally associated with the changes in the interest rate environment subsequent to its purchase. Also, see Note 3 to our condensed consolidated financial statements, which summarizes the aggregate amount of gross unrealized losses by asset class in which the fair value of investments available for sale has been less than cost for less than 12 months and for 12 months or more.

(2)Based on ratings issued by Moody’s, if available. S&P or Fitch rating utilized if Moody’s not available.

Rank	December 31, 2022
($ in thousands)	Security	Fair Value
1	US Treasury 2.875% 06/15/2025	$	39,908
2	US Treasury 1.500% 08/15/2026	31,025
3	Federal Home Loan Banks 0.000% 01/03/2023	27,080
4	US Treasury 0.250% 05/31/2025	23,249
5	US Treasury 2.500% 01/31/2024	19,911
6	US Treasury 0.000% 02/23/2023	19,879
7	US Treasury 2.625% 06/30/2023	19,562
8	US Treasury 2.000% 04/30/2024	19,369
9	US Treasury 0.875% 06/30/2026	17,584
10	US Treasury 0.125% 10/15/2023	17,003
Total		$	234,570
Percent of Investments Available for Sale		4.9		%

44

The following tables include municipal debt securities for states that represent more than 10% of the total municipal bond position as of March 31, 2023:

($ in thousands)	Fair Value		Amortized Cost		Credit Rating (1), (2)
New York
New York City Transitional Finance Authority Future Tax Secured Revenue	$	12,017	$	12,547	Aa1
City of New York NY	9,187		8,967		Aa2
Metropolitan Transportation Authority	6,640		6,959		A3
Port Authority of New York & New Jersey	6,435		7,085		Aa3
Metropolitan Transportation Authority Payroll Mobility Tax Revenue	6,431		7,204		Aa1
State of New York Sales Tax Revenue	4,616		4,936		Aa1
State of New York Personal Income Tax Revenue	4,615		4,677		Aa1
State University of New York Dormitory Facilities Revenue	3,897		3,981		Aa3
University of Rochester	3,412		3,234		Aa3
New York City Water & Sewer System	2,995		2,923		Aa1
New York City Transitional Finance Authority Building Aid Revenue	2,768		2,782		Aa2
Triborough Bridge & Tunnel Authority	2,710		2,640		Aa3
Research Foundation of State University of New York/The	2,344		2,470		A1
Rochester Institute of Technology	2,183		2,230		A1
City of Yonkers NY	2,147		2,289		A3
Long Island Power Authority	1,688		1,669		A2
Trustees of Columbia University in the City of New York/The	1,319		1,309		Aaa
New York State Thruway Authority	1,279		1,274		A1
Yankee Stadium LLC	711		793		A1
New York University	281		281		Aa2
County of Nassau NY	277		273		A1
	$	77,952	$	80,523

(1)Certain of the above securities may include financial guaranty insurance or state enhancements. The above ratings include the effect of these credit enhancements, if applicable.

(2)Based on ratings issued by Moody’s, if available. S&P or Fitch rating utilized if Moody’s not available.

Off-Balance Sheet Arrangements

    Essent Guaranty has entered into fully collateralized reinsurance agreements ("Radnor Re Transactions") with unaffiliated special purpose insurers domiciled in Bermuda. The Radnor Re special purpose insurers are special purpose variable interest entities that are not consolidated in our condensed consolidated financial statements because we do not have the unilateral power to direct those activities that are significant to their economic performance. As of March 31, 2023, our estimated off-balance sheet maximum exposure to loss from the Radnor Re entities was $0.5 million, representing the estimated net present value of investment earnings on the assets in the reinsurance trusts. See Note 4 to our condensed consolidated financial statements for additional information.

Critical Accounting Policies

As of the filing date of this report, there were no significant changes in our critical accounting policies from those discussed in our 2022 Form 10-K. See Note 2 to our condensed consolidated financial statements for recently issued accounting standards adopted or under evaluation.

45

Item 3.   Quantitative and Qualitative Disclosures About Market Risk

We own and manage a large investment portfolio of various holdings, types and maturities. Investment income is one of our primary sources of cash flow supporting operations and claim payments. The assets within the investment portfolio are exposed to the same factors that affect overall financial market performance. While our investment portfolio is exposed to factors affecting markets worldwide, it is most sensitive to fluctuations in the drivers of U.S. markets.

We manage market risk via defined investment policy implemented by our treasury function with oversight from our board of directors and our senior management. Important drivers of our market risk exposure monitored and managed by us include but are not limited to:

•Changes to the level of interest rates.  Increasing interest rates may reduce the value of certain fixed-rate bonds held in the investment portfolio. Higher rates may cause variable-rate assets to generate additional income. Decreasing rates will have the reverse impact. Significant changes in interest rates can also affect persistency and claim rates which may in turn require that the investment portfolio be restructured to better align it with future liabilities and claim payments. Such restructuring may cause investments to be liquidated when market conditions are adverse.

•Changes to the term structure of interest rates.  Rising or falling rates typically change by different amounts along the yield curve. These changes may have unforeseen impacts on the value of certain assets.

•Market volatility/changes in the real or perceived credit quality of investments.  Deterioration in the quality of investments, identified through changes to our own or third-party (e.g., rating agency) assessments, will reduce the value and potentially the liquidity of investments.

•Concentration Risk.  If the investment portfolio is highly concentrated in one asset, or in multiple assets whose values are highly correlated, the value of the total portfolio may be greatly affected by the change in value of just one asset or a group of highly correlated assets.

•Prepayment Risk.  Bonds may have call provisions that permit debtors to repay prior to maturity when it is to their advantage. This typically occurs when rates fall below the interest rate of the debt.

Market risk is measured for all investment assets at the individual security level. Market risks that are not fully captured by the quantitative analysis are highlighted. In addition, material market risk changes that occur from the last reporting period to the current are discussed. Changes to how risks are managed will also be identified and described.

At March 31, 2023, the effective duration of our investments available for sale was 4.0 years, which means that an instantaneous parallel shift (movement up or down) in the yield curve of 100 basis points would result in a change of 4.0% in fair value of our investments available for sale. Excluding short-term investments, our investments available for sale effective duration was 4.3 years, which means that an instantaneous parallel shift (movement up or down) in the yield curve of 100 basis points would result in a change of 4.3% in fair value of our investments available for sale.

Item 4.   Controls and Procedures

Disclosure Controls and Procedures

Our management carried out an evaluation, under the supervision and with the participation of our chief executive officer and chief financial officer, of the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this Quarterly Report. Based on this evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective as of March 31, 2023, the end of the period covered by this Quarterly Report.

Changes in Internal Control Over Financial Reporting

During our most recent fiscal quarter, there has not been any change in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

46

PART II — OTHER INFORMATION

Item 1.   Legal Proceedings

We are not currently subject to any material legal proceedings.

Item 1A.   Risk Factors

Risk factors that affect our business and financial results are discussed in Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022. Except as discussed below, there have been no material changes in our risk factors from those previously disclosed in our Annual Report. You should carefully consider the risks described in our Annual Report, which could materially affect our business, financial condition or future results. The risks described in our Annual Report, along with the disclosure below are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, and/or operating results. If any of the risks actually occur, our business, financial condition, and/or results of operations could be negatively affected.

Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds

Repurchases of Securities

The table below sets forth information regarding repurchases of our common shares during the three months ended March 31, 2023.

Period ($ in thousands, except per share amounts)	Total Number of Shares Purchased	Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (1)
January 1 - January 31, 2023	4,848	$	38.55	—
February 1 - February 28, 2023	—	N/A		—
March 1 - March 31, 2023	497,983	$	38.99	431,904
Total	502,831			431,904	$	233,433

(1)As of March 31, 2023, the Company was authorized to purchase up to $250 million of its common shares, announced in May 2022, of which $16.6 million had been utilized. The remaining $233.4 million in the table represents the amount available to repurchase shares under the share repurchase plan as of March 31, 2023. In April 2023, the Company repurchased an additional 374 thousand shares at a total cost of $15.1 million. After the April repurchases, the amount remaining under the share repurchase plan was $218.3 million.

47

Item 6.   Exhibits

(a)                                 Exhibits:

Exhibit No.		Description
10.1	*	Offer Letter between Essent US Holdings, Inc. and David Weinstock dated March 14, 2023 (incorporated herein by reference to Exhibit 10.1 of the Current Report on Form 8-K (File No. 001-36157) filed on March 15, 2023)
10.2	*	Essent Group Ltd. 2013 Long-Term Incentive Plan, as amended and restated
31.1		Certification of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2		Certification of Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1		Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101		The following financial information from this Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, formatted in Inline XBRL: (i) the Condensed Consolidated Balance Sheets (Unaudited); (ii) the Condensed Consolidated Statements of Comprehensive Income (Unaudited); (iii) the Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited); (iv) the Condensed Consolidated Statements of Cash Flows (Unaudited); and (v) the Notes to Condensed Consolidated Financial Statements (Unaudited).
*		Management contract or compensatory plan or arrangement.

48

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized, on the date indicated.

	ESSENT GROUP LTD.
Date: May 9, 2023	/s/ MARK A. CASALE
	Mark A. Casale
	President, Chief Executive Officer and Chairman (Principal Executive Officer)
Date: May 9, 2023	/s/ DAVID B. WEINSTOCK
	David B. Weinstock
	Senior Vice President and Chief Financial Officer (Principal Financial Officer)

49

EX-10.2

SECOND AMENDED AND RESTATED
ESSENT GROUP LTD.
2013 LONG-TERM INCENTIVE PLAN
ADOPTED BY THE BOARD OF DIRECTORS: FEBRUARY 7, 2023
APPROVED BY THE SHAREHOLDERS: MAY 2, 2023
TERMINATION DATE: FEBRUARY 7, 2033

1.Purpose.

The purpose of the Plan is to assist the Company in attracting, retaining, motivating, and rewarding certain employees, officers, directors, and consultants of the Company and its Affiliates and promoting the creation of long-term value for stockholders of the Company by closely aligning the interests of such individuals with those of such stockholders. The Plan authorizes the award of Stock-based and cash-based incentives to Eligible Persons to encourage such Eligible Persons to expend maximum effort in the creation of stockholder value. The Plan was originally adopted on October 30, 2013, was subsequently amended and restated on February 8, 2017 and was further amended and restated in its present form on February 7, 2023 (the “Second Restatement Date”), subject to the approval of the Company’s shareholders to, among other things, extend the termination date of the Plan to the tenth anniversary of the Second Restatement Date.

2.Definitions.

For purposes of the Plan, the following terms shall be defined as set forth below:

(a)“Affiliate” means, with respect to any Person, any other Person that, directly or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with, such Person.

(b)“Award” means any Option, Restricted Stock, Restricted Stock Unit, Stock Appreciation Right, Performance Award, or other Stock-based award granted under the Plan.

(c)“Award Agreement” means an Option Agreement, a Restricted Stock Agreement, an RSU Agreement, a SAR Agreement, a Performance Award Agreement, or an agreement governing the grant of any other Stock-based Award granted under the Plan.

(d)“Board” means the Board of Directors of the Company.

(e)“Cause” means, with respect to any Participant and in the absence of an Award Agreement or Participant Agreement otherwise defining Cause, (1) the Participant’s plea of nolo contendere, conviction of or indictment for, any crime (whether or not involving the Company or its Affiliates) (i) constituting a felony or (ii) that has, or could reasonably be expected to result in, an adverse impact on the performance of the Participant’s duties to the Service Recipient, or otherwise has, or could reasonably be expected to result in, an adverse impact on the business or reputation of the Company or its Affiliates, (2) conduct of the Participant, in connection with the Participant’s employment or service, that has resulted, or could reasonably be expected to result, in material injury to the business or reputation of the Company or its Affiliates, (3) any material violation of the policies of the Company or its Affiliates, including, but not limited to, those relating to sexual harassment or the disclosure or misuse of confidential information, or those set forth in the manuals or statements of policy of the Company or its Affiliates; or (4) willful neglect in the performance of the Participant’s duties for the Service Recipient or willful or repeated failure or refusal to perform such duties. In the event that there is an Award Agreement or Participant Agreement defining Cause, “Cause” shall

have the meaning provided in such agreement, and a Termination by the Service Recipient for Cause hereunder shall not be deemed to have occurred unless all applicable notice and cure periods in such Award Agreement or Participant Agreement are complied with.

(f)“Change in Control” means the first of the following to occur after the Effective Date:

(1)Acquisition of Controlling Interest. Any Person or group of Persons acting in concert (other than Persons who are employees at any time more than one year before a transaction) becomes the beneficial owner (within the meaning of Rule 13d-3 promulgated under the Exchange Act), directly or indirectly, of securities of the Company representing thirty-five percent (35%) or more of the combined voting power of the Company’s then outstanding securities, excluding, however, the following: (A) any acquisition directly from the Company, (B) any acquisition by the Company; (C) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any corporation controlled by the Company; or (D) any underwriter temporarily holding securities pursuant to an offering of such securities. In applying the preceding sentence, an agreement to vote securities shall be disregarded unless its ultimate purpose is to cause what would otherwise be Change in Control, as reasonably determined by the Board.

(2)Change in Board Control. During any consecutive one-year period commencing after the Effective Date, individuals who constituted the Board at the beginning of the period (or their approved replacements, as defined in the next sentence) cease for any reason to constitute a majority of the Board. A new director shall be considered an “approved replacement” director if his or her election (or nomination for election) was approved by a vote of at least a majority of the directors then still in office who either were directors at the beginning of the period or were themselves approved replacement directors, but in either case excluding any director whose initial assumption of office occurred as a result of an actual or threatened solicitation of proxies or consents by or on behalf of any Person other than the Board.

(3)Merger. The Company consummates a merger, or consolidation of the Company with any other corporation unless: (a) the voting securities of the Company outstanding immediately before the merger or consolidation would continue to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) at least fifty percent (50%) of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation; and (b) no Person (other than Persons who are employees at any time more than one year before the transaction) becomes the beneficial owner, directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the combined voting power of the Company’s then outstanding securities.

(4)Sale of Assets. The Company consummates a sale or disposition of all, or substantially all, of the Company’s assets.

(5)Liquidation or Dissolution. The Company implements a plan for liquidation or dissolution of the Company.

Notwithstanding the foregoing, (x) a “Change in Control” shall not be deemed to have occurred by virtue of the consummation of any transaction or series of integrated transactions immediately following which the record holders of the common stock of the Company immediately prior to such transaction or series of transactions continue to have substantially the same proportionate ownership in an entity which owns all or substantially all of the assets of the Company

2

immediately following such transaction or series of transactions and (y) with respect to the payment of any amount that constitutes a deferral of compensation subject to Section 409A of the Code payable upon a Change in Control, a “Change in Control” shall not be deemed to have occurred unless the Change in Control constitutes a change in the ownership or effective control of the Company or in the ownership of a substantial portion of the assets of the Company under Section 409A(a)(2)(A)(v) of the Code.

(g)“Code” means the U.S. Internal Revenue Code of 1986, as amended from time to time, including the rules and regulations thereunder and any successor provisions, rules and regulations thereto.

(h)“Committee” means the Board or such other committee consisting of two or more individuals appointed by the Board to administer the Plan and each other individual or committee of individuals designated to exercise authority under the Plan.

(i)“Company” means Essent Group Ltd., a limited liability company organized under the laws of Bermuda, and its successors by operation of law.

(j)“Corporate Event” has the meaning set forth in Section 11(b) hereof.

(k)“Data” has the meaning set forth in Section 21(e) hereof.

(l)“Disability” means, in the absence of an Award Agreement or Participant Agreement otherwise defining Disability, the permanent and total disability of such Participant within the meaning of Section 22(e)(3) of the Code. In the event that there is an Award Agreement or Participant Agreement defining Disability, “Disability” shall have the meaning provided in such Award Agreement or Participant Agreement.

(m)“Disqualifying Disposition” means any disposition (including any sale) of Stock acquired upon the exercise of an Incentive Stock Option made within the period that ends either (1) two years after the date on which the Participant was granted the Incentive Stock Option or (2) one year after the date upon which the Participant acquired the Stock.

(n)“Effective Date” means October 30, 2013.

(o)“Eligible Person” means (1) each employee and officer of the Company or any of its Affiliates, including each such employee and officer who may also be a director of the Company or any of its Affiliates, (2) each non-employee director of the Company or any of its Affiliates, (3) each other natural Person who provides substantial services to the Company or any of its Affiliates as a consultant or advisor (or a wholly owned alter ego entity of the natural Person providing such services of which such Person is an employee, shareholder or partner) and who is designated as eligible by the Committee, and (4) each natural Person who has been offered employment by the Company or any of its Affiliates; provided that such prospective employee may not receive any payment or exercise any right relating to an Award until such Person has commenced employment or service with the Company or its Affiliates; provided further, however, that (i) with respect to any Award that is intended to qualify as a “stock right” that does not provide for a “deferral of compensation” within the meaning of Section 409A of the Code, the term Affiliate as used in this Section 2(o) shall include only those corporations or other entities in the unbroken chain of corporations or other entities beginning with the Company where each of the corporations or other entities in the unbroken chain other than the last corporation or other entity owns stock possessing at least fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations or other entities in the chain, and (ii) with respect to any Award that is intended to qualify as an Incentive Stock Option, the term “Affiliate” as used in this Section 2(o) shall include only those entities that

3

qualify as a “subsidiary corporation” with respect to the Company within the meaning of Section 424(f) of the Code. An employee on an approved leave of absence may be considered as still in the employ of the Company or any of its Affiliates for purposes of eligibility for participation in the Plan.

(p)“Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended from time to time, including the rules and regulations thereunder and any successor provisions, rules and regulations thereto.

(q)“Expiration Date” means, with respect to an Option or Stock Appreciation Right, the date on which the term of such Option or Stock Appreciation Right expires, as determined under Section 5(b) or 8(b) hereof, as applicable.

(r)“Fair Market Value” means, as of any date when the Stock is listed on one or more national securities exchanges, the closing price reported on the principal national securities exchange on which such Stock is listed and traded on the date of determination or, if the closing price is not reported on such date of determination, the closing price reported on the most recent date prior to the date of determination. If the Stock is not listed on a national securities exchange, “Fair Market Value” shall mean the amount determined by the Board in good faith, and in a manner consistent with Section 409A of the Code, to be the fair market value per share of Stock.

(s)“GAAP” means the U.S. Generally Accepted Accounting Principles, as in effect from time to time.

(t)“Incentive Stock Option” means an Option intended to qualify as an incentive stock option within the meaning of Section 422 of the Code.

(u)“Nonqualified Stock Option” means an Option not intended to qualify as an Incentive Stock Option.

(v)“Option” means a conditional right, granted to a Participant under Section 5 hereof, to purchase Stock at a specified price during a specified time period.

(w)“Option Agreement” means a written agreement (including an electronic writing to the extent permitted by applicable law) between the Company and a Participant evidencing the terms and conditions of an individual Option grant.

(x)“Participant” means an Eligible Person who has been granted an Award under the Plan or, if applicable, such other Person who holds an Award.

(y)“Participant Agreement” means an employment or other services agreement between a Participant and the Service Recipient that describes the terms and conditions of such Participant’s employment or service with the Service Recipient and is effective as of the date of determination.

(z)“Performance Award” means an Award granted to a Participant under Section 9 hereof, which Award is subject to the achievement of Performance Objectives during a Performance Period. A Performance Award shall be designated as a Performance Share or a Performance Unit at the time of grant.

(aa)“Performance Award Agreement” means a written agreement (including an electronic writing to the extent permitted by applicable law) between the Company and a Participant evidencing the terms and conditions of an individual Performance Award grant.

4

(ab)“Performance Objectives” means the performance objectives established pursuant to the Plan for Participants who have received Performance Awards.

(ac)“Performance Period” means the period of time designated by the Committee over which the achievement of one or more Performance Objectives will be measured for the purpose of determining a Participant’s right to and the payment of an Award. Performance Periods may be of varying and overlapping duration, at the sole discretion of the Committee.

(ad)“Performance Share” means a Performance Award denominated in shares of Stock which may be earned in whole or in part based upon the achievement of Performance Objectives during a Performance Period.

(ae)“Performance Unit” means a Performance Award denominated as a notional unit representing the right to receive one share of Stock (or the cash value of one share of Stock, if so determined by the Committee) which may be earned in whole or in part based upon the achievement of Performance Objectives during a Performance Period.

(af)“Person” means any individual, corporation, partnership, firm, joint venture, association, joint-stock company, trust, unincorporated organization, or other entity.

(ag)“Plan” means this Essent Group Ltd. 2013 Long-Term Incentive Plan, as may be amended from time to time.

(ah)“Qualified Member” means a member of the Committee who is a “Non-Employee Director” within the meaning of Rule 16b3 under the Exchange Act and an “independent director” as defined under, as applicable, the NASDAQ Listing Rules, the NYSE Listed Company Manual or other applicable stock exchange rules.

(ai)“Qualifying Committee” has the meaning set forth in Section 3(b) hereof.

(aj)“Restricted Stock” means Stock granted to a Participant under Section 6 hereof that is subject to certain restrictions and to a risk of forfeiture.

(ak)“Restricted Stock Agreement” means a written agreement (including an electronic writing to the extent permitted by applicable law) between the Company and a Participant evidencing the terms and conditions of an individual Restricted Stock grant.

(al)“Restricted Stock Unit” means a notional unit representing the right to receive one share of Stock (or the cash value of one share of Stock, if so determined by the Committee) on a specified settlement date.

(am)“RSU Agreement” means a written agreement (including an electronic writing to the extent permitted by applicable law) between the Company and a Participant evidencing the terms and conditions of an individual grant of Restricted Stock Units.

(an)“SAR Agreement” means a written agreement (including an electronic writing to the extent permitted by applicable law) between the Company and a Participant evidencing the terms and conditions of an individual grant of Stock Appreciation Rights.

(ao)“Securities Act” means the U.S. Securities Act of 1933, as amended from time to time, including the rules and regulations thereunder and any successor provisions, rules and regulations thereto.

5

(ap)“Service Recipient” means, with respect to a Participant holding an Award, either the Company or an Affiliate of the Company by which the original recipient of such Award is, or following a Termination was most recently, principally employed or to which such original recipient provides, or following a Termination was most recently providing, services, as applicable.

(aq)“Stock” means the Company’s common shares, par value $0.015 per share, and such other securities as may be substituted for such stock pursuant to Section 11 hereof.

(ar)“Stock Appreciation Right” means a conditional right to receive an amount equal to the value of the appreciation in the Stock over a specified period. Except in the event of extraordinary circumstances, as determined in the sole discretion of the Committee, or pursuant to Section 11(b) hereof, Stock Appreciation Rights shall be settled in Stock.

(as)“Substitute Award” has the meaning set forth in Section 4(a) hereof.

(at)“Termination” means the termination of a Participant’s employment or service, as applicable, with the Service Recipient; provided, however, that, if so determined by the Committee at the time of any change in status in relation to the Service Recipient (e.g., a Participant ceases to be an employee and begins providing services as a consultant, or vice versa), such change in status will not be deemed a Termination hereunder. Unless otherwise determined by the Committee, in the event that the Service Recipient ceases to be an Affiliate of the Company (by reason of sale, divestiture, spin-off, or other similar transaction), unless a Participant’s employment or service is transferred to another entity that would constitute the Service Recipient immediately following such transaction, such Participant shall be deemed to have suffered a Termination hereunder as of the date of the consummation of such transaction. Notwithstanding anything herein to the contrary, a Participant’s change in status in relation to the Service Recipient (for example, a change from employee to consultant) shall not be deemed a Termination hereunder with respect to any Awards constituting “nonqualified deferred compensation” subject to Section 409A of the Code that are payable upon a Termination unless such change in status constitutes a “separation from service” within the meaning of Section 409A of the Code. Any payments in respect of an Award constituting nonqualified deferred compensation subject to Section 409A of the Code that are payable upon a Termination shall be delayed for such period as may be necessary to meet the requirements of Section 409A(a)(2)(B)(i) of the Code. On the first business day following the expiration of such period, the Participant shall be paid, in a single lump sum without interest, an amount equal to the aggregate amount of all payments delayed pursuant to the preceding sentence, and any remaining payments not so delayed shall continue to be paid pursuant to the payment schedule applicable to such Award.

3.Administration.

(a)Authority of the Committee. Except as otherwise provided below, the Plan shall be administered by the Committee. The Committee shall have full and final authority, in each case subject to and consistent with the provisions of the Plan, to (1) select Eligible Persons to become Participants, (2) grant Awards, (3) determine the type, number of shares of Stock subject to, other terms and conditions of, and all other matters relating to, Awards, (4) prescribe Award Agreements (which need not be identical for each Participant) and rules and regulations for the administration of the Plan, (5) construe and interpret the Plan and Award Agreements and correct defects, supply omissions, and reconcile inconsistencies therein, (6) suspend the right to exercise Awards during any period that the Committee deems appropriate to comply with applicable securities laws, and thereafter extend the exercise period of an Award by an equivalent period of time or such shorter period required by, or necessary to comply with,

6

applicable law, and (7) make all other decisions and determinations as the Committee may deem necessary or advisable for the administration of the Plan. Any action of the Committee shall be final, conclusive, and binding on all Persons, including, without limitation, the Company, its stockholders and Affiliates, Eligible Persons, Participants, and beneficiaries of Participants. Notwithstanding anything in the Plan to the contrary, the Committee shall have the ability to accelerate the vesting of any outstanding Award at any time and for any reason. For the avoidance of doubt, the Board shall have the authority to take all actions under the Plan that the Committee is permitted to take.

(b)Manner of Exercise of Committee Authority. At any time that a member of the Committee is not a Qualified Member, any action of the Committee relating to an Award granted or to be granted to a Participant who is then subject to Section 16 of the Exchange Act in respect of the Company, must be taken by the remaining members of the Committee or a subcommittee, designated by the Committee or the Board, composed solely of two or more Qualified Members (a “Qualifying Committee”). Any action authorized by such a Qualifying Committee shall be deemed the action of the Committee for purposes of the Plan. The express grant of any specific power to a Qualifying Committee, and the taking of any action by such a Qualifying Committee, shall not be construed as limiting any power or authority of the Committee.

(c)Delegation. To the extent permitted by applicable law, the Committee may delegate to officers or employees of the Company or any of its Affiliates, or committees thereof, the authority, subject to such terms as the Committee shall determine, to perform such functions under the Plan, including, but not limited to, administrative functions, as the Committee may determine appropriate. The Committee may appoint agents to assist it in administering the Plan. Any actions taken by an officer or employee delegated authority pursuant to this Section 3(c) within the scope of such delegation shall, for all purposes under the Plan, be deemed to be an action taken by the Committee. Notwithstanding the foregoing or any other provision of the Plan to the contrary, any Award granted under the Plan to any Eligible Person who is not an employee of the Company or any of its Affiliates (including any non-employee director of the Company or any Affiliate) or to any Eligible Person who is subject to Section 16 of the Exchange Act must be expressly approved by the Committee or Qualifying Committee in accordance with Section 3(b) above.

(d)Section 409A; Section 457A. All Awards made under the Plan that are intended to be “deferred compensation” subject to Section 409A or Section 457A of the Code shall be interpreted, administered and construed to comply with Section 409A or Section 457A, as applicable, and all Awards made under the Plan that are intended to be exempt from Section 409A or Section 457A shall be interpreted, administered and construed to comply with and preserve such exemption, as applicable. The Committee shall have full authority to give effect to the intent of the foregoing sentence. To the extent necessary to give effect to this intent, in the case of any conflict or potential inconsistency between the Plan and a provision of any Award or Award Agreement with respect to an Award, the Plan shall govern. Notwithstanding the foregoing, neither the Company nor the Committee shall have any liability to any Person in the event Section 409A or Section 457A applies to any Award in a manner that results in adverse tax consequences for the Participant or any of his or her beneficiaries or transferees.

4.Shares Available Under the Plan; Other Limitations.

(a)Number of Shares Available for Delivery. Subject to adjustment as provided in Section 11 hereof, the total number of shares of Stock reserved and available for delivery in connection with Awards under the Plan shall equal 5,615,530. Shares of Stock delivered under the Plan shall consist of authorized and unissued shares or previously issued shares of Stock reacquired by the Company on the open market or by private purchase.

7

Notwithstanding the foregoing, (i) except as may be required by reason of Section 422 of the Code, the number of shares of Stock available for issuance hereunder shall not be reduced by shares issued pursuant to Awards issued or assumed in connection with a merger or acquisition as contemplated by, as applicable, NASDAQ Listing Rule 5635(c) and IM-5635-1, NYSE Listed Company Manual Section 303A.08, AMEX Company Guide Section 711, or other applicable stock exchange rules, and their respective successor rules and listing exchange promulgations (each such Award, a “Substitute Award”); and (ii) shares of Stock shall not be deemed to have been issued pursuant to the Plan with respect to any portion of an Award that is settled in cash.

(b)Share Counting Rules. The Committee may adopt reasonable counting procedures to ensure appropriate counting, avoid double-counting (as, for example, in the case of tandem awards or Substitute Awards) and make adjustments if the number of shares of Stock actually delivered differs from the number of shares previously counted in connection with an Award. Other than with respect to a Substitute Award, to the extent that an Award expires or is canceled, forfeited, settled in cash, or otherwise terminated without delivery to the Participant of the full number of shares of Stock to which the Award related, the undelivered shares of Stock will again be available for grant. Shares of Stock withheld in payment of the exercise price or taxes relating to an Award and shares of Stock equal to the number surrendered in payment of any exercise price or taxes relating to an Award shall be deemed to constitute shares delivered to the Participant and shall not be deemed to again be available for delivery under the Plan.

(c)Incentive Stock Options. No more than 5,615,530 shares of Stock (subject to adjustment as provided in Section 11 hereof) reserved for issuance hereunder may be issued or transferred upon exercise or settlement of Incentive Stock Options.

(d)Shares Available Under Acquired Plans. Additionally, to the extent permitted by NYSE Listed Company Manual Section 303A.08, NASDAQ Listing Rule 5635(c) or other applicable stock exchange rules, subject to applicable law, in the event that a company acquired by the Company or with which the Company combines has shares available under a pre-existing plan approved by stockholders and not adopted in contemplation of such acquisition or combination, the shares available for grant pursuant to the terms of such pre-existing plan (as adjusted, to the extent appropriate, using the exchange ratio or other adjustment or valuation ratio or formula used in such acquisition or combination to determine the consideration payable to the holders of common stock of the entities party to such acquisition or combination) may be used for Awards under the Plan and shall not reduce the number of shares of Stock reserved and available for delivery in connection with Awards under the Plan; provided that Awards using such available shares shall not be made after the date awards could have been made under the terms of such pre-existing plan, absent the acquisition or combination, and shall only be made to individuals who were not employed by the Company or any subsidiary of the Company immediately prior to such acquisition or combination.

(e)Minimum Vesting Period. No Award may vest over a period that is less than one (1) year from the date of grant; provided, however, that the foregoing minimum vesting period shall not apply: (i) to Awards granted in payment of or exchange for an equivalent amount of salary, bonus or other earned cash compensation (including Performance Shares); (ii) to a Substitute Award that does not reduce the vesting period of the award being replaced or assumed; or (iii) to Awards involving an aggregate number of shares of Stock not in excess of five percent (5%) of the aggregate number of shares of Stock that may be delivered in connection with Awards (as set forth in Section 4 hereof).

(f)Limitation on Awards to Non-Employee Directors. Notwithstanding anything to the contrary herein, the maximum number of shares of Stock that may be subject to Awards granted to any non-employee director of the Company in any one calendar year shall not exceed 50,000 shares of Stock (subject to adjustment as provided in Section 11 hereof).

8

5.Options.

(a)General. Certain Options granted under the Plan may be intended to be Incentive Stock Options; however, no Incentive Stock Options may be granted hereunder following the tenth (10th) anniversary of the Second Restatement Date. Options may be granted to Eligible Persons in such form and having such terms and conditions as the Committee shall deem appropriate; provided, however, that Incentive Stock Options may be granted only to Eligible Persons who are employees of the Company or an Affiliate (as such definition is limited pursuant to Section 2(o) hereof) of the Company. The provisions of separate Options shall be set forth in separate Option Agreements, which agreements need not be identical. No dividends or dividend equivalents shall be paid on Options.

(b)Term. The term of each Option shall be set by the Committee at the time of grant; provided, however, that no Option granted hereunder shall be exercisable after, and each Option shall expire, ten (10) years from the date it was granted.

(c)Exercise Price. The exercise price per share of Stock for each Option shall be set by the Committee at the time of grant; provided, however, that if an Option is intended to qualify as either (1) a “stock right” that does not provide for a “deferral of compensation” within the meaning of Section 409A of the Code, or (2) an Incentive Stock Option, then in each case the applicable exercise price shall not be less than the Fair Market Value on the date of grant, subject to Section 5(g) below in the case of any Incentive Stock Option. Notwithstanding the foregoing, in the case of an Option that is a Substitute Award and that is intended to be either (1) a “stock right” that does not provide for a “deferral of compensation” within the meaning of Section 409A of the Code, or (2) an Incentive Stock Option, the exercise price per share of Stock for such Option may be less than the Fair Market Value on the date of grant; provided, that such exercise price is determined in a manner consistent with the provisions of Section 409A of the Code and, if applicable, Section 424(a) of the Code.

(d)Payment for Stock. Payment for shares of Stock acquired pursuant to an Option granted hereunder shall be made in full upon exercise of the Option in a manner approved by the Committee, which may include any of the following payment methods: (1) in immediately available funds in U.S. dollars, or by certified or bank cashier’s check, (2) by delivery of shares of Stock having a value equal to the exercise price, (3) by a broker-assisted cashless exercise in accordance with procedures approved by the Committee, whereby payment of the Option exercise price or tax withholding obligations may be satisfied, in whole or in part, with shares of Stock subject to the Option by delivery of an irrevocable direction to a securities broker (on a form prescribed by the Committee) to sell shares of Stock and to deliver all or part of the sale proceeds to the Company in payment of the aggregate exercise price and, if applicable, the amount necessary to satisfy the Company’s withholding obligations, or (4) by any other means approved by the Committee (including, by delivery of a notice of “net exercise” to the Company, pursuant to which the Participant shall receive the number of shares of Stock underlying the Option so exercised reduced by the number of shares of Stock equal to the aggregate exercise price of the Option divided by the Fair Market Value on the date of exercise). Notwithstanding anything herein to the contrary, if the Committee determines that any form of payment available hereunder would be in violation of Section 402 of the Sarbanes-Oxley Act of 2002, such form of payment shall not be available.

(e)Vesting. Subject to the provisions of Section 4(e), Options shall vest and become exercisable in such manner, on such date or dates, or upon the achievement of performance or other conditions, in each case as may be determined by the Committee and set forth in an Option Agreement; provided, however, that notwithstanding any such vesting dates, the Committee may in its sole discretion accelerate the vesting of any Option at any time and for any reason. Unless otherwise specifically determined by the Committee, the vesting of an

9

Option shall occur only while the Participant is employed by or rendering services to the Service Recipient, and all vesting shall cease upon a Participant’s Termination for any reason. If an Option is exercisable in installments, such installments or portions thereof that become exercisable shall remain exercisable until the Option expires, is canceled or otherwise terminates.

(f)Termination of Employment or Service. Except as provided by the Committee in an Option Agreement, Participant Agreement or otherwise:

(1)In the event of a Participant’s Termination prior to the applicable Expiration Date for any reason other than (i) by the Service Recipient for Cause, or (ii) by reason of the Participant’s death or Disability, (A) all vesting with respect to such Participant’s outstanding Options shall cease, (B) all of such Participant’s outstanding unvested Options shall terminate and be forfeited for no consideration as of the date of such Termination, and (C) all of such Participant’s outstanding vested Options shall terminate and be forfeited for no consideration on the earlier of (x) the applicable Expiration Date and (y) the date that is ninety (90) days after the date of such Termination.

(2)In the event of a Participant’s Termination prior to the applicable Expiration Date by reason of such Participant’s death or Disability, (i) all vesting with respect to such Participant’s outstanding Options shall cease, (ii) all of such Participant’s outstanding unvested Options shall terminate and be forfeited for no consideration as of the date of such Termination, and (iii) all of such Participant’s outstanding vested Options shall terminate and be forfeited for no consideration on the earlier of (x) the applicable Expiration Date and (y) the date that is twelve (12) months after the date of such Termination. In the event of a Participant’s death, such Participant’s Options shall remain exercisable by the Person or Persons to whom such Participant’s rights under the Options pass by will or by the applicable laws of descent and distribution until the applicable Expiration Date, but only to the extent that the Options were vested at the time of such Termination.

(3)In the event of a Participant’s Termination prior to the applicable Expiration Date by the Service Recipient for Cause, all of such Participant’s outstanding Options (whether or not vested) shall immediately terminate and be forfeited for no consideration as of the date of such Termination.

(g)Special Provisions Applicable to Incentive Stock Options.

(1)No Incentive Stock Option may be granted to any Eligible Person who, at the time the Option is granted, owns directly, or indirectly within the meaning of Section 424(d) of the Code, stock possessing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or of any parent or subsidiary thereof, unless such Incentive Stock Option (i) has an exercise price of at least one hundred ten percent (110%) of the Fair Market Value on the date of the grant of such Option and (ii) cannot be exercised more than five (5) years after the date it is granted.

(2)To the extent that the aggregate Fair Market Value (determined as of the date of grant) of Stock for which Incentive Stock Options are exercisable for the first time by any Participant during any calendar year (under all plans of the Company and its Affiliates) exceeds $100,000, such excess Incentive Stock Options shall be treated as Nonqualified Stock Options.

(3)Each Participant who receives an Incentive Stock Option must agree to notify the Company in writing immediately after the Participant makes a

10

Disqualifying Disposition of any Stock acquired pursuant to the exercise of an Incentive Stock Option.

6.Restricted Stock.

(a)General. Restricted Stock may be granted to Eligible Persons in such form and having such terms and conditions as the Committee shall deem appropriate. The provisions of separate Awards of Restricted Stock shall be set forth in separate Restricted Stock Agreements, which agreements need not be identical. Subject to the restrictions set forth in Section 6(b) hereof, and except as otherwise set forth in the applicable Restricted Stock Agreement, the Participant shall generally have the rights and privileges of a stockholder as to such Restricted Stock, including the right to vote such Restricted Stock. Cash dividends and stock dividends, if any, with respect to the Restricted Stock shall be withheld by the Company for the Participant’s account, and shall be subject to forfeiture to the same degree as the shares of Restricted Stock to which such dividends relate. Except as otherwise determined by the Committee, no interest will accrue or be paid on the amount of any cash dividends withheld.

(b)Vesting and Restrictions on Transfer. Subject to the provisions of Section 4(e), Restricted Stock shall vest in such manner, on such date or dates, or upon the achievement of performance or other conditions, in each case as may be determined by the Committee and set forth in a Restricted Stock Agreement; provided, however, that notwithstanding any such vesting dates, the Committee may in its sole discretion accelerate the vesting of any Award of Restricted Stock at any time and for any reason. Unless otherwise specifically determined by the Committee, the vesting of an Award of Restricted Stock shall occur only while the Participant is employed by or rendering services to the Service Recipient, and all vesting shall cease upon a Participant’s Termination for any reason. In addition to any other restrictions set forth in a Participant’s Restricted Stock Agreement, the Participant shall not be permitted to sell, transfer, pledge, or otherwise encumber the Restricted Stock prior to the time the Restricted Stock has vested pursuant to the terms of the Restricted Stock Agreement.

(c)Termination of Employment or Service. Except as provided by the Committee in a Restricted Stock Agreement, Participant Agreement or otherwise, in the event of a Participant’s Termination for any reason prior to the time that such Participant’s Restricted Stock has vested, (1) all vesting with respect to such Participant’s Restricted Stock shall cease, and (2) as soon as practicable following such Termination, the Company shall repurchase from the Participant, and the Participant shall sell, all of such Participant’s unvested shares of Restricted Stock at a purchase price equal to the original purchase price paid for the Restricted Stock; provided,that if the original purchase price paid for the Restricted Stock is equal to zero dollars ($0), such unvested shares of Restricted Stock shall be forfeited to the Company by the Participant for no consideration as of the date of such Termination.

7.Restricted Stock Units.

(a)General. Restricted Stock Units may be granted to Eligible Persons in such form and having such terms and conditions as the Committee shall deem appropriate. The provisions of separate Restricted Stock Units shall be set forth in separate RSU Agreements, which agreements need not be identical.

(b)Vesting. Subject to the provisions of Section 4(e), Restricted Stock Units shall vest in such manner, on such date or dates, or upon the achievement of performance or other conditions, in each case as may be determined by the Committee and set forth in an RSU Agreement; provided, however, that notwithstanding any such vesting dates, the Committee may in its sole discretion accelerate the vesting of any Restricted Stock Unit at any time and for any reason. Unless otherwise specifically determined by the Committee, the vesting of a Restricted

11

Stock Unit shall occur only while the Participant is employed by or rendering services to the Service Recipient, and all vesting shall cease upon a Participant’s Termination for any reason.

(c)Settlement. Restricted Stock Units shall be settled in Stock, cash, or property, as determined by the Committee, in its sole discretion, on the date or dates determined by the Committee and set forth in an RSU Agreement. Unless otherwise set forth in a Participant’s Agreement, Participant shall not be entitled to dividends, if any, or dividend equivalents, with respect to Restricted Stock Units prior to settlement, and, to the extent a Participant is entitled to any rights to any dividends or dividend equivalents, any such dividends or dividend equivalents with respect to the Restricted Stock Units shall be withheld by the Company for the Participant’s account, and shall be subject to forfeiture to the same degree as the Restricted Stock Units to which such dividends relate. Except as otherwise determined by the Committee, no interest will accrue or be paid on the amount of any dividends or dividend equivalents withheld.

(d)Termination of Employment or Service. Except as provided by the Committee in an RSU Agreement, Participant Agreement or otherwise, in the event of a Participant’s Termination for any reason prior to the time that such Participant’s Restricted Stock Units have been settled, (1) all vesting with respect to such Participant’s Restricted Stock Units shall cease, (2) all of such Participant’s outstanding unvested Restricted Stock Units shall be forfeited for no consideration as of the date of such Termination, and (3) any shares remaining undelivered with respect to vested Restricted Stock Units then held by such Participant shall be delivered on the delivery date or dates specified in the RSU Agreement.

8.Stock Appreciation Rights.

(a)General. Stock Appreciation Rights may be granted to Eligible Persons in such form and having such terms and conditions as the Committee shall deem appropriate. The provisions of separate Stock Appreciation Rights shall be set forth in separate SAR Agreements, which agreements need not be identical. No dividends or dividend equivalents shall be paid on Stock Appreciation Rights.

(b)Term. The term of each Stock Appreciation Right shall be set by the Committee at the time of grant; provided, however, that no Stock Appreciation Right granted hereunder shall be exercisable after, and each Stock Appreciation Right shall expire, ten (10) years from the date it was granted.

(c)Base Price. The base price per share of Stock for each Stock Appreciation Right shall be set by the Committee at the time of grant; provided, however, that if a Stock Appreciation Right is intended to qualify as a “stock right” that does not provide for a “deferral of compensation” within the meaning of Section 409A of the Code, then the applicable base price shall not be less than the Fair Market Value on the date of grant. Notwithstanding the foregoing, in the case of a Stock Appreciation Right that is a Substitute Award and that is intended to qualify as a “stock right” that does not provide for a “deferral of compensation” within the meaning of Section 409A of the Code, the base price per share of Stock for such Stock Appreciation Right may be less than the Fair Market Value on the date of grant; provided, that such base price is determined in a manner consistent with the provisions of Section 409A of the Code.

(d)Vesting. Subject to the provisions of Section 4(e), Stock Appreciation Rights shall vest and become exercisable in such manner, on such date or dates, or upon the achievement of performance or other conditions, in each case as may be determined by the Committee and set forth in a SAR Agreement; provided, however, that notwithstanding any such vesting dates, the Committee may in its sole discretion accelerate the vesting of any Stock

12

Appreciation Right at any time and for any reason. Unless otherwise specifically determined by the Committee, the vesting of a Stock Appreciation Right shall occur only while the Participant is employed by or rendering services to the Service Recipient, and all vesting shall cease upon a Participant’s Termination for any reason. If a Stock Appreciation Right is exercisable in installments, such installments or portions thereof that become exercisable shall remain exercisable until the Stock Appreciation Right expires, is canceled or otherwise terminates.

(e)Payment upon Exercise. Payment upon exercise of a Stock Appreciation Right may be made in cash, Stock, or property as specified in the SAR Agreement or determined by the Committee, in each case having a value in respect of each share of Stock underlying the portion of the Stock Appreciation Right so exercised, equal to the difference between the base price of such Stock Appreciation Right and the Fair Market Value of one (1) share of Stock on the exercise date. For purposes of clarity, each share of Stock to be issued in settlement of a Stock Appreciation Right is deemed to have a value equal to the Fair Market Value of one (1) share of Stock on the exercise date. In no event shall fractional shares be issuable upon the exercise of a Stock Appreciation Right, and in the event that fractional shares would otherwise be issuable, the number of shares issuable will be rounded down to the next lower whole number of shares, and the Participant will be entitled to receive a cash payment equal to the value of such fractional share.

(f)Termination of Employment or Service. Except as provided by the Committee in a SAR Agreement, Participant Agreement or otherwise:

(1)In the event of a Participant’s Termination prior to the applicable Expiration Date for any reason other than (i) by the Service Recipient for Cause, or (ii) by reason of the Participant’s death or Disability, (A) all vesting with respect to such Participant’s outstanding Stock Appreciation Rights shall cease, (B) all of such Participant’s outstanding unvested Stock Appreciation Rights shall terminate and be forfeited for no consideration as of the date of such Termination, and (C) all of such Participant’s outstanding vested Stock Appreciation Rights shall terminate and be forfeited for no consideration on the earlier of (x) the applicable Expiration Date and (y) the date that is ninety (90) days after the date of such Termination.

(2)In the event of a Participant’s Termination prior to the applicable Expiration Date by reason of such Participant’s death or Disability, (i) all vesting with respect to such Participant’s outstanding Stock Appreciation Rights shall cease, (ii) all of such Participant’s outstanding unvested Stock Appreciation Rights shall terminate and be forfeited for no consideration as of the date of such Termination, and (iii) each of such Participant’s outstanding vested Stock Appreciation Rights shall terminate and be forfeited for no consideration on the earlier of (x) the applicable Expiration Date and (y) the date that is twelve (12) months after the date of such Termination. In the event of a Participant’s death, such Participant’s Stock Appreciation Rights shall remain exercisable by the Person or Persons to whom such Participant’s rights under the Stock Appreciation Rights pass by will or by the applicable laws of descent and distribution until the applicable Expiration Date, but only to the extent that the Stock Appreciation Rights were vested at the time of such Termination.

(3)In the event of a Participant’s Termination prior to the applicable Expiration Date by the Service Recipient for Cause, all of such Participant’s outstanding Stock Appreciation Rights (whether or not vested) shall immediately terminate and be forfeited for no consideration as of the date of such Termination.

9.Performance Awards.

13

(a)General. Performance Awards may be granted to Eligible Persons in such form and having such terms and conditions as the Committee shall deem appropriate. The provisions of separate Performance Awards, including the determination of the Committee with respect to the form of payout of Performance Awards, shall be set forth in separate Performance Award Agreements, which agreements need not be identical. Unless otherwise set forth in an Award Agreement evidencing a Participant’s Performance Award, (i) cash dividends and stock dividends, if any, with respect to the Performance Awards shall be withheld by the Company for the Participant’s account, and shall be subject to forfeiture to the same degree as the Performance Shares to which such dividends relate and (ii) a Participant shall not be entitled to dividends, if any, or dividend equivalents with respect to Performance Awards that are not earned and vested. Except as otherwise determined by the Committee, no interest will accrue or be paid on the amount of any cash dividends withheld.

(b)Value of Performance Awards. Each Performance Unit shall have an initial value that is established by the Committee at the time of grant. Each Performance Share shall have an initial value equal to the Fair Market Value of the Stock on the date of grant. In addition to any other non-performance terms included in the Performance Award Agreement, the Committee shall set the applicable Performance Objectives in its discretion, which objectives, depending on the extent to which they are met, will determine the value and number of Performance Units or Performance Shares, as the case may be, that will be paid out to the Participant.

(c)Earning of Performance Awards. Upon the expiration of the applicable Performance Period or other non-performance-based vesting period, if longer, the holder of a Performance Award shall be entitled to receive with respect to the Performance Units or Performance Shares, a payout based on the value and number of the applicable Performance Units or Performance Shares earned by the Participant over the Performance Period, to be determined as a function of the extent to which the corresponding Performance Objectives have been achieved and any other non-performance-based terms met. The Committee may specify a target, threshold or maximum amount payable and may set a formula for determining the amount of Performance Awards earned if performance is at or above the threshold level but falls short of the maximum achievement of the specified Performance Objectives.

(d)Form and Timing of Payment of Performance Awards. Payment of earned Performance Awards shall be as determined by the Committee and as evidenced in the Performance Award Agreement. Subject to the terms of the Plan, the Committee, in its sole discretion, may pay earned Performance Units and Performance Shares in the form of cash, Stock, or other Awards (or in any combination thereof) equal to the value of the earned Performance Units or Performance Shares, as the case may be, at the close of the applicable Performance Period, or as soon as practicable after the end of the Performance Period. Any cash, Stock, or other Awards issued in connection with a Performance Award may be issued subject to any restrictions deemed appropriate by the Committee.

(e)Termination of Employment or Service. Except as provided by the Committee in a Performance Award Agreement, Participant Agreement or otherwise, if, prior to the end of an applicable Performance Period, a Participant undergoes a Termination for any reason, all of such Participant’s Performance Awards shall be forfeited by the Participant to the Company for no consideration.

(f)Performance Objectives. Each Performance Award shall specify the Performance Objectives that must be achieved before such Performance Award shall become earned. The Company may also specify a minimum acceptable level of achievement below which no payment will be made and may set forth a formula for determining the amount of any

14

payment to be made if performance is at or above such minimum acceptable level but falls short of the maximum achievement of the specified Performance Objectives.

(g)Negative Discretion. Notwithstanding satisfaction of any completion of any Performance Objectives, the number of shares of Stock, cash or other benefits granted, issued, retainable and/or vested under a Performance Award on account of satisfaction of such Performance Objectives may be reduced by the Committee on the basis of such further considerations as the Committee, in its sole discretion, will determine.

10.Other Stock-Based Awards.

The Committee is authorized, subject to limitations under applicable law, to grant to Participants such other Awards that may be denominated or payable in, valued in whole or in part by reference to, or otherwise based upon or related to Stock, as deemed by the Committee to be consistent with the purposes of the Plan. The Committee may also grant Stock as a bonus (whether or not subject to any vesting requirements or other restrictions on transfer), and may grant other Awards in lieu of obligations of the Company or an Affiliate to pay cash or deliver other property under the Plan or under other plans or compensatory arrangements, subject to such terms as shall be determined by the Committee. The terms and conditions applicable to such Awards shall be determined by the Committee and evidenced by Award Agreements, which agreements need not be identical.

11.Adjustment for Recapitalization, Merger, etc.

(a)Capitalization Adjustments. The aggregate number of shares of Stock that may be delivered in connection with Awards (as set forth in Section 4 hereof), the numerical share limits in Section 4, the number of shares of Stock covered by each outstanding Award, and the price per share of Stock underlying each such Award shall be equitably and proportionally adjusted or substituted, as determined by the Committee, in its sole discretion, as to the number, price, or kind of a share of Stock or other consideration subject to such Awards (1) in the event of changes in the outstanding Stock or in the capital structure of the Company by reason of stock dividends, extraordinary cash dividends, stock splits, reverse stock splits, recapitalizations, reorganizations, mergers, amalgamations, consolidations, combinations, exchanges, or other relevant changes in capitalization occurring after the date of grant of any such Award (including any Corporate Event); (2) in connection with any extraordinary dividend declared and paid in respect of shares of Stock, whether payable in the form of cash, stock, or any other form of consideration; or (3) in the event of any change in applicable laws or circumstances that results in or could result in, in either case, as determined by the Committee in its sole discretion, any substantial dilution or enlargement of the rights intended to be granted to, or available for, Participants in the Plan.

(b)Corporate Events. Notwithstanding the foregoing, except as provided by the Committee in an Award Agreement, Participant Agreement or otherwise, in connection with (i) a merger, amalgamation, or consolidation involving the Company in which the Company is not the surviving corporation, (ii) a merger, amalgamation, or consolidation involving the Company in which the Company is the surviving corporation but the holders of shares of Stock receive securities of another corporation or other property or cash, (iii) a Change in Control, or (iv) the reorganization, dissolution or liquidation of the Company (each, a “Corporate Event”), the Committee may, in its discretion, provide for any one or more of the following:

(1)The assumption or substitution of any or all Awards in connection with such Corporate Event, in which case the Awards shall be subject to the adjustment set forth in Section 11(a) above, and to the extent that such Awards are Performance Awards or other Awards that vest subject to the achievement of Performance Objectives

15

or similar performance criteria, such Performance Objectives or similar performance criteria shall be adjusted appropriately to reflect the Corporate Event

(2)The acceleration of vesting of any or all Awards, subject to the consummation of such Corporate Event; provided that any Performance Awards or other Awards that vest subject to the achievement of Performance Objectives or similar performance criteria will be deemed earned (i) based on actual performance through the date of the Corporate Event, or (ii) at the target level (or if no target is specified, the maximum level), in the event actual performance cannot be measured through the date of the Corporate Event, in each case, with respect to all unexpired Performance Periods or Performance Periods for which satisfaction of the Performance Objectives or other material terms for the applicable Performance Period has not been certified by the Committee prior to the date of the Corporate Event;

(3)The cancellation of any or all Awards (whether vested or unvested) as of the consummation of such Corporate Event, together with the payment to the Participants holding vested Awards (including any Awards that would vest upon the Corporate Event but for such cancellation) so canceled of an amount based upon the per-share consideration being paid for the Stock in connection with such Corporate Event, less, in the case of Options, Stock Appreciation Rights, and other Awards subject to exercise, the applicable exercise or base price; provided, however, that holders of Options, Stock Appreciation Rights, and other Awards subject to exercise shall be entitled to consideration in respect of cancellation of such Awards only if the per-share consideration less the applicable exercise or base price is greater than zero dollars ($0), and to the extent that the per-share consideration is less than or equal to the applicable exercise or base price, such Awards shall be canceled for no consideration;

(4)The cancellation of any or all Options, Stock Appreciation Rights and other Awards subject to exercise not assumed or substituted in connection with such Corporate Event (whether vested or unvested) as of the consummation of such Corporate Event; provided that all Options, Stock Appreciation Rights and other Awards to be so canceled pursuant to this paragraph (4) shall first become exercisable for a period of at least ten (10) days prior to such Corporate Event, with any exercise during such period of any unvested Options, Stock Appreciation Rights or other Awards to be (A) contingent upon and subject to the occurrence of the Corporate Event, and (B) effectuated by such means as are approved by the Committee; and

(5)The replacement of any or all Awards (other than Awards that are intended to qualify as “stock rights” that do not provide for a “deferral of compensation” within the meaning of Section 409A of the Code) with a cash incentive program that preserves the value of the Awards so replaced (determined as of the consummation of the Corporate Event), with subsequent payment of cash incentives subject to the same vesting conditions as applicable to the Awards so replaced and payment to be made within thirty (30) days of the applicable vesting date.

Payments to holders pursuant to paragraph (3) above shall be made in cash or, in the sole discretion of the Committee, and to the extent applicable, in the form of such other consideration necessary for a Participant to receive property, cash, or securities (or a combination thereof) as such Participant would have been entitled to receive upon the occurrence of the transaction if the Participant had been, immediately prior to such transaction, the holder of the number of shares of Stock covered by the Award at such time (less any applicable exercise or base price). In addition, in connection with any Corporate Event, prior to any payment or adjustment contemplated under this Section 11(b), the Committee may require a Participant to (A) represent and warrant as to the unencumbered title to his or her Awards, (B) bear such Participant’s pro-rata share of any post-

16

closing indemnity obligations, and be subject to the same post-closing purchase price adjustments, escrow terms, offset rights, holdback terms, and similar conditions as the other holders of Stock, and (C) deliver customary transfer documentation as reasonably determined by the Committee. The Committee need not take the same action or actions with respect to all Awards or portions thereof or with respect to all Participants. The Committee may take different actions with respect to the vested and unvested portions of an Award.

(c)Fractional Shares. Any adjustment provided under this Section 11 may, in the Committee’s discretion, provide for the elimination of any fractional share that might otherwise become subject to an Award. No cash settlements shall be made with respect to fractional shares so eliminated.

12.Use of Proceeds.

The proceeds received from the sale of Stock pursuant to the Plan shall be used for general corporate purposes.

13.Rights and Privileges as a Stockholder.

Except as otherwise specifically provided in the Plan, no Person shall be entitled to the rights and privileges of Stock ownership in respect of shares of Stock that are subject to Awards hereunder until such shares have been issued to that Person.

14.Transferability of Awards.

Awards may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the applicable laws of descent and distribution, and to the extent subject to exercise, Awards may not be exercised during the lifetime of the grantee other than by the grantee. Notwithstanding the foregoing, except with respect to Incentive Stock Options, Awards and a Participant’s rights under the Plan shall be transferable for no value to the extent provided in an Award Agreement or otherwise determined at any time by the Committee.

15.Employment or Service Rights.

No individual shall have any claim or right to be granted an Award under the Plan or, having been selected for the grant of an Award, to be selected for the grant of any other Award. Neither the Plan nor any action taken hereunder shall be construed as giving any individual any right to be retained in the employ or service of the Company or an Affiliate of the Company.

16.Compliance with Laws.

The obligation of the Company to deliver Stock upon issuance, vesting, exercise, or settlement of any Award shall be subject to all applicable laws, rules, and regulations, and to such approvals by governmental agencies as may be required. Notwithstanding any terms or conditions of any Award to the contrary, the Company shall be under no obligation to offer to sell or to sell, and shall be prohibited from offering to sell or selling, any shares of Stock pursuant to an Award unless such shares have been properly registered for sale with the U.S. Securities and Exchange Commission pursuant to the Securities Act (or with a similar non-U.S. regulatory agency pursuant to a similar law or regulation) or unless the Company has received an opinion of counsel, satisfactory to the Company, that such shares may be offered or sold without such registration pursuant to an available exemption therefrom and the terms and conditions of such exemption have been fully complied with. The Company shall be under no obligation to register for sale or resale under the Securities Act any of the shares of Stock to be offered or sold

17

under the Plan or any shares of Stock to be issued upon exercise or settlement of Awards. If the shares of Stock offered for sale or sold under the Plan are offered or sold pursuant to an exemption from registration under the Securities Act, the Company may restrict the transfer of such shares and may legend the Stock certificates representing such shares in such manner as it deems advisable to ensure the availability of any such exemption.

17.Withholding Obligations.

As a condition to the issuance, vesting, exercise, or settlement of any Award (or upon the making of an election under Section 83(b) of the Code), the Committee may require that a Participant satisfy, through deduction or withholding from any payment of any kind otherwise due to the Participant, or through such other arrangements as are satisfactory to the Committee, the amount of all federal, state, and local income and other taxes of any kind required or permitted to be withheld in connection with such issuance, vesting, exercise, or settlement (or election). The Committee, in its discretion, may permit shares of Stock to be used to satisfy tax withholding requirements, and such shares shall be valued at their Fair Market Value as of the issuance, vesting, exercise, or settlement date of the Award, as applicable. Depending on the withholding method, the Company may withhold by considering the applicable minimum statutorily required withholding rates or other applicable withholding rates in the applicable Participant’s jurisdiction, including maximum applicable rates that may be utilized without creating adverse accounting treatment under Financial Accounting Standards Board Accounting Standards Codification Topic 718 (or any successor pronouncement thereto).

18.Amendment of the Plan or Awards.

(a)Amendment of Plan. The Board or the Committee may amend the Plan at any time and from time to time.

(b)Amendment of Awards. The Board or the Committee may amend the terms of any one or more Awards at any time and from time to time.

(c)Stockholder Approval; No Material Impairment. Notwithstanding anything herein to the contrary, no amendment to the Plan or any Award shall be effective without stockholder approval to the extent that such approval is required pursuant to applicable law or the applicable rules of each national securities exchange on which the Stock is listed. Additionally, no amendment to the Plan or any Award shall materially impair a Participant’s rights under any Award unless the Participant consents in writing (it being understood that no action taken by the Board or the Committee that is expressly permitted under the Plan, including, without limitation, any actions described in Section 11 hereof, shall constitute an amendment to the Plan or an Award for such purpose). Notwithstanding the foregoing, subject to the limitations of applicable law, if any, and without an affected Participant’s consent, the Board or the Committee may amend the terms of the Plan or any one or more Awards from time to time as necessary to bring such Awards into compliance with applicable law, including, without limitation, Section 409A of the Code.

(d)No Repricing of Awards Without Stockholder Approval. Notwithstanding Section 18(a) or 18(b) above, or any other provision of the Plan, the repricing of Awards shall not be permitted without stockholder approval. For this purpose, a “repricing” means any of the following (or any other action that has the same effect as any of the following): (1) changing the terms of an Award to lower its exercise or base price (other than on account of capital adjustments resulting from share splits, etc., as described in Section 11(a) hereof), (2) any other action that is treated as a repricing under GAAP, and (3) repurchasing for cash or canceling an Award in exchange for another Award at a time when its exercise or base price is greater than the

18

Fair Market Value of the underlying Stock, unless the cancellation and exchange occurs in connection with an event set forth in Section 11(b) hereof.

19.Termination or Suspension of the Plan.

The Board or the Committee may suspend or terminate the Plan at any time. Unless sooner terminated, the Plan shall terminate on the day before the tenth (10th) anniversary of the date the stockholders of the Company approve the second amendment and restatement of the Plan, as approved on the Second Restatement Date. No Awards may be granted under the Plan while the Plan is suspended or after it is terminated; provided, however, that following any suspension or termination of the Plan, the Plan shall remain in effect for the purpose of governing all Awards then outstanding hereunder until such time as all Awards under the Plan have been terminated, forfeited, or otherwise canceled, or earned, exercised, settled, or otherwise paid out, in accordance with their terms.

20.Effective Date of the Plan.

The Plan is effective as of the Effective Date.

21.Miscellaneous.

(a)Certificates. Stock acquired pursuant to Awards granted under the Plan may be evidenced in such a manner as the Committee shall determine. If certificates representing Stock are registered in the name of the Participant, the Committee may require that (1) such certificates bear an appropriate legend referring to the terms, conditions, and restrictions applicable to such Stock, (2) the Company retain physical possession of the certificates, and (3) the Participant deliver a stock power to the Company, endorsed in blank, relating to the Stock. Notwithstanding the foregoing, the Committee may determine, in its sole discretion, that the Stock shall be held in book-entry form rather than delivered to the Participant pending the release of any applicable restrictions.

(b)Clawback/Recoupment Policy. Notwithstanding anything contained herein to the contrary, all Awards granted under the Plan shall be and remain subject to any incentive compensation clawback or recoupment policy currently in effect or as may be adopted by the Board (or a committee or subcommittee of the Board) and, in each case, as may be amended from time to time. No such policy adoption or amendment shall in any event require the prior consent of any Participant. No recovery of compensation under such a clawback policy will be an event giving rise to a right to resign for “good reason” or “constructive termination” (or similar term) under any agreement with the Company or any of its Affiliates. In the event that an Award is subject to more than one such policy, the policy with the most restrictive clawback or recoupment provisions shall govern such Award, subject to applicable law.

(c)Data Privacy. As a condition of receipt of any Award, each Participant explicitly and unambiguously consents to the collection, use, and transfer, in electronic or other form, of personal data as described in this Section 21(c) by and among, as applicable, the Company and its Affiliates for the exclusive purpose of implementing, administering, and managing the Plan and Awards and the Participant’s participation in the Plan. In furtherance of such implementation, administration, and management, the Company and its Affiliates may hold certain personal information about a Participant, including, but not limited to, the Participant’s name, home address, telephone number, date of birth, social security or insurance number or other identification number, salary, nationality, job title(s), information regarding any securities of the Company or any of its Affiliates, and details of all Awards (the “Data”). In addition to transferring the Data amongst themselves as necessary for the purpose of implementation, administration, and management of the Plan and Awards and the Participant’s participation in the

19

Plan, the Company and its Affiliates may each transfer the Data to any third parties assisting the Company in the implementation, administration, and management of the Plan and Awards and the Participant’s participation in the Plan. Recipients of the Data may be located in the Participant’s country or elsewhere, and the Participant’s country and any given recipient’s country may have different data privacy laws and protections. By accepting an Award, each Participant authorizes such recipients to receive, possess, use, retain, and transfer the Data, in electronic or other form, for the purposes of assisting the Company in the implementation, administration, and management of the Plan and Awards and the Participant’s participation in the Plan, including any requisite transfer of such Data as may be required to a broker or other third party with whom the Company or the Participant may elect to deposit any shares of Stock. The Data related to a Participant will be held only as long as is necessary to implement, administer, and manage the Plan and Awards and the Participant’s participation in the Plan. A Participant may, at any time, view the Data held by the Company with respect to such Participant, request additional information about the storage and processing of the Data with respect to such Participant, recommend any necessary corrections to the Data with respect to the Participant, or refuse or withdraw the consents herein in writing, in any case without cost, by contacting his or her local human resources representative. The Company may cancel the Participant’s eligibility to participate in the Plan, and in the Committee’s discretion, the Participant may forfeit any outstanding Awards if the Participant refuses or withdraws the consents described herein. For more information on the consequences of refusal to consent or withdrawal of consent, Participants may contact their local human resources representative.

(d)Participants Outside of the United States. The Committee may modify the terms of any Award under the Plan made to or held by a Participant who is then a resident, or is primarily employed or providing services, outside of the United States in any manner deemed by the Committee to be necessary or appropriate in order that such Award shall conform to laws, regulations, and customs of the country in which the Participant is then a resident or primarily employed or providing services, or so that the value and other benefits of the Award to the Participant, as affected by non-U.S. tax laws and other restrictions applicable as a result of the Participant’s residence, employment, or providing services abroad, shall be comparable to the value of such Award to a Participant who is a resident, or is primarily employed or providing services, in the United States. An Award may be modified under this Section 21(d) in a manner that is inconsistent with the express terms of the Plan, so long as such modifications will not contravene any applicable law or regulation or result in actual liability under Section 16(b) of the Exchange Act for the Participant whose Award is modified. Additionally, the Committee may adopt such procedures and sub-plans as are necessary or appropriate to permit participation in the Plan by Eligible Persons who are non-U.S. nationals or are primarily employed or providing services outside the United States.

(e)No Liability of Committee Members. Neither any member of the Committee nor any of the Committee’s permitted delegates shall be liable personally by reason of any contract or other instrument executed by such member or on his or her behalf in his or her capacity as a member of the Committee or for any mistake of judgment made in good faith, and the Company shall indemnify and hold harmless each member of the Committee and each other employee, officer, or director of the Company to whom any duty or power relating to the administration or interpretation of the Plan may be allocated or delegated, against all costs and expenses (including counsel fees) and liabilities (including sums paid in settlement of a claim) arising out of any act or omission to act in connection with the Plan, unless arising out of such Person’s own fraud or willful misconduct; provided, however, that approval of the Board shall be required for the payment of any amount in settlement of a claim against any such Person. The foregoing right of indemnification shall not be exclusive of any other rights of indemnification to which such Persons may be entitled under the Company’s certificate or articles of incorporation or byelaws, each as may be amended from time to time, as a matter of law, or otherwise, or any power that the Company may have to indemnify them or hold them harmless.

20

(f)Payments Following Accidents or Illness. If the Committee shall find that any Person to whom any amount is payable under the Plan is unable to care for his or her affairs because of illness or accident, or is a minor, or has died, then any payment due to such Person or his or her estate (unless a prior claim therefor has been made by a duly appointed legal representative) may, if the Committee so directs the Company, be paid to his or her spouse, child, relative, an institution maintaining or having custody of such Person, or any other Person deemed by the Committee to be a proper recipient on behalf of such Person otherwise entitled to payment. Any such payment shall be a complete discharge of the liability of the Committee and the Company therefor.

(g)Governing Law. The Plan shall be governed by and construed in accordance with the internal laws of Bermuda without reference to the principles of conflicts of laws thereof.

(h)Funding. No provision of the Plan shall require the Company, for the purpose of satisfying any obligations under the Plan, to purchase assets or place any assets in a trust or other entity to which contributions are made or otherwise to segregate any assets, nor shall the Company be required to maintain separate bank accounts, books, records, or other evidence of the existence of a segregated or separately maintained or administered fund for such purposes. Participants shall have no rights under the Plan other than as unsecured general creditors of the Company, except that insofar as they may have become entitled to payment of additional compensation by performance of services, they shall have the same rights as other employees and service providers under general law.

(i)Reliance on Reports. Each member of the Committee and each member of the Board shall be fully justified in relying, acting, or failing to act, and shall not be liable for having so relied, acted, or failed to act in good faith, upon any report made by the independent public accountant of the Company and its Affiliates and upon any other information furnished in connection with the Plan by any Person or Persons other than such member.

(j)Electronic Delivery of Documents. The Company may deliver by email or other electronic means (including posting on a web site maintained by the Company or by a third party under contract with the Company) all documents relating to the Plan or any Award thereunder (including without limitation, Plan prospectuses) and all other documents that the Company is required to deliver to its stockholders (including without limitation, annual reports and proxy statements).

(k)Titles and Headings. The titles and headings of the sections in the Plan are for convenience of reference only, and in the event of any conflict, the text of the Plan, rather than such titles or headings, shall control.

*    *    *

21

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Mark A. Casale, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Essent Group Ltd.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 9, 2023 

/s/ MARK A. CASALE

Mark A. Casale

President, Chief Executive Officer and Chairman

(Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION

I, David B. Weinstock, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Essent Group Ltd.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 9, 2023 

/s/ DAVID B. WEINSTOCK

David B. Weinstock

Senior Vice President and Chief Financial Officer

(Principal Financial Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, Mark A. Casale, President, Chief Executive Officer and Chairman of Essent Group Ltd. (the “Company”), and David B. Weinstock, Senior Vice President and Chief Financial Officer of the Company, each hereby certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

(1) the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2023 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 9, 2023

/s/ MARK A. CASALE

Mark A. Casale

President, Chief Executive Officer and Chairman

/s/ DAVID B. WEINSTOCK

David B. Weinstock

Senior Vice President and Chief Financial Officer

XML

Cover Page - shares	3 Months Ended
	Mar. 31, 2023	May 05, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2023
Document Transition Report	false
Entity File Number	001-36157
Entity Registrant Name	ESSENT GROUP LTD.
Entity Incorporation, State or Country Code	D0
Entity Address, Address Line One	Clarendon House
Entity Address, Address Line Two	2 Church Street
Entity Address, City or Town	Hamilton
Entity Address, Postal Zip Code	HM11
Entity Address, Country	BM
City Area Code	441
Local Phone Number	297-9901
Title of 12(b) Security	Common Shares, $0.015 par value
Trading Symbol	ESNT
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		107,258,772
Entity Central Index Key	0001448893
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1

XML

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Investments
Total investments available for sale	$ 4,950,036	$ 4,741,625
Other invested assets	255,288	257,941
Total investments	5,205,324	4,999,566
Cash	68,633	81,240
Accrued investment income	36,896	33,162
Accounts receivable	61,282	57,399
Deferred policy acquisition costs	9,511	9,910
Property and equipment (at cost, less accumulated depreciation of $68,050 in 2023 and $67,352 in 2022)	18,514	19,571
Prepaid federal income tax	418,460	418,460
Other assets	108,886	104,489
Total assets	5,927,506	5,723,797
Liabilities
Reserve for losses and LAE	216,022	216,464
Unearned premium reserve	157,529	162,887
Net deferred tax liability	383,116	356,810
Credit facility borrowings (at carrying value, less unamortized deferred costs of $3,872 in 2023 and $4,136 in 2022)	421,128	420,864
Other accrued liabilities	100,770	104,463
Total liabilities	1,278,565	1,261,488
Commitments and contingencies (see Note 7)
Stockholders’ Equity
Common shares, $0.015 par value: Authorized - 233,333; issued and outstanding - 107,659 shares in 2023 and 107,683 shares in 2022	1,615	1,615
Additional paid-in capital	1,334,607	1,350,377
Accumulated other comprehensive loss	(324,037)	(382,790)
Retained earnings	3,636,756	3,493,107
Total stockholders’ equity	4,648,941	4,462,309
Total liabilities and stockholders’ equity	5,927,506	5,723,797
Fixed maturities available for sale, at fair value (amortized cost: 2023 — $4,977,284; 2022 — $4,932,574)
Investments
Total investments available for sale	4,602,284	4,489,598
Short-term investments available for sale, at fair value (amortized cost: 2023 — $347,800; 2022 — $252,282)
Investments
Total investments available for sale	$ 347,752	$ 252,027

XML

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) shares in Thousands, $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Investment available for sale
Amortized cost	$ 5,325,085	$ 5,184,856
Property and equipment
Accumulated depreciation	68,050	67,352
Credit facility borrowings
Unamortized deferred costs	$ 3,872	$ 4,136
Stockholders’ equity
Common shares, par value (in dollars per share)	$ 0.015	$ 0.015
Common shares, authorized (in shares)	233,333	233,333
Common shares, issued (in shares)	107,659	107,683
Common shares, outstanding (in shares)	107,659	107,683
Fixed maturities
Investment available for sale
Amortized cost	$ 4,977,284	$ 4,932,574
Short-term investments
Investment available for sale
Amortized cost	$ 347,800	$ 252,282

XML

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenues:
Net premiums written	$ 205,900	$ 199,731
Decrease in unearned premiums	5,358	15,599
Net premiums earned	211,258	215,330
Net investment income	43,236	24,680
Realized investment losses, net	(488)	(7,352)
(Loss) income from other invested assets	(2,702)	24,705
Other income	4,942	7,248
Total revenues	256,246	264,611
Losses and expenses:
(Benefit) provision for losses and LAE	(180)	(106,858)
Other underwriting and operating expenses	48,195	40,796
Interest expense	6,936	2,226
Total losses and expenses	54,951	(63,836)
Income before income taxes	201,295	328,447
Income tax expense	30,468	54,280
Net income	$ 170,827	$ 274,167
Earnings per share:
Basic (in dollars per share)	$ 1.60	$ 2.53
Diluted (in dollars per share)	$ 1.59	$ 2.52
Weighted average shares outstanding:
Basic (in shares)	106,943	108,166
Diluted (in shares)	107,585	108,590
Net income	$ 170,827	$ 274,167
Other comprehensive income (loss):
Change in unrealized appreciation (depreciation) of investments, net of tax expense (benefit) of $9,428 and ($35,897) in the three months ended March 31, 2023 and 2022	58,753	(203,006)
Total other comprehensive income (loss)	58,753	(203,006)
Comprehensive income	$ 229,580	$ 71,161

XML

Condensed Consolidated Statements of Comprehensive Income (Unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Statement of Comprehensive Income [Abstract]
Change in unrealized appreciation (depreciation) of investments, tax expense (benefit)	$ 9,428	$ (35,897)

XML

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Shares	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings	Treasury Stock
Balance, beginning of period at Dec. 31, 2021		$ 1,641	$ 1,428,952	$ 50,707	$ 2,754,814	$ 0
Changes in Stockholders' Equity
Dividends and dividend equivalents declared			227		(21,819)
Issuance of management incentive shares		7	(7)
Stock-based compensation expense			4,807
Treasury stock acquired						(75,422)
Cancellation of treasury stock		(26)	(75,396)			75,422
Other comprehensive income (loss)	$ (203,006)			(203,006)
Net income	274,167				274,167
Balance, end of period at Mar. 31, 2022	4,215,068	1,622	1,358,583	(152,299)	3,007,162	0
Balance, beginning of period at Dec. 31, 2022	4,462,309	1,615	1,350,377	(382,790)	3,493,107	0
Changes in Stockholders' Equity
Dividends and dividend equivalents declared			403		(27,178)
Issuance of management incentive shares		8	(8)
Stock-based compensation expense			5,106
Treasury stock acquired						(21,279)
Cancellation of treasury stock		(8)	(21,271)			21,279
Other comprehensive income (loss)	58,753			58,753
Net income	170,827				170,827
Balance, end of period at Mar. 31, 2023	$ 4,648,941	$ 1,615	$ 1,334,607	$ (324,037)	$ 3,636,756	$ 0

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating Activities
Net income	$ 170,827	$ 274,167
Adjustments to reconcile net income to net cash provided by operating activities:
Loss on the sale of investments, net	488	7,352
Loss (income) from other invested assets	2,702	(24,705)
Distribution of income from other invested assets	851	4,452
Depreciation and amortization	698	755
Stock-based compensation expense	5,106	4,807
Amortization of premium on investment securities	3,203	7,123
Deferred income tax provision	16,878	22,162
Change in:
Accrued investment income	(3,734)	3,313
Accounts receivable	(2,602)	1,009
Deferred policy acquisition costs	399	1,030
Other assets	(4,061)	4,910
Reserve for losses and LAE	(442)	(114,373)
Unearned premium reserve	(5,358)	(15,599)
Other accrued liabilities	(166)	4,226
Net cash provided by operating activities	184,789	180,629
Investing Activities
Net change in short-term investments	(95,725)	(204,276)
Purchase of investments available for sale	(798,280)	(281,565)
Proceeds from maturity of investments available for sale	412,441	54,035
Proceeds from sales of investments available for sale	333,513	493,211
Purchase of other invested assets	(1,945)	(21,796)
Return of investment from other invested assets	1,044	0
Purchase of property and equipment	(390)	(716)
Net cash (used in) provided by investing activities	(149,342)	38,893
Financing Activities
Treasury stock acquired	(21,279)	(75,422)
Payment of issuance costs for credit facility	0	(154)
Dividends paid	(26,775)	(21,592)
Net cash used in financing activities	(48,054)	(97,168)
Net (decrease) increase in cash	(12,607)	122,354
Cash at beginning of year	81,240	81,491
Cash at end of period	68,633	203,845
Supplemental Disclosure of Cash Flow Information
Income tax payments	0	0
Interest payments	(6,402)	(1,886)
Noncash Transactions
Lease liabilities arising from obtaining right-of-use assets	$ 87	$ 9,174

XML

Nature of Operations and Basis of Presentation

3 Months Ended

Mar. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Nature of Operations and Basis of Presentation

Nature of Operations and Basis of Presentation

Essent Group Ltd. (“Essent Group”) is a Bermuda-based holding company, which, through its wholly-owned subsidiaries, offers private mortgage insurance and reinsurance for mortgages secured by residential properties located in the United States. Mortgage insurance facilitates the sale of low down payment (generally less than 20%) mortgage loans into the secondary mortgage market, primarily to two government-sponsored enterprises (“GSEs”), Fannie Mae and Freddie Mac.

The primary mortgage insurance operations are conducted through Essent Guaranty, Inc. (“Essent Guaranty”), which is domiciled in the state of Pennsylvania. Essent Guaranty is headquartered in Radnor, Pennsylvania and maintains an operations center in Winston-Salem, North Carolina. Essent Guaranty is approved as a qualified mortgage insurer by the GSEs and is licensed to write mortgage insurance in all 50 states and the District of Columbia.

Essent Guaranty reinsures new insurance written ("NIW") to Essent Reinsurance Ltd. (“Essent Re”), an affiliated Bermuda domiciled Class 3A Insurer licensed pursuant to Section 4 of the Bermuda Insurance Act 1978 that provides insurance and reinsurance coverage of mortgage credit risk. In April 2021, Essent Guaranty and Essent Re agreed to increase the quota share reinsurance coverage provided by Essent Re from 25% to 35% effective January 1, 2021. The quota share reinsurance coverage provided for Essent Guaranty’s NIW prior to January 1, 2021 will continue to be 25%, the quota share percentage in effect at the time NIW was first ceded. Essent Re also provides insurance and reinsurance to Freddie Mac and Fannie Mae. In 2016, Essent Re formed Essent Agency (Bermuda) Ltd., a wholly-owned subsidiary, which provides underwriting consulting services to third-party reinsurers. In accordance with certain state law requirements, Essent Guaranty also reinsures that portion of the risk that is in excess of 25% of the mortgage balance with respect to any loan insured prior to April 1, 2019, after consideration of other reinsurance, to Essent Guaranty of PA, Inc. (“Essent PA”), an affiliate domiciled in the state of Pennsylvania.

In addition to offering mortgage insurance, we provide contract underwriting services on a limited basis through CUW Solutions, LLC ("CUW Solutions"), a Delaware limited liability company, that provides, among other things, mortgage contract underwriting services to lenders and mortgage insurance underwriting services to affiliates. CUW Solutions is headquartered in Radnor, Pennsylvania and it maintains an operations center in Winston-Salem, North Carolina that is subleased from Essent Guaranty.

We have prepared the condensed consolidated financial statements included herein pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). We have condensed or omitted certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) pursuant to such rules and regulations. In the opinion of management, the statements include all adjustments (which include normal recurring adjustments) required for a fair statement of financial position, results of operations and cash flows for the interim periods presented. These statements should be read in conjunction with the consolidated financial statements and notes thereto, including Note 1 and Note 2 to the consolidated financial statements, included in our Annual Report on Form 10-K for the year ended December 31, 2022, which discloses the principles of consolidation and a summary of significant accounting policies. The results of operations for the interim periods are not necessarily indicative of the results for the full year. We evaluated the need to recognize or disclose events that occurred subsequent to March 31, 2023 prior to the issuance of these condensed consolidated financial statements.

XML

Recently Issued Accounting Standards

3 Months Ended

Mar. 31, 2023

Accounting Policies [Abstract]

Recently Issued Accounting Standards

Recently Issued Accounting Standards

Accounting Standards Not Yet Adopted

    In March 2020, the Financial Accounting Standards Board ("FASB") issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments in this update provide temporary optional guidance to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform. It provides optional expedients and exceptions for applying generally accepted accounting principles to contract, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. This standard may be elected and applied prospectively over time from March 12, 2020 through December 31, 2024, as amended by ASU

2022-06, as reference rate reform activities occur. The adoption of, and future elections under, this ASU are not expected to have a material impact on our consolidated financial statements as the ASU will ease, if warranted, the requirements for accounting for the future effects of the rate reform. We continue to monitor the impact the discontinuance of LIBOR or another reference rate will have on our contracts and other transactions.

In June 2022, the FASB issued ASU No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. This update clarifies the guidance in ASC 820 on the fair value measurement of an equity security that is subject to a contractual sale restriction and requires specific disclosures related to such an equity security. The update clarifies that a contractual sale restriction prohibiting the sale of an equity security is a characteristic of the reporting entity holding the equity security and is not included in the equity security's unit of account. Accordingly, an entity should not consider the contractual sale restriction when measuring the equity security’s fair value. The update also requires specific disclosures related to equity securities that are subject to contractual sale restrictions, including (1) the fair value of such equity securities reflected in the balance sheet, (2) the nature and remaining duration of the corresponding restrictions, and (3) any circumstances that could cause a lapse in the restrictions. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years, with early adoption permitted. The adoption of this ASU is not expected to have a material effect on the Company's consolidated operating results or financial position.

XML

Investments

3 Months Ended

Mar. 31, 2023

Investments, Debt and Equity Securities [Abstract]

Investments

Investments

Investments available for sale consist of the following:

March 31, 2023 (In thousands)	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value
U.S. Treasury securities	$	497,267	$	843	$	(22,326)	$	475,784
U.S. agency securities	12,696		8		(14)		12,690
U.S. agency mortgage-backed securities	950,645		1,286		(101,807)		850,124
Municipal debt securities (1)	650,470		5,489		(46,949)		609,010
Non-U.S. government securities	69,606		—		(6,588)		63,018
Corporate debt securities (2)	1,575,643		3,040		(116,087)		1,462,596
Residential and commercial mortgage securities	601,606		208		(59,801)		542,013
Asset-backed securities	680,460		314		(32,665)		648,109
Money market funds	286,692		—		—		286,692
Total investments available for sale	$	5,325,085	$	11,188	$	(386,237)	$	4,950,036

December 31, 2022 (In thousands)	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value
U.S. Treasury securities	$	584,173	$	341	$	(28,076)	$	556,438
U.S. agency securities	49,059		7		(8)		49,058
U.S. agency mortgage-backed securities	898,675		258		(115,190)		783,743
Municipal debt securities (1)	661,934		2,010		(61,254)		602,690
Non-U.S. government securities	69,651		—		(7,252)		62,399
Corporate debt securities (2)	1,546,513		1,195		(133,387)		1,414,321
Residential and commercial mortgage securities	577,915		390		(66,481)		511,824
Asset-backed securities	660,345		72		(35,856)		624,561
Money market funds	136,591		—		—		136,591
Total investments available for sale	$	5,184,856	$	4,273	$	(447,504)	$	4,741,625

	March 31,		December 31,
(1) The following table summarizes municipal debt securities as of :	2023		2022
Special revenue bonds	81.4	%	79.0	%
General obligation bonds	18.5		20.9
Certificate of participation bonds	—		—
Tax allocation bonds	0.1		0.1
Total	100.0	%	100.0	%

	March 31,		December 31,
(2) The following table summarizes corporate debt securities as of :	2023		2022
Financial	40.8	%	40.5	%
Consumer, non-cyclical	18.5		17.9
Consumer, cyclical	7.2		6.8
Industrial	6.7		6.8
Utilities	5.7		6.1
Communications	8.6		8.4
Technology	4.8		4.9
Energy	5.5		6.4
Basic Materials	2.1		2.1
Government	0.1		0.1
Total	100.0	%	100.0	%

The amortized cost and fair value of investments available for sale at March 31, 2023, by contractual maturity, are shown below. Expected maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Because most U.S. agency mortgage-backed securities, residential and commercial mortgage securities and asset-backed securities provide for periodic payments throughout their lives, they are listed below in separate categories.

(In thousands)	Amortized Cost		Fair Value
U.S. Treasury securities:
Due in 1 year	$	130,959	$	129,312
Due after 1 but within 5 years	313,584		297,672
Due after 5 but within 10 years	38,335		34,655
Due after 10 years	14,389		14,145
Subtotal	497,267		475,784
U.S. agency securities:
Due in 1 year	11,125		11,111
Due after 1 but within 5 years	1,571		1,579
Subtotal	12,696		12,690
Municipal debt securities:
Due in 1 year	6,006		5,977
Due after 1 but within 5 years	88,888		86,924
Due after 5 but within 10 years	175,352		167,037
Due after 10 years	380,224		349,072
Subtotal	650,470		609,010
Non-U.S. government securities:
Due in 1 year	10,020		10,012
Due after 1 but within 5 years	33,759		32,824
Due after 5 but within 10 years	5,532		4,512
Due after 10 years	20,295		15,670
Subtotal	69,606		63,018
Corporate debt securities:
Due in 1 year	241,103		238,178
Due after 1 but within 5 years	635,267		605,227
Due after 5 but within 10 years	484,388		433,797
Due after 10 years	214,885		185,394
Subtotal	1,575,643		1,462,596
U.S. agency mortgage-backed securities	950,645		850,124
Residential and commercial mortgage securities	601,606		542,013
Asset-backed securities	680,460		648,109
Money market funds	286,692		286,692
Total investments available for sale	$	5,325,085	$	4,950,036

The components of realized investment (losses) gains, net on the condensed consolidated statements of comprehensive income were as follows:

	Three Months Ended March 31,
(In thousands)	2023		2022
Realized gross gains	$	869	$	12,576
Realized gross losses	1,357		13,091
Impairment loss	—		6,837

The fair value of investments available for sale in an unrealized loss position and the related unrealized losses for which no allowance for credit loss has been recorded were as follows:

	Less than 12 months				12 months or more				Total
March 31, 2023 (In thousands)	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses
U.S. Treasury securities	$	184,036	$	(2,069)	$	256,893	$	(20,257)	$	440,929	$	(22,326)
U.S. agency securities	11,111		(14)		—		—		11,111		(14)
U.S. agency mortgage-backed securities	144,039		(3,586)		643,734		(98,221)		787,773		(101,807)
Municipal debt securities	150,068		(2,840)		244,856		(44,109)		394,924		(46,949)
Non-U.S. government securities	36,274		(472)		26,744		(6,116)		63,018		(6,588)
Corporate debt securities	467,974		(11,248)		774,083		(104,839)		1,242,057		(116,087)
Residential and commercial mortgage securities	136,012		(7,065)		395,814		(52,736)		531,826		(59,801)
Asset-backed securities	168,303		(4,755)		423,814		(27,910)		592,117		(32,665)
Total	$	1,297,817	$	(32,049)	$	2,765,938	$	(354,188)	$	4,063,755	$	(386,237)

	Less than 12 months				12 months or more				Total
December 31, 2022 (In thousands)	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses
U.S. Treasury securities	$	321,848	$	(12,381)	$	169,795	$	(15,695)	$	491,643	$	(28,076)
U.S. agency securities	7,117		(8)		—		—		7,117		(8)
U.S. agency mortgage-backed securities	351,310		(34,193)		415,743		(80,997)		767,053		(115,190)
Municipal debt securities	335,784		(41,620)		64,766		(19,634)		400,550		(61,254)
Non-U.S. government securities	48,071		(2,914)		14,328		(4,338)		62,399		(7,252)
Corporate debt securities	811,217		(69,415)		421,307		(63,972)		1,232,524		(133,387)
Residential and commercial mortgage securities	265,934		(22,628)		242,366		(43,853)		508,300		(66,481)
Asset-backed securities	333,080		(15,454)		258,572		(20,402)		591,652		(35,856)
Total	$	2,474,361	$	(198,613)	$	1,586,877	$	(248,891)	$	4,061,238	$	(447,504)

At March 31, 2023 and December 31, 2022, we held 2,526 and 2,578 individual investment securities, respectively, that were in an unrealized loss position. We assess our intent to sell these securities and whether we will be required to sell these securities before the recovery of their amortized cost basis when determining whether to record an impairment on the securities in an unrealized loss position. In assessing whether the decline in the fair value at March 31, 2023 of any of these securities resulted from a credit loss or other factors, we made inquiries of our investment managers to determine that each issuer was current on its scheduled interest and principal payments. We reviewed the credit rating of these securities noting that approximately 98% of the securities at March 31, 2023 had investment-grade ratings. We concluded that gross unrealized losses noted above were primarily associated with the changes in interest rates subsequent to purchase rather than due to credit

impairment. There were no impairments in the three months ended March 31, 2023. We recorded impairments of $6.8 million due to our intent to sell securities in an unrealized loss position in the three months ended March 31, 2022.

The Company's other invested assets at March 31, 2023 and December 31, 2022 totaled $255.3 million and $257.9 million, respectively. Other invested assets are principally comprised of limited partnership interests which are generally accounted for under the equity method or fair value using net asset value (or its equivalent) as a practical expedient. Our proportionate share of earnings or losses or changes in fair value are reported in income from other invested assets on the condensed consolidated statements of comprehensive income. For entities accounted for under the equity method that follow industry-specific guidance for investment companies, our proportionate share of earnings or losses includes changes in the fair value of the underlying assets of these entities. Due to the timing of receiving financial information from these partnerships, the results are generally reported on a one month or quarter lag.

Other invested assets that are accounted for at fair value using the net asset value (or its equivalent) as a practical expedient totaled $163.1 million as of March 31, 2023. The majority of these investments were in limited partnerships invested in real estate or consumer credit. At March 31, 2023, maximum future funding commitments were $49.0 million. For limited partnership investments that have a contractual expiration date, we expect the liquidation of the underlying assets to occur over the next one to eight years. For certain of these investments, the Company does not have the contractual option to redeem but receives distributions based on the liquidation of the underlying assets. In addition, the Company generally does not have the ability to sell or transfer these investments without the consent from the general partner of individual limited partnerships.

The fair value of investments deposited with insurance regulatory authorities to meet statutory requirements was $9.2 million at March 31, 2023 and $9.1 million at December 31, 2022. In connection with its insurance and reinsurance activities, Essent Re is required to maintain assets in trusts for the benefit of its contractual counterparties. The fair value of the investments on deposit in these trusts was $671.8 million at March 31, 2023 and $972.4 million at December 31, 2022. Essent Guaranty is required to maintain assets on deposit in connection with its fully collateralized reinsurance agreements (see Note 4). The fair value of the assets on deposit was $8.7 million at March 31, 2023 and $8.6 million at December 31, 2022. Essent Guaranty is also required to maintain assets on deposit for the benefit of the sponsor of a fixed income investment commitment. The fair value of the assets on deposit was $9.1 million at March 31, 2023 and $9.1 million at December 31, 2022.

Net investment income consists of: 

	Three Months Ended March 31,
(In thousands)	2023		2022
Fixed maturities	$	43,473	$	26,223
Short-term investments	1,721		44
Gross investment income	45,194		26,267
Investment expenses	(1,958)		(1,587)
Net investment income	$	43,236	$	24,680

XML

Reinsurance

3 Months Ended

Mar. 31, 2023

Reinsurance Disclosures [Abstract]

Reinsurance

Reinsurance

In the ordinary course of business, our insurance subsidiaries may use reinsurance to provide protection against adverse loss experience and to expand our capital sources. Reinsurance recoverables are recorded as assets and included in other assets on our condensed consolidated balance sheets, predicated on a reinsurer's ability to meet their obligations under the reinsurance agreements. If the reinsurers are unable to satisfy their obligations under the agreements, our insurance subsidiaries would be liable for such defaulted amounts.

The effect of reinsurance on net premiums written and earned is as follows:

	Three Months Ended  March 31,
(In thousands)	2023		2022
Net premiums written:
Direct	$	239,491	$	220,254
Ceded (1)	(33,591)		(20,523)
Net premiums written	$	205,900	$	199,731
Net premiums earned:
Direct	$	244,849	$	235,853
Ceded (1)	(33,591)		(20,523)
Net premiums earned	$	211,258	$	215,330

(1)Net of profit commission.

Quota Share Reinsurance

    Essent Guaranty has entered into quota share reinsurance agreements with a panels of third-party reinsurers ("QSR" agreements). Each of the third-party reinsurers has an insurer financial strength rating of A- or better by S&P Global Ratings, A.M. Best or both. Under each QSR agreement, Essent Guaranty will cede premiums earned on all eligible policies written during a specified period, in exchange for reimbursement of ceded claims and claims expenses on covered policies, a specified ceding commission, and a profit commission that varies directly and inversely with ceded claims. Essent Guaranty has certain termination rights under each QSR agreement, including the option to terminate each QSR agreement subject to a termination fee.

The following tables summarizes Essent Guaranty's quota share reinsurance agreements as of March 31, 2023:

QSR Agreement	Coverage Period	Ceding Percentage	Ceding Commission	Profit Commission
QSR-2019	September 1, 2019-December 31, 2020	(1)	20%	63%	(2)
QSR-2022	January 1, 2022-December 31, 2022	20%	20%	62%
QSR-2023	January 1, 2023-December 31, 2023	17.5%	20%	58%

_______________________________________________________________________________

(1)Under QSR-2019, Essent Guaranty cedes 40% of premiums on singles policies and 20% on all other policies.

(2)The original profit commission on QSR-2019 was up to 60%; however because Essent Guaranty did not exercise its option to terminate the QSR Agreement on December 31, 2021, the maximum profit commission that Essent Guaranty could earn increased to 63% in 2022 and thereafter.

Total RIF ceded under the QSR agreements was $7.3 billion as of March 31, 2023.

Excess of Loss Reinsurance

Essent Guaranty has entered into fully collateralized reinsurance agreements ("Radnor Re Transactions") with unaffiliated special purpose insurers domiciled in Bermuda. For the reinsurance coverage periods, Essent Guaranty and its affiliates retain the first layer of the respective aggregate losses, and a Radnor Re special purpose insurer will then provide second layer coverage up to the outstanding reinsurance coverage amount. Essent Guaranty and its affiliates retain losses in excess of the outstanding reinsurance coverage amount. The reinsurance premium due to each Radnor Re special purpose insurer is calculated by multiplying the outstanding reinsurance coverage amount at the beginning of a period by a coupon rate, which is the sum of one-month LIBOR or SOFR plus a risk margin, and then subtracting actual investment income collected on the assets in the related reinsurance trust during that period. The aggregate excess of loss reinsurance coverage decreases over a ten-year period as the underlying covered mortgages amortize. Essent Guaranty has rights to terminate the Radnor Re

Transactions. The Radnor Re entities collateralized the coverage by issuing mortgage insurance-linked notes ("ILNs") in an aggregate amount equal to the initial coverage to unaffiliated investors. The notes have ten-year legal maturities and are non-recourse to any assets of Essent Guaranty or its affiliates. The proceeds of the notes were deposited into reinsurance trusts for the benefit of Essent Guaranty and will be the source of reinsurance claim payments to Essent Guaranty and principal repayments on the ILNs.

Essent Guaranty has also entered into reinsurance agreements with panels of reinsurers that provide aggregate excess of loss coverage immediately above or pari-passu to the coverage provided by the Radnor Re Transactions. The aggregate excess of loss reinsurance coverage decreases over a ten-year period as the underlying covered mortgages amortize. Essent Guaranty has rights to terminate these reinsurance agreements.

Essent Guaranty entered into a reinsurance agreement with a panel of reinsurers that provides excess of loss coverage on new insurance written from October 1, 2021 through December 31, 2022. For the reinsurance coverage period, Essent Guaranty and its affiliates retain the first layer of the respective aggregate losses, and the reinsurance panel will then provide second layer coverage up to the outstanding reinsurance coverage amount. Essent Guaranty and its affiliates retain losses in excess of the outstanding reinsurance coverage amount.

The following table summarizes Essent Guaranty's excess of loss reinsurance agreements as of March 31, 2023:

Vintage Year	Reinsurer	Effective Date	Optional Termination Date
2017	Panel of Reinsurers	November 1, 2018	October 1, 2023	(1)
2018	Radnor Re 2019-1 Ltd.	February 28, 2019	February 25, 2026
2018	Panel of Reinsurers	February 28, 2019	February 25, 2026
2019	Radnor Re 2020-1 Ltd.	January 30, 2020	January 25, 2027
2019	Panel of Reinsurers	January 30, 2020	January 25, 2027
2020 & 2021	Radnor Re 2021-1 Ltd.	June 23, 2021	June 26, 2028
2021	Radnor Re 2021-2 Ltd.	November 10, 2021	November 25, 2027
2021 & 2022	Panel of Reinsurers	June 1, 2022	January 1, 2030
2021 & 2022	Radnor Re 2022-1 Ltd.	September 21, 2022	September 25, 2028

(1) If the reinsurance agreement is not terminated at the optional termination date, the reinsurance premium increases by 50%.

The following table summarizes Essent Guaranty's excess of loss reinsurance coverages and retentions as of March 31, 2023:

(In thousands)					Remaining Reinsurance in Force
Vintage Year	Remaining Insurance in Force		Remaining Risk in Force		ILN		Other Reinsurance			Total		Remaining First Layer Retention
2017	5,511,131		1,450,432		—		70,895		(7)	70,895		421,003		(10)
2018	6,349,474		1,644,287		325,537		76,144		(8)	401,681		248,221
2019 (2)	7,859,217		2,029,598		395,889		43,991		(9)	439,880		214,485
2020 & 2021 (3)	38,168,321		9,652,777		414,005		—			414,005		278,909
2021 (4)	40,543,749		10,825,130		399,786		—			399,786		279,400
2021 & 2022 (5)	74,276,338		19,998,840		—		141,992			141,992		507,114
2021 & 2022 (6)	33,357,208		8,966,697		237,868		—			237,868		303,761
Total	$	206,065,438	$	54,567,761	$	1,773,085	$	333,022		$	2,106,107	$	2,025,706	(11)

(2) Reinsurance coverage on new insurance written from January 1, 2019 through August 31, 2019.

(3) Reinsurance coverage on new insurance written from August 1, 2020 through March 31, 2021.

(4) Reinsurance coverage on new insurance written from April 1, 2021 through September 30, 2021.

(5) Reinsurance coverage on new insurance written from October 1, 2021 through December 31, 2022.

(6) Reinsurance coverage on new insurance written from October 1, 2021 through July 31, 2022.

(7) Coverage provided immediately above the coverage provided by Radnor Re 2018-1 Ltd.

(8) Coverage provided pari-passu to the coverage provided by Radnor Re 2019-1 Ltd.

(9) Coverage provided pari-passu to the coverage provided by Radnor Re 2020-1 Ltd.

(10) The original and remaining first layer retention is associated with reinsurance provided by a panel of reinsurers. Amounts reported in prior periods reflected the retention associated with an ILN that is no longer outstanding as of March 31, 2023.

(11) The total remaining first layer retention differs from the sum of the individual reinsurance transactions as a result of overlapping coverage between certain transactions.

    Based on the level of delinquencies reported to us, the ILN transactions entered into prior to March 31, 2020 became subject to a "trigger event" as of June 25, 2020. The amortization of principal of the notes issued by the unaffiliated special purpose insurers in connection with those ILN transactions is suspended and the aggregate excess of loss reinsurance coverage will not amortize during the continuation of a trigger event. Radnor Re 2020-1 was no longer subject to a trigger event as of July 25, 2022.

The amount of monthly reinsurance premiums ceded to the Radnor Re entities will fluctuate due to changes in one-month LIBOR or SOFR and changes in money market rates that affect investment income collected on the assets in the reinsurance trusts. As the reinsurance premium will vary based on changes in these rates, we concluded that the Radnor Re Transactions contain embedded derivatives that will be accounted for separately like freestanding derivatives. The change in the fair value of the embedded derivatives is reported in earnings and included in other income.

In connection with the Radnor Re Transactions, we concluded that the risk transfer requirements for reinsurance accounting were met as each Radnor Re entity is assuming significant insurance risk and a reasonable possibility of a significant loss. In addition, we assessed whether each Radnor Re entity was a variable interest entity ("VIE") and the appropriate accounting for the Radnor Re entities if they were VIEs. A VIE is a legal entity that does not have sufficient equity at risk to finance its activities without additional subordinated financial support or is structured such that equity investors lack the ability to make significant decisions relating to the entity’s operations through voting rights or do not substantively participate in the gains and losses of the entity. A VIE is consolidated by its primary beneficiary. The primary beneficiary is the entity that has both (1) the power to direct the activities of the VIE that most significantly affect the entity’s economic performance and (2) the obligation to absorb losses or the right to receive benefits that could be potentially significant to the VIE. While also considering these factors, the consolidation conclusion depends on the breadth of the decision-making ability and ability to influence activities that significantly affect the economic performance of the VIE. We concluded that the Radnor Re entities are VIEs. However, given that Essent Guaranty (1) does not have the unilateral power to direct the activities that most significantly affect their economic performance and (2) does not have the obligation to absorb losses or the right to receive benefits that could be potentially significant to these entities, the Radnor Re entities are not consolidated in these financial statements.

The following table presents total assets of each Radnor Re special purpose insurer as well as our maximum exposure to loss associated with each Radnor Re entity, representing the fair value of the embedded derivatives, using observable inputs in active markets (Level 2), included in other assets (other accrued liabilities) on our condensed consolidated balance sheet and the estimated net present value of investment earnings on the assets in the reinsurance trusts, each as of March 31, 2023:

			Maximum Exposure to Loss
(In thousands)	Total VIE Assets		On - Balance Sheet		Off - Balance Sheet		Total
Radnor Re 2019-1 Ltd.	325,537		(2,218)		90		(2,128)
Radnor Re 2020-1 Ltd.	395,889		(1,286)		158		(1,128)
Radnor Re 2021-1 Ltd.	414,005		(4,657)		98		(4,559)
Radnor Re 2021-2 Ltd.	$	399,786	$	(3,849)	$	95	$	(3,754)
Radnor Re 2022-1 Ltd.	$	237,868	$	695	$	78	$	773
Total	$	1,773,085	$	(11,315)	$	519	$	(10,796)

XML

Reserve for Losses and Loss Adjustment Expenses

3 Months Ended

Mar. 31, 2023

Liability for Future Policy Benefits and Unpaid Claims and Claims Adjustment Expense [Abstract]

Reserve for Losses and Loss Adjustment Expenses

Reserve for Losses and Loss Adjustment Expenses

The following table provides a reconciliation of the beginning and ending reserve balances for losses and loss adjustment expenses (“LAE”) for the three months ended March 31:

(In thousands)	2023		2022
Reserve for losses and LAE at beginning of period	$	216,464	$	407,445
Less: Reinsurance recoverables	14,618		25,940
Net reserve for losses and LAE at beginning of period	201,846		381,505
Add provision for losses and LAE, net of reinsurance, occurring in:
Current period	32,694		24,369
Prior years	(32,874)		(131,227)
Net incurred losses and LAE during the current period	(180)		(106,858)
Deduct payments for losses and LAE, net of reinsurance, occurring in:
Current period	—		1
Prior years	2,001		909
Net loss and LAE payments during the current period	2,001		910
Net reserve for losses and LAE at end of period	199,665		273,737
Plus: Reinsurance recoverables	16,357		19,335
Reserve for losses and LAE at end of period	$	216,022	$	293,072

For the three months ended March 31, 2023, $2.0 million was paid for incurred claims and claim adjustment expenses attributable to insured events of prior years. There has been a $32.9 million favorable prior year development during the three months ended March 31, 2023. Reserves remaining as of March 31, 2023 for prior years are $167.0 million as a result of re-estimation of unpaid losses and loss adjustment expenses. For the three months ended March 31, 2022, $0.9 million was paid for incurred claims and claim adjustment expenses attributable to insured events of prior years. There was a $131.2 million favorable prior year development during the three months ended March 31, 2022. Reserves remaining as of March 31, 2022 for prior years were $249.4 million as a result of re-estimation of unpaid losses and loss adjustment expenses. In both periods, the favorable prior years' loss development was the result of a re-estimation of amounts ultimately to be paid on prior year defaults in the default inventory, including the impact of previously identified defaults that cured. Original estimates are increased or decreased as additional information becomes known regarding individual claims.

Due to business restrictions, stay-at-home orders and travel restrictions initially implemented in March 2020 as a result of COVID-19, unemployment in the United States increased significantly in the second quarter of 2020, declining during the second half of 2020 through 2022. As unemployment is one of the most common reasons for borrowers to default on their mortgage, the increase in unemployment has increased the number of delinquencies on the mortgages that we insure and has the potential to increase claim frequencies on defaults.

In response to the COVID-19 pandemic, the United States government enacted a number of policies to provide fiscal stimulus to the economy and relief to those affected by this global disaster. Specifically, mortgage forbearance programs and foreclosure moratoriums were instituted by Federal legislation along with actions taken by the Federal Housing Finance Agency (“FHFA”), Fannie Mae and Freddie Mac (collectively the “GSEs”). The mortgage forbearance plans provide for eligible homeowners who were adversely impacted by COVID-19 to temporarily reduce or suspend their mortgage payments for up to 18 months for loans in an active COVID-19-related forbearance program as of February 28, 2021. For borrowers that have the ability to begin to pay their mortgage at the end of the forbearance period, we expect that mortgage servicers will work with them to modify their loans at which time the mortgage will be removed from delinquency status. We believe that the forbearance process could have a favorable effect on the frequency of claims that we ultimately pay.

The defaulted loans reported to us in the second and third quarters of 2020 had reached the end of their forbearance periods as of March 31, 2022. During the first quarter of 2022, the Early COVID Defaults cured at elevated levels, and the cumulative cure rate for the Early COVID Defaults at March 31, 2022 exceeded our initial estimated cure rate implied by our estimate of ultimate loss for these defaults established at the onset of the pandemic. Based on cure activity through March 31, 2022 and our expectations for future cure activity, as of March 31, 2022, we lowered our estimate of ultimate loss for the Early

COVID Defaults from 7% to 4% of the initial risk in force. During the three months ended June 30, 2022, Early COVID Defaults cured at levels that exceeded our estimate as of March 31, 2022, and we further lowered our estimate of loss for these defaults as of June 30, 2022 to 2% of the initial risk in force. These revisions to our estimate of ultimate loss for the Early COVID Defaults resulted in a benefit recorded to the provision for losses of $164.1 million for the year ended December 31, 2022. Due to the level of Early COVID Defaults remaining in the default inventory, beginning in the third quarter of 2022, we resumed reserving for the Early COVID Defaults using our normal reserve methodology. The transition of defaults to foreclosure or claim has not returned to pre-pandemic levels. As a result, the level of defaults in the default inventory that have missed twelve or more payments is above pre-pandemic levels.

The economy in the United States is currently experiencing elevated levels of consumer price inflation. The Federal Reserve has increased the target federal funds rate several times during 2022 and 2023 in an effort to reduce consumer price inflation. These rate increases have resulted in higher mortgage interest rates which may lower home sale activity and affect the options available to delinquent borrowers. It is reasonably possible that our estimate of losses could change in the near term as a result of changes in the economic environment, the impact of elevated levels of consumer price inflation on home sale activity, housing inventory, and home prices. The impact on our reserves in future periods will be dependent upon the amount of delinquent notices received from loan servicers and our expectations for the amount of ultimate losses on these delinquencies.

XML

Debt Obligations

3 Months Ended

Mar. 31, 2023

Debt Disclosure [Abstract]

Debt Obligations

Debt Obligations

Credit Facility

Essent Group and its subsidiaries, Essent Irish Intermediate Holdings Limited and Essent US Holdings, Inc. (collectively, the "Borrowers"), are parties to a five-year secured credit facility with a committed capacity of $825 million (the Credit Facility"). The Credit Facility also provides for up to $175 million aggregate principal amount of uncommitted incremental term loan and/or revolving credit facilities that may be exercised at the Borrowers’ option so long as the Borrowers receive commitments from the lenders. Borrowings under the Credit Facility may be used for working capital and general corporate purposes, including, without limitation, capital contributions to Essent’s insurance and reinsurance subsidiaries. Borrowings accrue interest at a floating rate tied to a standard short-term borrowing index, selected at the Company’s option, plus an applicable margin. A commitment fee is due quarterly on the average daily amount of the undrawn revolving commitment. The applicable margin and the commitment fee are based on the senior unsecured debt rating or long-term issuer rating of Essent Group to the extent available, or the insurer financial strength rating of Essent Guaranty. The annual commitment fee rate at March 31, 2023 was 0.25%. The obligations under the Credit Facility are secured by certain assets of the Borrowers, excluding the stock and assets of its insurance and reinsurance subsidiaries. The Credit Facility contains several covenants, including financial covenants relating to minimum net worth, capital and liquidity levels, maximum debt to capitalization level and Essent Guaranty's compliance with the PMIERs (see Note 14). The borrowings under the Credit Facility contractually mature on December 10, 2026. As of March 31, 2023, the Company was in compliance with the covenants and $425 million had been borrowed under the term loan portion of the Credit Facility with a weighted average interest rate of 6.52%. As of December 31, 2022, $425 million had been borrowed with a weighted average interest rate of 6.02%.

XML

Commitments and Contingencies

3 Months Ended

Mar. 31, 2023

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Obligations under Guarantees

Under the terms of CUW Solutions' contract underwriting agreements with lenders and subject to contractual limitations on liability, we agree to indemnify certain lenders against losses incurred in the event that we make an error in determining whether loans processed meet specified underwriting criteria, to the extent that such error materially restricts or impairs the salability of such loan, results in a material reduction in the value of such loan or results in the lender repurchasing the loan. The indemnification may be in the form of monetary or other remedies. No remedy payments were made in the three months ended March 31, 2023, and we paid less than $0.1 million related to remedies in the three months ended March 31, 2022. As of March 31, 2023, management believes any potential claims for indemnification related to contract underwriting services through March 31, 2023 are not material to our consolidated financial position or results of operations.

In addition to the indemnifications discussed above, in the normal course of business, we enter into agreements or other relationships with third parties pursuant to which we may be obligated under specified circumstances to indemnify the counterparties with respect to certain matters. Our contractual indemnification obligations typically arise in the context of agreements entered into by us to, among other things, purchase or sell services, finance our business and business transactions,

lease real property and license intellectual property. The agreements we enter into in the normal course of business generally require us to pay certain amounts to the other party associated with claims or losses if they result from our breach of the agreement, including the inaccuracy of representations or warranties. The agreements we enter into may also contain other indemnification provisions that obligate us to pay amounts upon the occurrence of certain events, such as the negligence or willful misconduct of our employees, infringement of third-party intellectual property rights or claims that performance of the agreement constitutes a violation of law. Generally, payment by us under an indemnification provision is conditioned upon the other party making a claim, and typically we can challenge the other party’s claims. Further, our indemnification obligations may be limited in time and/or amount, and in some instances, we may have recourse against third parties for certain payments made by us under an indemnification agreement or obligation. As of March 31, 2023, contingencies triggering material indemnification obligations or payments have not occurred historically and are not expected to occur. The nature of the indemnification provisions in the various types of agreements and relationships described above are believed to be low risk and pervasive, and we consider them to have a remote risk of loss or payment. We have not recorded any provisions on the condensed consolidated balance sheets related to indemnifications.

XML

Capital Stock

3 Months Ended

Mar. 31, 2023

Banking Regulation, Total Capital [Abstract]

Capital Stock

Capital Stock

Our authorized share capital consists of 233.3 million shares of a single class of common shares. The common shares have no preemptive rights or other rights to subscribe for additional shares, and no rights of redemption, conversion or exchange. Under certain circumstances and subject to the provisions of Bermuda law and our bye-laws, we may be required to make an offer to repurchase shares held by members. The common shares rank pari passu with one another in all respects as to rights of payment and distribution. In general, holders of common shares will have one vote for each common share held by them and will be entitled to vote, on a non-cumulative basis, at all meetings of shareholders. In the event that a shareholder is considered a 9.5% Shareholder under our bye-laws, such shareholder's votes will be reduced by whatever amount is necessary so that after any such reduction the votes of such shareholder will not result in any other person being treated as a 9.5% Shareholder with respect to the vote on such matter. Under these provisions certain shareholders may have their voting rights limited to less than one vote per share, while other shareholders may have voting rights in excess of one vote per share.

Dividends

The following table presents the amounts declared and paid per common share each quarter:

Quarter Ended	2023		2022
March 31	$	0.25	$	0.20
June 30	—		0.21
September 30	—		0.22
December 31	—		0.23
Total dividends per common share declared and paid	$	0.25	$	0.86

In May 2023, the Board of Directors declared a quarterly cash dividend of $0.25 per common share payable on June 12, 2023 to shareholders of record on June 1, 2023.

Share Repurchase Plan

In May 2022, the Board of Directors approved a share repurchase plan that authorizes the Company to repurchase up to $250 million of its common shares in the open market by the end of 2023. Through March 31, 2023, the Company repurchased 431,904 common shares at a cost of $16.6 million under the 2022 plan, leaving $233.4 million remaining unused under the authorized repurchase plan as of March 31, 2023.

XML

Stock-Based Compensation

3 Months Ended

Mar. 31, 2023

Share-Based Payment Arrangement [Abstract]

Stock-Based Compensation

Stock-Based Compensation

In 2013, Essent Group's Board of Directors adopted, and Essent Group's shareholders approved, the Essent Group Ltd. 2013 Long-Term Incentive Plan (the "2013 Plan"), which was effective upon completion of the initial public offering. The types of awards available under the 2013 Plan include nonvested shares, nonvested share units, non-qualified share options, incentive stock options, share appreciation rights, and other share-based or cash-based awards. Nonvested shares and nonvested share units granted under the 2013 Plan have rights to dividends, which entitle holders to the same dividend value per share as holders of common shares in the form of dividend equivalent units ("DEUs"). DEUs are subject to the same vesting and other terms and conditions as the corresponding nonvested shares and nonvested share units. DEUs vest when the underlying shares or share units vest and are forfeited if the underlying share or share units forfeit prior to vesting. The maximum number of shares and share units available for issuance is 7.5 million under the 2013 Plan. As of March 31, 2023, there were 2.0 million common shares available for future grant under the 2013 Plan.

The following table summarizes nonvested common share, nonvested common share unit and DEU activity for the three months ended March 31, 2023:

	Time and Performance- Based Share Awards			Time-Based Share Awards			Share Units			DEUs
(Shares in thousands)	Number of Shares	Weighted Average Grant Date Fair Value		Number of Shares	Weighted Average Grant Date Fair Value		Number of Share Units	Weighted Average Grant Date Fair Value		Dividend Equivalent Units	Weighted Average Grant Date Fair Value
Outstanding at beginning of year	647	$	20.99	138	$	45.94	350	$	45.51	37	$	40.86
Granted	300	12.66		76	43.51		436	38.41		11	37.88
Vested	(103)	51.52		(64)	56.65		(131)	49.16		(14)	40.31
Forfeited	—	—		—	—		(13)	39.25		—	40.57
Outstanding at March 31, 2023	844	$	14.29	150	$	44.40	642	$	40.07	34	$	40.15

In February 2023, certain members of senior management were granted nonvested common shares under the 2013 Plan that were subject to time-based and performance-based vesting. The time-based share awards granted in February 2023 vest in three equal installments commencing on March 1 of the year following the grant year. The performance-based share awards granted in February 2023 vest based upon our compounded annual book value per share growth percentage and relative total shareholder return during a three-year performance period that commenced on January 1, 2023 and vest on March 1, 2026. Shares were issued at the maximum 200% of target. The portion of these nonvested performance-based share awards that will be earned is as follows:

		Relative Total Shareholder Return vs. S&P 1500 Financial Services Index
		≤25th percentile		50th percentile "Target"		≥75th percentile
Three-Year Book Value Per Share CAGR	10% "Target"	100	%	150	%	200	%
	9%	75	%	125	%	175	%
	8%	50	%	100	%	150	%
	6%	25	%	75	%	125	%
	5%	0	%	50	%	100	%

In the event that the compounded annual book value per share growth or the relative total shareholder return falls between the performance levels shown above, the nonvested common shares earned will be determined on a straight-line basis between the respective levels shown.

In January 2023, nonvested common share units were issued to all vice president and staff level employees and are subject to time-based vesting in three equal installments on January 6, 2024, 2025 and 2026. In connection with our incentive program covering bonus awards for performance year 2022, in February 2023, time-based share units were issued to certain employees that vest in three equal installments on March 1, 2024, 2025 and 2026.

Quoted market prices are used for the valuation of common shares granted that do not contain a market condition under ASC 718. The performance-based share awards granted in February 2021 contain a market condition and were valued based on analysis provided by a third-party valuation firm using a risk neutral simulation taking into effect the vesting conditions of the grant.

In February 2021, the performance-based share awards granted in 2019 and 2020 to certain members of senior management were amended to provide that such awards will no longer be subject to the achievement of the compounded annual book value per share growth metrics and will be subject to only service-based vesting. As a result, the shares subject to the amended 2019 and 2020 awards vested on March 1, 2022 and March 1, 2023, respectively.

The total fair value on the vesting date of nonvested shares, share units or DEUs that vested was $13.2 million and $16.3 million for the three months ended March 31, 2023 and 2022, respectively. As of March 31, 2023, there was $34.0 million of total unrecognized compensation expense related to nonvested shares or share units outstanding at March 31, 2023 and we expect to recognize the expense over a weighted average period of 2.5 years.

Employees have the option to tender shares to Essent Group to pay the minimum employee statutory withholding taxes associated with shares upon vesting. Common shares tendered by employees to pay employee withholding taxes totaled 111,820 in the three months ended March 31, 2023. The tendered shares were recorded at cost and included in treasury stock. All treasury stock has been cancelled as of March 31, 2023.

Compensation expense, net of forfeitures, and related tax effects recognized in connection with nonvested shares was as follows:

	Three Months Ended March 31,
(In thousands)	2023		2022
Compensation expense	$	5,106	$	4,807
Income tax benefit	1,018		957

XML

Dividend Restrictions

3 Months Ended

Mar. 31, 2023

Statutory Accounting Practices, Statutory Amount Available for Dividend Payments [Abstract]

Dividends Restrictions

Dividends Restrictions

Our U.S. insurance subsidiaries are subject to certain capital and dividend rules and regulations as prescribed by jurisdictions in which they are authorized to operate. Under the insurance laws of the Commonwealth of Pennsylvania, Essent Guaranty and Essent PA may pay dividends during any 12-month period in an amount equal to the greater of (i) 10% of the preceding year-end statutory policyholders' surplus or (ii) the preceding year's statutory net income. The Pennsylvania statute also specifies that dividends and other distributions can be paid out of positive unassigned surplus without prior approval. At March 31, 2023, Essent Guaranty had unassigned surplus of approximately $286.8 million and Essent PA had unassigned surplus of approximately $14.1 million. In three months ended March 31, 2023 and 2022, Essent Guaranty paid dividends of $90 million and $100 million, respectively, to its parent, Essent US Holdings, Inc. Essent PA did not pay a dividend in the three months ended March 31, 2023 or 2022. As of March 31, 2023, Essent Guaranty and Essent PA could pay additional ordinary dividends in 2023 of $286.8 million and $5.3 million, respectively.

Essent Re is subject to certain dividend restrictions as prescribed by the Bermuda Monetary Authority and under certain agreements with counterparties. In connection with the quota share reinsurance agreement with Essent Guaranty, Essent Re has agreed to maintain a minimum total equity of $100 million. As of March 31, 2023, Essent Re had total equity of $1.6 billion.

At March 31, 2023, our insurance subsidiaries were in compliance with these rules, regulations and agreements.

XML

Earnings per Share (EPS)

3 Months Ended

Mar. 31, 2023

Earnings Per Share [Abstract]

Earnings per Share (EPS)

Earnings per Share (EPS)

The following table reconciles the net income and the weighted average common shares outstanding used in the computations of basic and diluted earnings per common share:

	Three Months Ended  March 31,
(In thousands, except per share amounts)	2023		2022
Net income	$	170,827	$	274,167
Basic weighted average shares outstanding	106,943		108,166
Dilutive effect of nonvested shares	642		424
Diluted weighted average shares outstanding	107,585		108,590
Basic earnings per share	$	1.60	$	2.53
Diluted earnings per share	$	1.59	$	2.52

There were 111,870 and 81,036 antidilutive shares for the three months ended March 31, 2023 and 2022.

Nonvested performance-based share awards are considered contingently issuable for purposes of the EPS calculation. The 2023, 2022 and 2021 performance-based share awards vest based upon our compounded annual book value per share growth percentage and relative total shareholder return during a three-year performance period. The performance-based share awards granted in years before 2021 vest based upon our compounded annual book value per share growth percentage during a three-year performance period. The following table summarizes the performance-based shares issuable if the reporting date was the end of the contingency period.

	2023 Performance-Based Grants		2022 Performance-Based Grants		2021 Performance-Based Grants		2020 Performance-Based Grants
Reporting Date	Percent Issuable Relative to Target	As a Percent of Shares Issued	Percent Issuable Relative to Target	As a Percent of Shares Issued	Percent Issuable Relative to Target	As a Percent of Shares Issued	Percent Issuable Relative to Target and Shares Issued
March 31, 2023	200%	100%	170%	85%	100%	50%
March 31, 2022			122%	61%	100%	50%	100%

XML

Accumulated Other Comprehensive Income (Loss)

3 Months Ended

Mar. 31, 2023

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Accumulated Other Comprehensive Income (Loss)

Accumulated Other Comprehensive Income (Loss)

The following table presents the rollforward of accumulated other comprehensive loss for the three months ended March 31, 2023 and 2022: 

	Three Months Ended March 31,
	2023						2022
(In thousands)	Before Tax		Tax Effect		Net of Tax		Before Tax		Tax Effect		Net of Tax
Balance at beginning of year	$	(443,230)	$	60,440	$	(382,790)	$	65,280	$	(14,573)	$	50,707
Other comprehensive income (loss):
Unrealized holding gains (losses) on investments:
Unrealized holding gains (losses) arising during the period	67,693		(9,476)		58,217		(246,255)		34,830		(211,425)
Less: Reclassification adjustment for losses included in net income (1)	488		48		536		7,352		1,067		8,419
Net unrealized gains (losses) on investments	68,181		(9,428)		58,753		(238,903)		35,897		(203,006)
Other comprehensive income (loss)	68,181		(9,428)		58,753		(238,903)		35,897		(203,006)
Balance at end of period	$	(375,049)	$	51,012	$	(324,037)	$	(173,623)	$	21,324	$	(152,299)

(1)Included in net realized investment losses on our condensed consolidated statements of comprehensive income.

XML

Fair Value of Financial Instruments

3 Months Ended

Mar. 31, 2023

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

Fair Value of Financial Instruments

We carry certain of our financial instruments at fair value. We define fair value as the current amount that would be exchanged to sell an asset or transfer a liability, other than in a forced liquidation.

Fair Value Hierarchy

ASC No. 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. The level within the fair value hierarchy to measure the financial instrument shall be determined based on the lowest level input that is significant to the fair value measurement. The three levels of the fair value hierarchy are as follows:

•Level 1 — Quoted prices for identical instruments in active markets accessible at the measurement date.

•Level 2 — Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and valuations in which all significant inputs are observable in active markets. Inputs are observable for substantially the full term of the financial instrument.

•Level 3 — Valuations derived from one or more significant inputs that are unobservable.

Determination of Fair Value

When available, we generally use quoted market prices to determine fair value and classify the financial instrument in Level 1. In cases where quoted market prices for similar financial instruments are available, we utilize these inputs for valuation techniques and classify the financial instrument in Level 2. In cases where quoted market prices are not available, fair values are based on estimates using discounted cash flows, present value or other valuation techniques. Those techniques are significantly affected by the assumptions used, including the discount rates and estimates of future cash flows and we classify the financial instrument in Level 3. Accordingly, the fair value estimates may not be realized in an immediate settlement of the instrument.

We used the following methods and assumptions in estimating fair values of financial instruments:

•Investments available for sale — Investments available for sale are valued using quoted market prices in active markets, when available, and those investments are classified as Level 1 of the fair value hierarchy. Level 1 investments available for sale include investments such as U.S. Treasury securities and money market funds. Investments available for sale are classified as Level 2 of the fair value hierarchy if quoted market prices are not available and fair values are estimated using quoted prices of similar securities or recently executed transactions for the securities. U.S. agency securities, U.S. agency mortgage-backed securities, municipal debt securities, non-U.S. government securities, corporate debt securities, residential and commercial mortgage securities and asset-backed securities are classified as Level 2 investments.

We use independent pricing sources to determine the fair value of securities available for sale in Level 1 and Level 2 of the fair value hierarchy. We use one primary pricing service to provide individual security pricing based on observable market data and receive one quote per security. To ensure securities are appropriately classified in the fair value hierarchy, we review the pricing techniques and methodologies of the independent pricing service and believe that their policies adequately consider market activity, either based on specific transactions for the issue valued or based on modeling of securities with similar credit quality, duration, yield and structure that were recently traded. U.S. agency securities, U.S. agency mortgage-backed securities, municipal debt securities, non-U.S. government securities and corporate debt securities are valued by our primary vendor using recently executed transactions and proprietary models based on observable inputs, such as interest rate spreads, yield curves and credit risk. Residential and commercial mortgage securities and asset-backed securities are valued by our primary vendor using proprietary models based on observable inputs, such as interest rate spreads, prepayment speeds and credit risk. As part of our evaluation of investment prices provided by our primary pricing service, we obtained and reviewed their pricing methodologies which include a description of how each security type is evaluated and priced. We review the reasonableness of prices received from our primary pricing service by comparison to prices obtained from additional pricing sources. We have not made any adjustments to the prices obtained from our primary pricing service.

Assets and Liabilities Measured at Fair Value

All assets measured at fair value are categorized in the table below based upon the lowest level of significant input to the valuations. All fair value measurements at the reporting date were on a recurring basis.

March 31, 2023 (In thousands)	Quoted Prices in Active  Markets for Identical Instruments (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
Recurring fair value measurements
Financial Assets:
U.S. Treasury securities	$	475,784	$	—	$	—	$	475,784
U.S. agency securities	—		12,690		—		12,690
U.S. agency mortgage-backed securities	—		850,124		—		850,124
Municipal debt securities	—		609,010		—		609,010
Non-U.S. government securities	—		63,018		—		63,018
Corporate debt securities	—		1,462,596		—		1,462,596
Residential and commercial mortgage securities	—		542,013		—		542,013
Asset-backed securities	—		648,109		—		648,109
Money market funds	286,692		—		—		286,692
Total assets at fair value (1) (2)	$	762,476	$	4,187,560	$	—	$	4,950,036

December 31, 2022 (In thousands)	Quoted Prices in Active  Markets for Identical Instruments (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
Recurring fair value measurements
Financial Assets:
U.S. Treasury securities	$	556,438	$	—	$	—	$	556,438
U.S. agency securities	—		49,058		—		49,058
U.S. agency mortgage-backed securities	—		783,743		—		783,743
Municipal debt securities	—		602,690		—		602,690
Non-U.S. government securities	—		62,399		—		62,399
Corporate debt securities	—		1,414,321		—		1,414,321
Residential and commercial mortgage securities	—		511,824		—		511,824
Asset-backed securities	—		624,561		—		624,561
Money market funds	136,591		—		—		136,591
Total assets at fair value (1)	$	693,029	$	4,048,596	$	—	$	4,741,625

(1)Does not include the fair value of embedded derivatives, which we have accounted for separately as freestanding derivatives and included in other assets or other accrued liabilities in our condensed consolidated balance sheet. See Note 4 for more information.

(2)Does not include certain other invested assets that are measured at fair value using the net asset value per share (or its equivalent) as a practical expedient, as applicable accounting standards do not provide for classification within the fair value hierarchy.

XML

Statutory Accounting

3 Months Ended

Mar. 31, 2023

Insurance [Abstract]

Statutory Accounting

Statutory Accounting

Our U.S. insurance subsidiaries prepare statutory-basis financial statements in accordance with the accounting practices prescribed or permitted by their respective state’s department of insurance, which is a comprehensive basis of accounting other than GAAP. We did not use any prescribed or permitted statutory accounting practices (individually or in the aggregate) that resulted in reported statutory surplus or capital that was significantly different from the statutory surplus or capital that would have been reported had National Association of Insurance Commissioners’ statutory accounting practices been followed. The following table presents Essent Guaranty’s and Essent PA’s statutory net income, statutory surplus and contingency reserve liability as of and for the three months ended March 31:

(In thousands)	2023		2022
Essent Guaranty
Statutory net income	$	123,936	$	200,277
Statutory surplus	992,134		1,081,986
Contingency reserve liability	2,105,708		1,862,482
Essent PA
Statutory net (loss) income	$	(112)	$	859
Statutory surplus	53,138		56,910
Contingency reserve liability	56,101		57,461

Net income determined in accordance with statutory accounting practices differs from GAAP. In 2023 and 2022, the more significant differences between net income determined under statutory accounting practices and GAAP for Essent Guaranty and Essent PA relate to policy acquisition costs and income taxes. Under statutory accounting practices, policy acquisition costs are expensed as incurred while such costs are capitalized and amortized to expense over the life of the policy under GAAP. We are eligible for a tax deduction, subject to certain limitations for amounts required by state law or regulation to be set aside in statutory contingency reserves when we purchase non-interest-bearing United States Mortgage Guaranty Tax and Loss Bonds (“T&L Bonds”) issued by the Treasury Department. Under statutory accounting practices, this deduction reduces the tax provision recorded by Essent Guaranty and Essent PA and, as a result, increases statutory net income and surplus as compared to net income and equity determined in accordance with GAAP.

At March 31, 2023 and 2022, the statutory capital of our U.S. insurance subsidiaries, which is defined as the total of statutory surplus and contingency reserves, was in excess of the statutory capital necessary to satisfy their regulatory requirements.

Effective December 31, 2015, Fannie Mae and Freddie Mac, at the direction of the Federal Housing Finance Agency, implemented new coordinated Private Mortgage Insurer Eligibility Requirements, which we refer to as the "PMIERs." The PMIERs represent the standards by which private mortgage insurers are eligible to provide mortgage insurance on loans owned or guaranteed by Fannie Mae and Freddie Mac. The PMIERs include financial strength requirements incorporating a risk-based framework that require approved insurers to have a sufficient level of liquid assets from which to pay claims. The PMIERs also include enhanced operational performance expectations and define remedial actions that apply should an approved insurer fail to comply with these requirements. In 2018, the GSEs released revised PMIERs framework ("PMIERs 2.0") which became effective on March 31, 2019. As of March 31, 2023, Essent Guaranty, our GSE-approved mortgage insurance company, was in compliance with PMIERs 2.0.

Statement of Statutory Accounting Principles No. 58, Mortgage Guaranty Insurance, requires mortgage insurers to establish a special contingency reserve for statutory accounting purposes included in total liabilities equal to 50% of earned premium for that year. This reserve is required to be maintained for a period of 120 months to protect against the effects of adverse economic cycles. After 120 months, the reserve is released to unassigned funds. In the event an insurer’s loss ratio in any calendar year exceeds 35%, however, the insurer may, after regulatory approval, release from its contingency reserves an amount equal to the excess portion of such losses. During the three months ended March 31, 2023, Essent Guaranty increased its contingency reserve by $57.0 million and Essent PA decreased its contingency reserve by $0.6 million. During the three months ended March 31, 2023 and 2022, Essent Guaranty released contingency reserves of $9.8 million and $2.6 million,

respectively, and Essent PA released contingency reserves of $0.8 million and $0.2 million, respectively, to unassigned funds upon completion of the 120 month holding period.

Under The Insurance Act 1978, as amended, and related regulations of Bermuda (the "Insurance Act"), Essent Re is required to annually prepare statutory financial statements and a statutory financial return in accordance with the financial reporting provisions of the Insurance Act, which is a basis other than GAAP. The Insurance Act also requires that Essent Re maintain minimum share capital of $1 million and must ensure that the value of its general business assets exceeds the amount of its general business liabilities by an amount greater than the prescribed minimum solvency margins and enhanced capital requirement pertaining to its general business. At December 31, 2022, all such requirements were met.

Essent Re's statutory capital and surplus was $1.6 billion as of March 31, 2023 and $1.5 billion as of December 31, 2022. Essent Re's statutory net income was $72.6 million and $89.6 million for the three months ended March 31, 2023 and 2022, respectively. Statutory capital and surplus as of March 31, 2023 and December 31, 2022 and statutory net income in the three months ended March 31, 2023 and 2022 determined in accordance with statutory accounting practices were not significantly different than the amounts determined under GAAP.

XML

Recently Issued Accounting Standards (Policies)

3 Months Ended

Mar. 31, 2023

Accounting Policies [Abstract]

Accounting Standards Not Yet Adopted

Accounting Standards Not Yet Adopted

    In March 2020, the Financial Accounting Standards Board ("FASB") issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments in this update provide temporary optional guidance to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform. It provides optional expedients and exceptions for applying generally accepted accounting principles to contract, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. This standard may be elected and applied prospectively over time from March 12, 2020 through December 31, 2024, as amended by ASU

2022-06, as reference rate reform activities occur. The adoption of, and future elections under, this ASU are not expected to have a material impact on our consolidated financial statements as the ASU will ease, if warranted, the requirements for accounting for the future effects of the rate reform. We continue to monitor the impact the discontinuance of LIBOR or another reference rate will have on our contracts and other transactions.

In June 2022, the FASB issued ASU No. 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. This update clarifies the guidance in ASC 820 on the fair value measurement of an equity security that is subject to a contractual sale restriction and requires specific disclosures related to such an equity security. The update clarifies that a contractual sale restriction prohibiting the sale of an equity security is a characteristic of the reporting entity holding the equity security and is not included in the equity security's unit of account. Accordingly, an entity should not consider the contractual sale restriction when measuring the equity security’s fair value. The update also requires specific disclosures related to equity securities that are subject to contractual sale restrictions, including (1) the fair value of such equity securities reflected in the balance sheet, (2) the nature and remaining duration of the corresponding restrictions, and (3) any circumstances that could cause a lapse in the restrictions. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years, with early adoption permitted. The adoption of this ASU is not expected to have a material effect on the Company's consolidated operating results or financial position.

XML

Investments (Tables)

3 Months Ended

Mar. 31, 2023

Investments, Debt and Equity Securities [Abstract]

Schedule of Investments Available for Sale

Investments available for sale consist of the following:

March 31, 2023 (In thousands)	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value
U.S. Treasury securities	$	497,267	$	843	$	(22,326)	$	475,784
U.S. agency securities	12,696		8		(14)		12,690
U.S. agency mortgage-backed securities	950,645		1,286		(101,807)		850,124
Municipal debt securities (1)	650,470		5,489		(46,949)		609,010
Non-U.S. government securities	69,606		—		(6,588)		63,018
Corporate debt securities (2)	1,575,643		3,040		(116,087)		1,462,596
Residential and commercial mortgage securities	601,606		208		(59,801)		542,013
Asset-backed securities	680,460		314		(32,665)		648,109
Money market funds	286,692		—		—		286,692
Total investments available for sale	$	5,325,085	$	11,188	$	(386,237)	$	4,950,036

December 31, 2022 (In thousands)	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value
U.S. Treasury securities	$	584,173	$	341	$	(28,076)	$	556,438
U.S. agency securities	49,059		7		(8)		49,058
U.S. agency mortgage-backed securities	898,675		258		(115,190)		783,743
Municipal debt securities (1)	661,934		2,010		(61,254)		602,690
Non-U.S. government securities	69,651		—		(7,252)		62,399
Corporate debt securities (2)	1,546,513		1,195		(133,387)		1,414,321
Residential and commercial mortgage securities	577,915		390		(66,481)		511,824
Asset-backed securities	660,345		72		(35,856)		624,561
Money market funds	136,591		—		—		136,591
Total investments available for sale	$	5,184,856	$	4,273	$	(447,504)	$	4,741,625

	March 31,		December 31,
(1) The following table summarizes municipal debt securities as of :	2023		2022
Special revenue bonds	81.4	%	79.0	%
General obligation bonds	18.5		20.9
Certificate of participation bonds	—		—
Tax allocation bonds	0.1		0.1
Total	100.0	%	100.0	%

	March 31,		December 31,
(2) The following table summarizes corporate debt securities as of :	2023		2022
Financial	40.8	%	40.5	%
Consumer, non-cyclical	18.5		17.9
Consumer, cyclical	7.2		6.8
Industrial	6.7		6.8
Utilities	5.7		6.1
Communications	8.6		8.4
Technology	4.8		4.9
Energy	5.5		6.4
Basic Materials	2.1		2.1
Government	0.1		0.1
Total	100.0	%	100.0	%

Schedule of Amortized Cost and Fair Value of Investments Available for Sale by Contractual Maturity

The amortized cost and fair value of investments available for sale at March 31, 2023, by contractual maturity, are shown below. Expected maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Because most U.S. agency mortgage-backed securities, residential and commercial mortgage securities and asset-backed securities provide for periodic payments throughout their lives, they are listed below in separate categories.

(In thousands)	Amortized Cost		Fair Value
U.S. Treasury securities:
Due in 1 year	$	130,959	$	129,312
Due after 1 but within 5 years	313,584		297,672
Due after 5 but within 10 years	38,335		34,655
Due after 10 years	14,389		14,145
Subtotal	497,267		475,784
U.S. agency securities:
Due in 1 year	11,125		11,111
Due after 1 but within 5 years	1,571		1,579
Subtotal	12,696		12,690
Municipal debt securities:
Due in 1 year	6,006		5,977
Due after 1 but within 5 years	88,888		86,924
Due after 5 but within 10 years	175,352		167,037
Due after 10 years	380,224		349,072
Subtotal	650,470		609,010
Non-U.S. government securities:
Due in 1 year	10,020		10,012
Due after 1 but within 5 years	33,759		32,824
Due after 5 but within 10 years	5,532		4,512
Due after 10 years	20,295		15,670
Subtotal	69,606		63,018
Corporate debt securities:
Due in 1 year	241,103		238,178
Due after 1 but within 5 years	635,267		605,227
Due after 5 but within 10 years	484,388		433,797
Due after 10 years	214,885		185,394
Subtotal	1,575,643		1,462,596
U.S. agency mortgage-backed securities	950,645		850,124
Residential and commercial mortgage securities	601,606		542,013
Asset-backed securities	680,460		648,109
Money market funds	286,692		286,692
Total investments available for sale	$	5,325,085	$	4,950,036

Schedule of Realized Gross Gains and Losses on Sale of Investments Available for Sale

The components of realized investment (losses) gains, net on the condensed consolidated statements of comprehensive income were as follows:

	Three Months Ended March 31,
(In thousands)	2023		2022
Realized gross gains	$	869	$	12,576
Realized gross losses	1,357		13,091
Impairment loss	—		6,837

Schedule of Fair Value of Investments in an Unrealized Loss Position and Related Unrealized Losses

The fair value of investments available for sale in an unrealized loss position and the related unrealized losses for which no allowance for credit loss has been recorded were as follows:

	Less than 12 months				12 months or more				Total
March 31, 2023 (In thousands)	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses
U.S. Treasury securities	$	184,036	$	(2,069)	$	256,893	$	(20,257)	$	440,929	$	(22,326)
U.S. agency securities	11,111		(14)		—		—		11,111		(14)
U.S. agency mortgage-backed securities	144,039		(3,586)		643,734		(98,221)		787,773		(101,807)
Municipal debt securities	150,068		(2,840)		244,856		(44,109)		394,924		(46,949)
Non-U.S. government securities	36,274		(472)		26,744		(6,116)		63,018		(6,588)
Corporate debt securities	467,974		(11,248)		774,083		(104,839)		1,242,057		(116,087)
Residential and commercial mortgage securities	136,012		(7,065)		395,814		(52,736)		531,826		(59,801)
Asset-backed securities	168,303		(4,755)		423,814		(27,910)		592,117		(32,665)
Total	$	1,297,817	$	(32,049)	$	2,765,938	$	(354,188)	$	4,063,755	$	(386,237)

	Less than 12 months				12 months or more				Total
December 31, 2022 (In thousands)	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses
U.S. Treasury securities	$	321,848	$	(12,381)	$	169,795	$	(15,695)	$	491,643	$	(28,076)
U.S. agency securities	7,117		(8)		—		—		7,117		(8)
U.S. agency mortgage-backed securities	351,310		(34,193)		415,743		(80,997)		767,053		(115,190)
Municipal debt securities	335,784		(41,620)		64,766		(19,634)		400,550		(61,254)
Non-U.S. government securities	48,071		(2,914)		14,328		(4,338)		62,399		(7,252)
Corporate debt securities	811,217		(69,415)		421,307		(63,972)		1,232,524		(133,387)
Residential and commercial mortgage securities	265,934		(22,628)		242,366		(43,853)		508,300		(66,481)
Asset-backed securities	333,080		(15,454)		258,572		(20,402)		591,652		(35,856)
Total	$	2,474,361	$	(198,613)	$	1,586,877	$	(248,891)	$	4,061,238	$	(447,504)

Schedule of Net Investment Income

Net investment income consists of: 

	Three Months Ended March 31,
(In thousands)	2023		2022
Fixed maturities	$	43,473	$	26,223
Short-term investments	1,721		44
Gross investment income	45,194		26,267
Investment expenses	(1,958)		(1,587)
Net investment income	$	43,236	$	24,680

XML

Reinsurance (Tables)

3 Months Ended

Mar. 31, 2023

Reinsurance Disclosures [Abstract]

Schedule of Effects of Reinsurance

The effect of reinsurance on net premiums written and earned is as follows:

	Three Months Ended  March 31,
(In thousands)	2023		2022
Net premiums written:
Direct	$	239,491	$	220,254
Ceded (1)	(33,591)		(20,523)
Net premiums written	$	205,900	$	199,731
Net premiums earned:
Direct	$	244,849	$	235,853
Ceded (1)	(33,591)		(20,523)
Net premiums earned	$	211,258	$	215,330

(1)Net of profit commission.

The following tables summarizes Essent Guaranty's quota share reinsurance agreements as of March 31, 2023:

QSR Agreement	Coverage Period	Ceding Percentage	Ceding Commission	Profit Commission
QSR-2019	September 1, 2019-December 31, 2020	(1)	20%	63%	(2)
QSR-2022	January 1, 2022-December 31, 2022	20%	20%	62%
QSR-2023	January 1, 2023-December 31, 2023	17.5%	20%	58%

_______________________________________________________________________________

(1)Under QSR-2019, Essent Guaranty cedes 40% of premiums on singles policies and 20% on all other policies.

(2)The original profit commission on QSR-2019 was up to 60%; however because Essent Guaranty did not exercise its option to terminate the QSR Agreement on December 31, 2021, the maximum profit commission that Essent Guaranty could earn increased to 63% in 2022 and thereafter.

Schedule of Coverages and Retentions

The following table summarizes Essent Guaranty's excess of loss reinsurance agreements as of March 31, 2023:

Vintage Year	Reinsurer	Effective Date	Optional Termination Date
2017	Panel of Reinsurers	November 1, 2018	October 1, 2023	(1)
2018	Radnor Re 2019-1 Ltd.	February 28, 2019	February 25, 2026
2018	Panel of Reinsurers	February 28, 2019	February 25, 2026
2019	Radnor Re 2020-1 Ltd.	January 30, 2020	January 25, 2027
2019	Panel of Reinsurers	January 30, 2020	January 25, 2027
2020 & 2021	Radnor Re 2021-1 Ltd.	June 23, 2021	June 26, 2028
2021	Radnor Re 2021-2 Ltd.	November 10, 2021	November 25, 2027
2021 & 2022	Panel of Reinsurers	June 1, 2022	January 1, 2030
2021 & 2022	Radnor Re 2022-1 Ltd.	September 21, 2022	September 25, 2028

(1) If the reinsurance agreement is not terminated at the optional termination date, the reinsurance premium increases by 50%.

The following table summarizes Essent Guaranty's excess of loss reinsurance coverages and retentions as of March 31, 2023:

(In thousands)					Remaining Reinsurance in Force
Vintage Year	Remaining Insurance in Force		Remaining Risk in Force		ILN		Other Reinsurance			Total		Remaining First Layer Retention
2017	5,511,131		1,450,432		—		70,895		(7)	70,895		421,003		(10)
2018	6,349,474		1,644,287		325,537		76,144		(8)	401,681		248,221
2019 (2)	7,859,217		2,029,598		395,889		43,991		(9)	439,880		214,485
2020 & 2021 (3)	38,168,321		9,652,777		414,005		—			414,005		278,909
2021 (4)	40,543,749		10,825,130		399,786		—			399,786		279,400
2021 & 2022 (5)	74,276,338		19,998,840		—		141,992			141,992		507,114
2021 & 2022 (6)	33,357,208		8,966,697		237,868		—			237,868		303,761
Total	$	206,065,438	$	54,567,761	$	1,773,085	$	333,022		$	2,106,107	$	2,025,706	(11)

(2) Reinsurance coverage on new insurance written from January 1, 2019 through August 31, 2019.

(3) Reinsurance coverage on new insurance written from August 1, 2020 through March 31, 2021.

(4) Reinsurance coverage on new insurance written from April 1, 2021 through September 30, 2021.

(5) Reinsurance coverage on new insurance written from October 1, 2021 through December 31, 2022.

(6) Reinsurance coverage on new insurance written from October 1, 2021 through July 31, 2022.

(7) Coverage provided immediately above the coverage provided by Radnor Re 2018-1 Ltd.

(8) Coverage provided pari-passu to the coverage provided by Radnor Re 2019-1 Ltd.

(9) Coverage provided pari-passu to the coverage provided by Radnor Re 2020-1 Ltd.

(10) The original and remaining first layer retention is associated with reinsurance provided by a panel of reinsurers. Amounts reported in prior periods reflected the retention associated with an ILN that is no longer outstanding as of March 31, 2023.

(11) The total remaining first layer retention differs from the sum of the individual reinsurance transactions as a result of overlapping coverage between certain transactions.

Schedule of VIE Assets and Total Maximum Exposure to Loss

The following table presents total assets of each Radnor Re special purpose insurer as well as our maximum exposure to loss associated with each Radnor Re entity, representing the fair value of the embedded derivatives, using observable inputs in active markets (Level 2), included in other assets (other accrued liabilities) on our condensed consolidated balance sheet and the estimated net present value of investment earnings on the assets in the reinsurance trusts, each as of March 31, 2023:

			Maximum Exposure to Loss
(In thousands)	Total VIE Assets		On - Balance Sheet		Off - Balance Sheet		Total
Radnor Re 2019-1 Ltd.	325,537		(2,218)		90		(2,128)
Radnor Re 2020-1 Ltd.	395,889		(1,286)		158		(1,128)
Radnor Re 2021-1 Ltd.	414,005		(4,657)		98		(4,559)
Radnor Re 2021-2 Ltd.	$	399,786	$	(3,849)	$	95	$	(3,754)
Radnor Re 2022-1 Ltd.	$	237,868	$	695	$	78	$	773
Total	$	1,773,085	$	(11,315)	$	519	$	(10,796)

XML

Reserve for Losses and Loss Adjustment Expenses (Tables)

3 Months Ended

Mar. 31, 2023

Liability for Future Policy Benefits and Unpaid Claims and Claims Adjustment Expense [Abstract]

Schedule of Reconciliation of Beginning and Ending Reserve Balances for Losses and Loss Adjustment Expenses (LAE)

The following table provides a reconciliation of the beginning and ending reserve balances for losses and loss adjustment expenses (“LAE”) for the three months ended March 31:

(In thousands)	2023		2022
Reserve for losses and LAE at beginning of period	$	216,464	$	407,445
Less: Reinsurance recoverables	14,618		25,940
Net reserve for losses and LAE at beginning of period	201,846		381,505
Add provision for losses and LAE, net of reinsurance, occurring in:
Current period	32,694		24,369
Prior years	(32,874)		(131,227)
Net incurred losses and LAE during the current period	(180)		(106,858)
Deduct payments for losses and LAE, net of reinsurance, occurring in:
Current period	—		1
Prior years	2,001		909
Net loss and LAE payments during the current period	2,001		910
Net reserve for losses and LAE at end of period	199,665		273,737
Plus: Reinsurance recoverables	16,357		19,335
Reserve for losses and LAE at end of period	$	216,022	$	293,072

XML

Capital Stock (Tables)

3 Months Ended

Mar. 31, 2023

Banking Regulation, Total Capital [Abstract]

Schedule of Dividends Declared and Paid

The following table presents the amounts declared and paid per common share each quarter:

Quarter Ended	2023		2022
March 31	$	0.25	$	0.20
June 30	—		0.21
September 30	—		0.22
December 31	—		0.23
Total dividends per common share declared and paid	$	0.25	$	0.86

XML

Stock-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of Nonvested Common Share and Nonvested Common Share Unit Activity

The following table summarizes nonvested common share, nonvested common share unit and DEU activity for the three months ended March 31, 2023:

	Time and Performance- Based Share Awards			Time-Based Share Awards			Share Units			DEUs
(Shares in thousands)	Number of Shares	Weighted Average Grant Date Fair Value		Number of Shares	Weighted Average Grant Date Fair Value		Number of Share Units	Weighted Average Grant Date Fair Value		Dividend Equivalent Units	Weighted Average Grant Date Fair Value
Outstanding at beginning of year	647	$	20.99	138	$	45.94	350	$	45.51	37	$	40.86
Granted	300	12.66		76	43.51		436	38.41		11	37.88
Vested	(103)	51.52		(64)	56.65		(131)	49.16		(14)	40.31
Forfeited	—	—		—	—		(13)	39.25		—	40.57
Outstanding at March 31, 2023	844	$	14.29	150	$	44.40	642	$	40.07	34	$	40.15

Schedule of Portion of Nonvested Common Shares Earned based upon Achievement of Compounded Annual Book Value per share Growth

The portion of these nonvested performance-based share awards that will be earned is as follows:

		Relative Total Shareholder Return vs. S&P 1500 Financial Services Index
		≤25th percentile		50th percentile "Target"		≥75th percentile
Three-Year Book Value Per Share CAGR	10% "Target"	100	%	150	%	200	%
	9%	75	%	125	%	175	%
	8%	50	%	100	%	150	%
	6%	25	%	75	%	125	%
	5%	0	%	50	%	100	%

Schedule of Compensation Expense, Net of Forfeitures, and Related Tax Effects Recognized in Connection with Nonvested shares

Compensation expense, net of forfeitures, and related tax effects recognized in connection with nonvested shares was as follows:

	Three Months Ended March 31,
(In thousands)	2023		2022
Compensation expense	$	5,106	$	4,807
Income tax benefit	1,018		957

XML

Earnings per Share (EPS) (Tables)

3 Months Ended

Mar. 31, 2023

Earnings Per Share [Abstract]

Schedule of Reconciliation of Net Income and Weighted Average Common Shares Outstanding used in Computations of Basic and Diluted Earnings per Common Share

The following table reconciles the net income and the weighted average common shares outstanding used in the computations of basic and diluted earnings per common share:

	Three Months Ended  March 31,
(In thousands, except per share amounts)	2023		2022
Net income	$	170,827	$	274,167
Basic weighted average shares outstanding	106,943		108,166
Dilutive effect of nonvested shares	642		424
Diluted weighted average shares outstanding	107,585		108,590
Basic earnings per share	$	1.60	$	2.53
Diluted earnings per share	$	1.59	$	2.52

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award

The following table summarizes the performance-based shares issuable if the reporting date was the end of the contingency period.

	2023 Performance-Based Grants		2022 Performance-Based Grants		2021 Performance-Based Grants		2020 Performance-Based Grants
Reporting Date	Percent Issuable Relative to Target	As a Percent of Shares Issued	Percent Issuable Relative to Target	As a Percent of Shares Issued	Percent Issuable Relative to Target	As a Percent of Shares Issued	Percent Issuable Relative to Target and Shares Issued
March 31, 2023	200%	100%	170%	85%	100%	50%
March 31, 2022			122%	61%	100%	50%	100%

XML

Accumulated Other Comprehensive Income (Loss) (Tables)

3 Months Ended

Mar. 31, 2023

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Schedule of Rollforward of Accumulated Other Comprehensive Loss

The following table presents the rollforward of accumulated other comprehensive loss for the three months ended March 31, 2023 and 2022: 

	Three Months Ended March 31,
	2023						2022
(In thousands)	Before Tax		Tax Effect		Net of Tax		Before Tax		Tax Effect		Net of Tax
Balance at beginning of year	$	(443,230)	$	60,440	$	(382,790)	$	65,280	$	(14,573)	$	50,707
Other comprehensive income (loss):
Unrealized holding gains (losses) on investments:
Unrealized holding gains (losses) arising during the period	67,693		(9,476)		58,217		(246,255)		34,830		(211,425)
Less: Reclassification adjustment for losses included in net income (1)	488		48		536		7,352		1,067		8,419
Net unrealized gains (losses) on investments	68,181		(9,428)		58,753		(238,903)		35,897		(203,006)
Other comprehensive income (loss)	68,181		(9,428)		58,753		(238,903)		35,897		(203,006)
Balance at end of period	$	(375,049)	$	51,012	$	(324,037)	$	(173,623)	$	21,324	$	(152,299)

(1)Included in net realized investment losses on our condensed consolidated statements of comprehensive income.

XML

Fair Value of Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2023

Fair Value Disclosures [Abstract]

Schedule of Assets and Liabilities Measured at Fair Vale on a Recurring Basis

All assets measured at fair value are categorized in the table below based upon the lowest level of significant input to the valuations. All fair value measurements at the reporting date were on a recurring basis.

March 31, 2023 (In thousands)	Quoted Prices in Active  Markets for Identical Instruments (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
Recurring fair value measurements
Financial Assets:
U.S. Treasury securities	$	475,784	$	—	$	—	$	475,784
U.S. agency securities	—		12,690		—		12,690
U.S. agency mortgage-backed securities	—		850,124		—		850,124
Municipal debt securities	—		609,010		—		609,010
Non-U.S. government securities	—		63,018		—		63,018
Corporate debt securities	—		1,462,596		—		1,462,596
Residential and commercial mortgage securities	—		542,013		—		542,013
Asset-backed securities	—		648,109		—		648,109
Money market funds	286,692		—		—		286,692
Total assets at fair value (1) (2)	$	762,476	$	4,187,560	$	—	$	4,950,036

December 31, 2022 (In thousands)	Quoted Prices in Active  Markets for Identical Instruments (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
Recurring fair value measurements
Financial Assets:
U.S. Treasury securities	$	556,438	$	—	$	—	$	556,438
U.S. agency securities	—		49,058		—		49,058
U.S. agency mortgage-backed securities	—		783,743		—		783,743
Municipal debt securities	—		602,690		—		602,690
Non-U.S. government securities	—		62,399		—		62,399
Corporate debt securities	—		1,414,321		—		1,414,321
Residential and commercial mortgage securities	—		511,824		—		511,824
Asset-backed securities	—		624,561		—		624,561
Money market funds	136,591		—		—		136,591
Total assets at fair value (1)	$	693,029	$	4,048,596	$	—	$	4,741,625

(1)Does not include the fair value of embedded derivatives, which we have accounted for separately as freestanding derivatives and included in other assets or other accrued liabilities in our condensed consolidated balance sheet. See Note 4 for more information.

(2)Does not include certain other invested assets that are measured at fair value using the net asset value per share (or its equivalent) as a practical expedient, as applicable accounting standards do not provide for classification within the fair value hierarchy.

XML

Statutory Accounting (Tables)

3 Months Ended

Mar. 31, 2023

Insurance [Abstract]

Schedule of Statutory Net Income, Statutory Surplus and Contingency Reserve Liability

The following table presents Essent Guaranty’s and Essent PA’s statutory net income, statutory surplus and contingency reserve liability as of and for the three months ended March 31:

(In thousands)	2023		2022
Essent Guaranty
Statutory net income	$	123,936	$	200,277
Statutory surplus	992,134		1,081,986
Contingency reserve liability	2,105,708		1,862,482
Essent PA
Statutory net (loss) income	$	(112)	$	859
Statutory surplus	53,138		56,910
Contingency reserve liability	56,101		57,461

XML

Nature of Operations and Basis of Presentation (Details) - state				3 Months Ended
	Jan. 01, 2021	Dec. 31, 2020	Mar. 31, 2019	Mar. 31, 2023
Affiliated Entity | Essent Guaranty
Insurance Premium Revenue Recognition
Number of states in which the entity is licensed to write mortgage insurance				50
Affiliated Entity | Essent Re | Quota share reinsurance
Insurance Premium Revenue Recognition
Reinsurance percentage	35.00%	25.00%
Affiliated Entity | Essent PA | Reinsurance for mortgage insurance coverage in excess of 25%
Insurance Premium Revenue Recognition
Reinsurance for mortgage insurance coverage threshold (in excess of)			25.00%
Maximum
Insurance Premium Revenue Recognition
Residential mortgage down payment percentage for which mortgage insurance is generally required (less than)				20.00%

XML

Investments - Schedule of Investments Available for Sale (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Investments available for sale
Amortized Cost	$ 5,325,085	$ 5,184,856
Unrealized Gains	11,188	4,273
Unrealized Losses	(386,237)	(447,504)
Fair Value	4,950,036	4,741,625
U.S. Treasury securities
Investments available for sale
Amortized Cost	497,267	584,173
Unrealized Gains	843	341
Unrealized Losses	(22,326)	(28,076)
Fair Value	475,784	556,438
U.S. agency securities
Investments available for sale
Amortized Cost	12,696	49,059
Unrealized Gains	8	7
Unrealized Losses	(14)	(8)
Fair Value	12,690	49,058
U.S. agency mortgage-backed securities
Investments available for sale
Amortized Cost	950,645	898,675
Unrealized Gains	1,286	258
Unrealized Losses	(101,807)	(115,190)
Fair Value	850,124	783,743
Municipal debt securities
Investments available for sale
Amortized Cost	650,470	661,934
Unrealized Gains	5,489	2,010
Unrealized Losses	(46,949)	(61,254)
Fair Value	609,010	602,690
Non-U.S. government securities
Investments available for sale
Amortized Cost	69,606	69,651
Unrealized Gains	0	0
Unrealized Losses	(6,588)	(7,252)
Fair Value	63,018	62,399
Corporate debt securities
Investments available for sale
Amortized Cost	1,575,643	1,546,513
Unrealized Gains	3,040	1,195
Unrealized Losses	(116,087)	(133,387)
Fair Value	1,462,596	1,414,321
Residential and commercial mortgage securities
Investments available for sale
Amortized Cost	601,606	577,915
Unrealized Gains	208	390
Unrealized Losses	(59,801)	(66,481)
Fair Value	542,013	511,824
Asset-backed securities
Investments available for sale
Amortized Cost	680,460	660,345
Unrealized Gains	314	72
Unrealized Losses	(32,665)	(35,856)
Fair Value	648,109	624,561
Money market funds
Investments available for sale
Amortized Cost	286,692	136,591
Unrealized Gains	0	0
Unrealized Losses	0	0
Fair Value	$ 286,692	$ 136,591

XML

Investments - Summary of Municipal Debt Securities and Corporate Debt Securities (Details)	Mar. 31, 2023	Dec. 31, 2022
Municipal debt securities
Investments available for sale
Percentage of debt securities	100.00%	100.00%
Municipal debt securities | Special revenue bonds
Investments available for sale
Percentage of debt securities	81.40%	79.00%
Municipal debt securities | General obligation bonds
Investments available for sale
Percentage of debt securities	18.50%	20.90%
Municipal debt securities | Certificate of participation bonds
Investments available for sale
Percentage of debt securities	0.00%	0.00%
Municipal debt securities | Tax allocation bonds
Investments available for sale
Percentage of debt securities	0.10%	0.10%
Corporate debt securities
Investments available for sale
Percentage of debt securities	100.00%	100.00%
Corporate debt securities | Financial
Investments available for sale
Percentage of debt securities	40.80%	40.50%
Corporate debt securities | Consumer, non-cyclical
Investments available for sale
Percentage of debt securities	18.50%	17.90%
Corporate debt securities | Consumer, cyclical
Investments available for sale
Percentage of debt securities	7.20%	6.80%
Corporate debt securities | Industrial
Investments available for sale
Percentage of debt securities	6.70%	6.80%
Corporate debt securities | Utilities
Investments available for sale
Percentage of debt securities	5.70%	6.10%
Corporate debt securities | Communications
Investments available for sale
Percentage of debt securities	8.60%	8.40%
Corporate debt securities | Technology
Investments available for sale
Percentage of debt securities	4.80%	4.90%
Corporate debt securities | Energy
Investments available for sale
Percentage of debt securities	5.50%	6.40%
Corporate debt securities | Basic Materials
Investments available for sale
Percentage of debt securities	2.10%	2.10%
Corporate debt securities | Government
Investments available for sale
Percentage of debt securities	0.10%	0.10%

XML

Investments - Schedule of Amortized Cost and Fair Value of Investments Available for Sale by Contractual Maturity (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Amortized Cost
Amortized Cost	$ 5,325,085	$ 5,184,856
Fair Value
Fair Value	4,950,036	4,741,625
U.S. Treasury securities
Amortized Cost
Due in 1 year	130,959
Due after 1 but within 5 years	313,584
Due after 5 but within 10 years	38,335
Due after 10 years	14,389
Subtotal	497,267
Amortized Cost	497,267	584,173
Fair Value
Due in 1 year	129,312
Due after 1 but within 5 years	297,672
Due after 5 but within 10 years	34,655
Due after 10 years	14,145
Subtotal	475,784
U.S. agency securities
Amortized Cost
Due in 1 year	11,125
Due after 1 but within 5 years	1,571
Subtotal	12,696
Amortized Cost	12,696	49,059
Fair Value
Due in 1 year	11,111
Due after 1 but within 5 years	1,579
Subtotal	12,690
Municipal debt securities
Amortized Cost
Due in 1 year	6,006
Due after 1 but within 5 years	88,888
Due after 5 but within 10 years	175,352
Due after 10 years	380,224
Subtotal	650,470
Amortized Cost	650,470	661,934
Fair Value
Due in 1 year	5,977
Due after 1 but within 5 years	86,924
Due after 5 but within 10 years	167,037
Due after 10 years	349,072
Subtotal	609,010
Non-U.S. government securities:
Amortized Cost
Due in 1 year	10,020
Due after 1 but within 5 years	33,759
Due after 5 but within 10 years	5,532
Due after 10 years	20,295
Subtotal	69,606
Amortized Cost	69,606	69,651
Fair Value
Due in 1 year	10,012
Due after 1 but within 5 years	32,824
Due after 5 but within 10 years	4,512
Due after 10 years	15,670
Subtotal	63,018
Corporate debt securities
Amortized Cost
Due in 1 year	241,103
Due after 1 but within 5 years	635,267
Due after 5 but within 10 years	484,388
Due after 10 years	214,885
Subtotal	1,575,643
Amortized Cost	1,575,643	1,546,513
Fair Value
Due in 1 year	238,178
Due after 1 but within 5 years	605,227
Due after 5 but within 10 years	433,797
Due after 10 years	185,394
Subtotal	1,462,596
U.S. agency mortgage-backed securities
Amortized Cost
Without single maturity date	950,645
Amortized Cost	950,645	898,675
Fair Value
Without single maturity date	850,124
Residential and commercial mortgage securities
Amortized Cost
Without single maturity date	601,606
Amortized Cost	601,606	577,915
Fair Value
Without single maturity date	542,013
Asset-backed securities
Amortized Cost
Without single maturity date	680,460
Amortized Cost	680,460	660,345
Fair Value
Without single maturity date	648,109
Money market funds
Amortized Cost
Without single maturity date	286,692
Amortized Cost	286,692	$ 136,591
Fair Value
Without single maturity date	$ 286,692

XML

Investments - Summary of Realized Gain and Loss and Investments in Unrealized Loss Position (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Realized gross gains	$ 869,000	$ 12,576,000
Realized gross losses	1,357,000	13,091,000
Impairment loss	0	$ 6,837,000
Fair Value
Less than 12 months	1,297,817,000		$ 2,474,361,000
12 months or more	2,765,938,000		1,586,877,000
Total	4,063,755,000		4,061,238,000
Gross Unrealized Losses
Less than 12 months	(32,049,000)		(198,613,000)
12 months or more	(354,188,000)		(248,891,000)
Total	(386,237,000)		(447,504,000)
U.S. Treasury securities
Fair Value
Less than 12 months	184,036,000		321,848,000
12 months or more	256,893,000		169,795,000
Total	440,929,000		491,643,000
Gross Unrealized Losses
Less than 12 months	(2,069,000)		(12,381,000)
12 months or more	(20,257,000)		(15,695,000)
Total	(22,326,000)		(28,076,000)
U.S. agency securities
Fair Value
Less than 12 months	11,111,000		7,117,000
12 months or more	0		0
Total	11,111,000		7,117,000
Gross Unrealized Losses
Less than 12 months	(14,000)		(8,000)
12 months or more	0		0
Total	(14,000)		(8,000)
U.S. agency mortgage-backed securities
Fair Value
Less than 12 months	144,039,000		351,310,000
12 months or more	643,734,000		415,743,000
Total	787,773,000		767,053,000
Gross Unrealized Losses
Less than 12 months	(3,586,000)		(34,193,000)
12 months or more	(98,221,000)		(80,997,000)
Total	(101,807,000)		(115,190,000)
Municipal debt securities
Fair Value
Less than 12 months	150,068,000		335,784,000
12 months or more	244,856,000		64,766,000
Total	394,924,000		400,550,000
Gross Unrealized Losses
Less than 12 months	(2,840,000)		(41,620,000)
12 months or more	(44,109,000)		(19,634,000)
Total	(46,949,000)		(61,254,000)
Non-U.S. government securities:
Fair Value
Less than 12 months	36,274,000		48,071,000
12 months or more	26,744,000		14,328,000
Total	63,018,000		62,399,000
Gross Unrealized Losses
Less than 12 months	(472,000)		(2,914,000)
12 months or more	(6,116,000)		(4,338,000)
Total	(6,588,000)		(7,252,000)
Corporate debt securities
Fair Value
Less than 12 months	467,974,000		811,217,000
12 months or more	774,083,000		421,307,000
Total	1,242,057,000		1,232,524,000
Gross Unrealized Losses
Less than 12 months	(11,248,000)		(69,415,000)
12 months or more	(104,839,000)		(63,972,000)
Total	(116,087,000)		(133,387,000)
Residential and commercial mortgage securities
Fair Value
Less than 12 months	136,012,000		265,934,000
12 months or more	395,814,000		242,366,000
Total	531,826,000		508,300,000
Gross Unrealized Losses
Less than 12 months	(7,065,000)		(22,628,000)
12 months or more	(52,736,000)		(43,853,000)
Total	(59,801,000)		(66,481,000)
Asset-backed securities
Fair Value
Less than 12 months	168,303,000		333,080,000
12 months or more	423,814,000		258,572,000
Total	592,117,000		591,652,000
Gross Unrealized Losses
Less than 12 months	(4,755,000)		(15,454,000)
12 months or more	(27,910,000)		(20,402,000)
Total	$ (32,665,000)		$ (35,856,000)

XML

Investments - Narrative (Details)	3 Months Ended
	Mar. 31, 2023 USD ($) security	Mar. 31, 2022 USD ($)	Dec. 31, 2022 USD ($) security
Investments available for sale
Number of investment securities in an unrealized loss position | security	2,526		2,578
Impairment loss	$ 0	$ 6,837,000
Other invested assets	255,288,000		$ 257,941,000
Fair value of investments deposited with insurance regulatory authorities	9,200,000		9,100,000
Essent Re
Investments available for sale
Fair value of the required investments on deposit in trusts	671,800,000		972,400,000
Essent Guaranty
Investments available for sale
Assets on deposit under reinsurance agreement	8,700,000		8,600,000
Assets on deposit for the benefit of the sponsor	9,100,000		$ 9,100,000
Limited Partnership Investments
Investments available for sale
Other assets, fair value	163,100,000
Funding commitments	$ 49,000,000
Limited Partnership Investments | Minimum
Investments available for sale
Asset liquidation period	1 year
Limited Partnership Investments | Maximum
Investments available for sale
Asset liquidation period	8 years
Securities | Credit Concentration Risk | Internal Investment Grade
Investments available for sale
Concentration risk, percentage	98.00%

XML

Investments - Net Investment Income (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Components of net investment income
Gross investment income	$ 45,194	$ 26,267
Investment expenses	(1,958)	(1,587)
Net investment income	43,236	24,680
Fixed maturities
Components of net investment income
Gross investment income	43,473	26,223
Short-term investments
Components of net investment income
Gross investment income	$ 1,721	$ 44

XML

Reinsurance - Effect on Net Premiums Written and Earned (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Net premiums written:
Direct	$ 239,491	$ 220,254
Ceded	(33,591)	(20,523)
Net premiums written	205,900	199,731
Net premiums earned:
Direct	244,849	235,853
Ceded	(33,591)	(20,523)
Net premiums earned	$ 211,258	$ 215,330

XML

Reinsurance - Quota Share Reinsurance (Details) - Reinsurance Policy, Type [Axis]: Quota Share Reinsurance - USD ($) $ in Billions		3 Months Ended	12 Months Ended
	Dec. 31, 2021	Mar. 31, 2023	Dec. 31, 2022
QSR-2019
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Ceded premiums earned related to percent of risk on all other eligible policies written		20.00%
Ceding commission		20.00%
Profit commission, maximum	60.00%	63.00%	63.00%
Ceded premiums earned related to percent of risk on eligible single premium policies		40.00%
QSR-2022
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Ceded premiums earned related to percent of risk on all other eligible policies written		20.00%
Ceding commission		20.00%
Profit commission, maximum		62.00%
RIF ceded		$ 7.3
QSR-2023
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Ceded premiums earned related to percent of risk on all other eligible policies written		17.50%
Ceding commission		20.00%
Profit commission, maximum		58.00%

XML

Reinsurance - Excess of Loss Reinsurance (Details) - Reinsurance Policy, Type [Axis]: Mortgage Insurance	3 Months Ended
	Mar. 31, 2023
Other Reinsurance | Essent Guaranty
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Amortization period	10 years
VIE | Mortgage Insurance Linked Notes | Radnor Re
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Reinsurance retention policy, debt issued to cover insurance, term	10 years
VIE | Radnor Re
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Amortization period	10 years

XML

Reinsurance - Premium Details (Details)	Mar. 31, 2023
Reinsurance Policy, Type [Axis]: Vintage Year 2017 | Panel of Reinsurers
Effects of Reinsurance [Line Items]
Risk margin increase after optional termination date	50.00%

XML

Reinsurance - Essent Guaranty's Excess of Loss Reinsurance Coverages and Retentions (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($)
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Remaining Insurance in Force	$ 206,065,438
Remaining Risk in Force	54,567,761
Remaining Reinsurance in Force	2,106,107
Remaining First Layer Retention	2,025,706
ILN
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Remaining Reinsurance in Force	1,773,085
Other Reinsurance
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Remaining Reinsurance in Force	333,022
Reinsurance Policy, Type [Axis]: Vintage Year 2017
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Remaining Insurance in Force	5,511,131
Remaining Risk in Force	1,450,432
Remaining Reinsurance in Force	70,895
Remaining First Layer Retention	421,003
Reinsurance Policy, Type [Axis]: Vintage Year 2017 | Radnor Re 2018-1 Ltd.
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Remaining Reinsurance in Force	0
Reinsurance Policy, Type [Axis]: Vintage Year 2017 | Other Reinsurance
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Remaining Reinsurance in Force	70,895
Reinsurance Policy, Type [Axis]: Vintage Year 2018
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Remaining Insurance in Force	6,349,474
Remaining Risk in Force	1,644,287
Remaining Reinsurance in Force	401,681
Remaining First Layer Retention	248,221
Reinsurance Policy, Type [Axis]: Vintage Year 2018 | Radnor Re 2019-1 Ltd.
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Remaining Reinsurance in Force	325,537
Reinsurance Policy, Type [Axis]: Vintage Year 2018 | Other Reinsurance
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Remaining Reinsurance in Force	76,144
Reinsurance Policy, Type [Axis]: Vintage Year 2019
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Remaining Insurance in Force	7,859,217
Remaining Risk in Force	2,029,598
Remaining Reinsurance in Force	439,880
Remaining First Layer Retention	214,485
Reinsurance Policy, Type [Axis]: Vintage Year 2019 | Radnor Re 2020-1 Ltd.
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Remaining Reinsurance in Force	395,889
Reinsurance Policy, Type [Axis]: Vintage Year 2019 | Other Reinsurance
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Remaining Reinsurance in Force	43,991
Reinsurance Policy, Type [Axis]: Vintage Year 2020 And 2021
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Remaining Insurance in Force	38,168,321
Remaining Risk in Force	9,652,777
Remaining Reinsurance in Force	414,005
Remaining First Layer Retention	278,909
Reinsurance Policy, Type [Axis]: Vintage Year 2020 And 2021 | Radnor Re 2021-1 Ltd.
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Remaining Reinsurance in Force	414,005
Reinsurance Policy, Type [Axis]: Vintage Year 2020 And 2021 | Other Reinsurance
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Remaining Reinsurance in Force	0
Reinsurance Policy, Type [Axis]: Vintage Year 2021
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Remaining Insurance in Force	40,543,749
Remaining Risk in Force	10,825,130
Remaining Reinsurance in Force	399,786
Remaining First Layer Retention	279,400
Reinsurance Policy, Type [Axis]: Vintage Year 2021 | Radnor Re 2021-2 Ltd.
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Remaining Reinsurance in Force	399,786
Reinsurance Policy, Type [Axis]: Vintage Year 2021 | Other Reinsurance
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Remaining Reinsurance in Force	0
Reinsurance Policy, Type [Axis]: Vintage Year 2021 And 2022 | Coverage Period One
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Remaining Insurance in Force	74,276,338
Remaining Risk in Force	19,998,840
Remaining Reinsurance in Force	141,992
Remaining First Layer Retention	507,114
Reinsurance Policy, Type [Axis]: Vintage Year 2021 And 2022 | Insurance Written Period
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Remaining Insurance in Force	33,357,208
Remaining Risk in Force	8,966,697
Remaining Reinsurance in Force	237,868
Remaining First Layer Retention	303,761
Reinsurance Policy, Type [Axis]: Vintage Year 2021 And 2022 | Radnor Re 2021-2 Ltd. | Coverage Period One
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Remaining Reinsurance in Force	0
Reinsurance Policy, Type [Axis]: Vintage Year 2021 And 2022 | Radnor Re 2021-2 Ltd. | Insurance Written Period
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Remaining Reinsurance in Force	237,868
Reinsurance Policy, Type [Axis]: Vintage Year 2021 And 2022 | Other Reinsurance | Coverage Period One
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Remaining Reinsurance in Force	141,992
Reinsurance Policy, Type [Axis]: Vintage Year 2021 And 2022 | Other Reinsurance | Insurance Written Period
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Remaining Reinsurance in Force	$ 0

XML

Reinsurance - Summary of Total Assets and Maximum Exposure Loss (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Variable Interest Entity [Line Items]
Total VIE Assets	$ 5,927,506	$ 5,723,797
VIE
Variable Interest Entity [Line Items]
Total VIE Assets	1,773,085
Maximum Exposure to Loss, On - Balance Sheet	(11,315)
Maximum Exposure to Loss, Off - Balance Sheet	519
Maximum Exposure to Loss	(10,796)
VIE | Radnor Re 2019-1 Ltd.
Variable Interest Entity [Line Items]
Total VIE Assets	325,537
Maximum Exposure to Loss, On - Balance Sheet	(2,218)
Maximum Exposure to Loss, Off - Balance Sheet	90
Maximum Exposure to Loss	(2,128)
VIE | Radnor Re 2020-1 Ltd.
Variable Interest Entity [Line Items]
Total VIE Assets	395,889
Maximum Exposure to Loss, On - Balance Sheet	(1,286)
Maximum Exposure to Loss, Off - Balance Sheet	158
Maximum Exposure to Loss	(1,128)
VIE | Radnor Re 2021-1 Ltd.
Variable Interest Entity [Line Items]
Total VIE Assets	414,005
Maximum Exposure to Loss, On - Balance Sheet	(4,657)
Maximum Exposure to Loss, Off - Balance Sheet	98
Maximum Exposure to Loss	(4,559)
VIE | Radnor Re 2021-2 Ltd.
Variable Interest Entity [Line Items]
Total VIE Assets	399,786
Maximum Exposure to Loss, On - Balance Sheet	(3,849)
Maximum Exposure to Loss, Off - Balance Sheet	95
Maximum Exposure to Loss	(3,754)
VIE | Radnor Re 2022-1 Ltd.
Variable Interest Entity [Line Items]
Total VIE Assets	237,868
Maximum Exposure to Loss, On - Balance Sheet	695
Maximum Exposure to Loss, Off - Balance Sheet	78
Maximum Exposure to Loss	$ 773

XML

Reserve for Losses and Loss Adjustment Expenses - Reconciliation of Reserve Balances for Losses and Loss Adjustment Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021
Reconciliation of the beginning and ending reserve balances for losses and loss adjustment expenses (LAE)
Reserve for losses and LAE at beginning of period	$ 216,464	$ 407,445
Less: Reinsurance recoverables	16,357	19,335	$ 14,618	$ 25,940
Net reserve for losses and LAE at beginning of period	201,846	381,505
Add provision for losses and LAE, net of reinsurance, occurring in:
Current period	32,694	24,369
Prior years	(32,874)	(131,227)
Net incurred losses and LAE during the current period	(180)	(106,858)
Deduct payments for losses and LAE, net of reinsurance, occurring in:
Current period	0	1
Prior years	2,001	909
Net loss and LAE payments during the current period	2,001	910
Net reserve for losses and LAE at end of period	199,665	273,737
Plus: Reinsurance recoverables	16,357	19,335	$ 14,618	$ 25,940
Reserve for losses and LAE at end of period	$ 216,022	$ 293,072

XML

Reserve for Losses and Loss Adjustment Expenses - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended			12 Months Ended	21 Months Ended
	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021
Liability for Claims and Claims Adjustment Expense [Line Items]
Incurred claims and claim adjustment expenses	$ 2,001		$ 909
Favorable prior year development	32,874		131,227
Reserve for losses and LAE, for prior years	$ 167,000		$ 249,400
Reduction of reserves on hurricane-related defaults				$ 164,100
COVID-19
Liability for Claims and Claims Adjustment Expense [Line Items]
Reserve rate		2.00%	4.00%		7.00%

XML

Debt Obligations (Details) - USD ($)		3 Months Ended
	Mar. 31, 2023	Mar. 31, 2023	Dec. 31, 2022
Credit Facility [Line Items]
Credit facility expiration period		5 years
Committed capacity	$ 825,000,000	$ 825,000,000
Amount outstanding, gross	$ 425,000,000	$ 425,000,000	$ 425,000,000
Weighted average interest rate during period	6.52%	6.52%	6.02%
Revolving Credit Facility
Credit Facility [Line Items]
Line of credit facility, accordion feature	$ 175,000,000	$ 175,000,000
Credit facility, commitment fee rate	0.25%

XML

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Indemnifications related to contract underwriting services
Loss Contingencies [Line Items]
Amount paid for remedies (less than three months ended March 31, 2022)	$ 0.0	$ 0.1

XML

Capital Stock - Narrative (Details)		3 Months Ended					11 Months Ended	12 Months Ended
	May 08, 2023 $ / shares	Mar. 31, 2023 vote $ / shares shares	Dec. 31, 2022 USD ($) vote $ / shares shares	Sep. 30, 2022 $ / shares	Jun. 30, 2022 $ / shares	Mar. 31, 2022 $ / shares	Mar. 31, 2023 USD ($) vote shares	Dec. 31, 2022 USD ($) vote $ / shares shares	May 31, 2022 USD ($)
Dividends Payable [Line Items]
Authorized share capital (in shares) | shares		233,333,000	233,333,000				233,333,000	233,333,000
Number of votes per share | vote		1					1
Shareholder ownership threshold for voting rights		9.50%
Maximum number of votes per share for certain shareholders under 9.5% shareholder provision | vote			1					1
Minimum number of votes per share for other shareholders under 9.5% shareholder provision | vote		1					1
Quarterly cash dividends declared (in dollars per share) | $ / shares		$ 0.25	$ 0.23	$ 0.22	$ 0.21	$ 0.20		$ 0.86
Quarterly cash dividends paid (in dollars per share) | $ / shares		$ 0.25	$ 0.23	$ 0.22	$ 0.21	$ 0.20		$ 0.86
Subsequent Event
Dividends Payable [Line Items]
Quarterly cash dividends declared (in dollars per share) | $ / shares	$ 0.25
Share Repurchase Plan 2022
Dividends Payable [Line Items]
Share repurchase approved amount | $									$ 250,000,000
Treasury stock acquired (in shares) | shares							431,904
Shares acquired | $							$ 16,600,000
Remaining authorized repurchase amount | $			$ 233,400,000					$ 233,400,000

XML

Capital Stock - Dividends (Details) - $ / shares		3 Months Ended								12 Months Ended
	Jun. 12, 2023	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Dividends Payable [Line Items]
Quarterly cash dividends declared (in dollars per share)					$ 0.25	$ 0.23	$ 0.22	$ 0.21	$ 0.20		$ 0.86
Quarterly cash dividends paid (in dollars per share)					$ 0.25	$ 0.23	$ 0.22	$ 0.21	$ 0.20		$ 0.86
Forecast
Dividends Payable [Line Items]
Quarterly cash dividends declared (in dollars per share)		$ 0	$ 0	$ 0						$ 0.25
Quarterly cash dividends paid (in dollars per share)	$ 0.25	$ 0	$ 0	$ 0						$ 0.25

XML

Stock-Based Compensation - Narrative (Details) - USD ($) $ in Millions	1 Months Ended		3 Months Ended
	Feb. 28, 2023	Feb. 28, 2021	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2013
Stock-based compensation
Shares tendered by employees to pay employee withholding taxes (in shares)			111,820
Nonvested shares, share units or DEU
Stock-based compensation
Total fair value of shares vested			$ 13.2	$ 16.3
Nonvested shares or share units outstanding
Stock-based compensation
Total unrecognized compensation expense			$ 34.0
Expected weighted average period for recognition of expense			2 years 6 months
Time-Based Share Awards | Employee | Share Units | Incentive Program Bonus Award Fiscal Year Performance
Stock-based compensation
Vesting period		3 years
Time-Based Share Awards | Employee | Share Units | Incentive Program Bonus Award Fiscal Year Performance | First Vesting Date
Stock-based compensation
Vesting percentage		33.33%
Time-Based Share Awards | Employee | Share Units | Incentive Program Bonus Award Fiscal Year Performance | Second Vesting Date
Stock-based compensation
Vesting percentage		33.33%
Time-Based Share Awards | Employee | Share Units | Incentive Program Bonus Award Fiscal Year Performance | Third Vesting Date
Stock-based compensation
Vesting percentage		33.33%
2013 Plan
Stock-based compensation
Shares authorized (in shares)					7,500,000
Number of share available for future grant (in shares)			2,000,000
2013 Plan | Time-Based Share Awards | Certain Senior Management | Nonvested shares
Stock-based compensation
Performance period	3 years
2013 Plan | Time-Based Share Awards | Certain Senior Management | Nonvested shares | First Vesting Date
Stock-based compensation
Vesting percentage		33.33%
2013 Plan | Time-Based Share Awards | Certain Senior Management | Nonvested shares | Second Vesting Date
Stock-based compensation
Vesting percentage		33.33%
2013 Plan | Time-Based Share Awards | Certain Senior Management | Nonvested shares | Third Vesting Date
Stock-based compensation
Vesting percentage		33.33%
2013 Plan | Vesting Based On Performance | Certain Senior Management | Nonvested shares
Stock-based compensation
Performance period	3 years
2013 Plan | Vesting Based On Performance | Certain Senior Management | Nonvested shares | Maximum
Stock-based compensation
Vesting percentile	200.00%

XML

Stock-Based Compensation - Summary of Nonvested Common Share and Common Share Unit Activity (Details) shares in Thousands	3 Months Ended
	Mar. 31, 2023 $ / shares shares
Nonvested shares | Time and Performance- Based Share Awards
Number of Shares
Outstanding at beginning of year (in shares) | shares	647
Granted (in shares) | shares	300
Vested (in shares) | shares	(103)
Forfeited (in shares) | shares	0
Outstanding at end of period (in shares) | shares	844
Weighted Average Grant Date Fair Value
Outstanding at beginning of year (in dollars per share) | $ / shares	$ 20.99
Granted (in dollars per share) | $ / shares	12.66
Vested (in dollars per share) | $ / shares	51.52
Forfeited (in dollars per share) | $ / shares	0
Outstanding at end of period (in dollars per share) | $ / shares	$ 14.29
Nonvested shares | Time-Based Share Awards
Number of Shares
Outstanding at beginning of year (in shares) | shares	138
Granted (in shares) | shares	76
Vested (in shares) | shares	(64)
Forfeited (in shares) | shares	0
Outstanding at end of period (in shares) | shares	150
Weighted Average Grant Date Fair Value
Outstanding at beginning of year (in dollars per share) | $ / shares	$ 45.94
Granted (in dollars per share) | $ / shares	43.51
Vested (in dollars per share) | $ / shares	56.65
Forfeited (in dollars per share) | $ / shares	0
Outstanding at end of period (in dollars per share) | $ / shares	$ 44.40
Share Units
Number of Shares
Outstanding at beginning of year (in shares) | shares	350
Granted (in shares) | shares	436
Vested (in shares) | shares	(131)
Forfeited (in shares) | shares	(13)
Outstanding at end of period (in shares) | shares	642
Weighted Average Grant Date Fair Value
Outstanding at beginning of year (in dollars per share) | $ / shares	$ 45.51
Granted (in dollars per share) | $ / shares	38.41
Vested (in dollars per share) | $ / shares	49.16
Forfeited (in dollars per share) | $ / shares	39.25
Outstanding at end of period (in dollars per share) | $ / shares	$ 40.07
DEUs
Number of Shares
Outstanding at beginning of year (in shares) | shares	37
Granted (in shares) | shares	11
Vested (in shares) | shares	(14)
Forfeited (in shares) | shares	0
Outstanding at end of period (in shares) | shares	34
Weighted Average Grant Date Fair Value
Outstanding at beginning of year (in dollars per share) | $ / shares	$ 40.86
Granted (in dollars per share) | $ / shares	37.88
Vested (in dollars per share) | $ / shares	40.31
Forfeited (in dollars per share) | $ / shares	40.57
Outstanding at end of period (in dollars per share) | $ / shares	$ 40.15

XML

Stock-Based Compensation - Summary of Nonvested Performance-based Share Awards (Details) - Nonvested shares - Forecast	36 Months Ended
	Dec. 31, 2025
10% "Target"
Stock-based compensation
Compounded Annual Growth Rate, Three Year Book Value	1000.00%
10% "Target" | Share-based Payment Arrangement, Less than or Equal to 25th Percentile [Member]
Stock-based compensation
Vesting percentile	100.00%
10% "Target" | Share-based Payment Arrangement, 50th Percentile [Member]
Stock-based compensation
Vesting percentile	150.00%
10% "Target" | Share-based Payment Arrangement, Greater than or Equal to 75th Percentile [Member]
Stock-based compensation
Vesting percentile	200.00%
9%
Stock-based compensation
Compounded Annual Growth Rate, Three Year Book Value	9.00%
9% | Share-based Payment Arrangement, Less than or Equal to 25th Percentile [Member]
Stock-based compensation
Vesting percentile	75.00%
9% | Share-based Payment Arrangement, 50th Percentile [Member]
Stock-based compensation
Vesting percentile	125.00%
9% | Share-based Payment Arrangement, Greater than or Equal to 75th Percentile [Member]
Stock-based compensation
Vesting percentile	175.00%
8%
Stock-based compensation
Compounded Annual Growth Rate, Three Year Book Value	8.00%
8% | Share-based Payment Arrangement, Less than or Equal to 25th Percentile [Member]
Stock-based compensation
Vesting percentile	50.00%
8% | Share-based Payment Arrangement, 50th Percentile [Member]
Stock-based compensation
Vesting percentile	100.00%
8% | Share-based Payment Arrangement, Greater than or Equal to 75th Percentile [Member]
Stock-based compensation
Vesting percentile	150.00%
6%
Stock-based compensation
Compounded Annual Growth Rate, Three Year Book Value	6.00%
6% | Share-based Payment Arrangement, Less than or Equal to 25th Percentile [Member]
Stock-based compensation
Vesting percentile	25.00%
6% | Share-based Payment Arrangement, 50th Percentile [Member]
Stock-based compensation
Vesting percentile	75.00%
6% | Share-based Payment Arrangement, Greater than or Equal to 75th Percentile [Member]
Stock-based compensation
Vesting percentile	125.00%
5%
Stock-based compensation
Compounded Annual Growth Rate, Three Year Book Value	5.00%
5% | Share-based Payment Arrangement, Less than or Equal to 25th Percentile [Member]
Stock-based compensation
Vesting percentile	0.00%
5% | Share-based Payment Arrangement, 50th Percentile [Member]
Stock-based compensation
Vesting percentile	50.00%
5% | Share-based Payment Arrangement, Greater than or Equal to 75th Percentile [Member]
Stock-based compensation
Vesting percentile	100.00%

XML

Stock-Based Compensation - Summary of Compensation Expense, Net of Forfeitures (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Share-Based Payment Arrangement [Abstract]
Compensation expense	$ 5,106	$ 4,807
Income tax benefit	$ 1,018	$ 957

XML

Dividends Restrictions (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Dividends Restrictions
Total equity	$ 4,648,941,000	$ 4,215,068,000	$ 4,462,309,000
Affiliated Entity | Essent Guaranty
Dividends Restrictions
Unassigned surplus	286,800,000
Dividends paid to parent company	90,000,000	100,000,000
Affiliated Entity | Essent PA
Dividends Restrictions
Unassigned surplus	14,100,000
Dividends paid to parent company	0	$ 0
Amount available for dividend distribution	5,300,000
Affiliated Entity | Essent Re
Dividends Restrictions
Total equity	1,600,000,000
Affiliated Entity | Essent Re | Minimum | Quota share reinsurance
Dividends Restrictions
Total equity	$ 100,000,000

XML

Earnings per Share (EPS) - Reconciliation of Net Income and Weighted Average Common Shares Outstanding (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Earnings Per Share [Abstract]
Net income	$ 170,827	$ 274,167
Basic weighted average shares outstanding (in shares)	106,943	108,166
Dilutive effect of nonvested shares (in shares)	642	424
Diluted weighted average shares outstanding (in shares)	107,585	108,590
Basic earnings per share (in dollars per share)	$ 1.60	$ 2.53
Diluted earnings per share (in dollars per share)	$ 1.59	$ 2.52

XML

Earnings per Share (EPS) - Narrative (Details) - shares	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Earnings Per Share [Abstract]
Antidilutive nonvested shares (in shares)	111,870	81,036

XML

Earnings per Share (EPS) - Schedule of Percent of Shares Issuable Under Terms of Agreement (Details)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
2023 Performance-Based Grants
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Vesting percent	200.00%
Percentage of award issuable if current period end were end of contingency period	100.00%
2022 Performance-Based Grants
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Performance period	3 years
Vesting percent	170.00%	122.00%
Percentage of award issuable if current period end were end of contingency period	85.00%	61.00%
2021 Performance-Based Grants
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Performance period	3 years
Vesting percent	100.00%	100.00%
Percentage of award issuable if current period end were end of contingency period	50.00%	50.00%
2020 Performance-Based Grants
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Vesting percent		100.00%

XML

Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Other comprehensive income (loss):
Other comprehensive income, before tax	$ 68,181	$ (238,903)
Other comprehensive income (loss):
Other comprehensive income, tax effect	(9,428)	35,897
Net of Tax
Balance, beginning of period	4,462,309
Other comprehensive income (loss):
Total other comprehensive income (loss)	58,753	(203,006)
Balance, end of period	4,648,941	4,215,068
Accumulated Other Comprehensive Loss
Before Tax
AOCI before tax, beginning of period	(443,230)	65,280
Other comprehensive income (loss):
AOCI before tax, end of period	(375,049)	(173,623)
Tax Effect
AOCI tax effect, beginning of period	60,440	(14,573)
Other comprehensive income (loss):
AOCI tax effect, end of period	51,012	21,324
Net of Tax
Balance, beginning of period	(382,790)	50,707
Other comprehensive income (loss):
Total other comprehensive income (loss)	58,753	(203,006)
Balance, end of period	(324,037)	(152,299)
Accumulated Net Investment Gains (Losses) On Investments
Other comprehensive income (loss):
Unrealized holding gains (losses) arising during the period, before tax	67,693	(246,255)
Less: Reclassification adjustment for losses included in net income, before tax	488	7,352
Other comprehensive income, before tax	68,181	(238,903)
Other comprehensive income (loss):
Unrealized holding gains (losses) arising during the period, tax effect	(9,476)	34,830
Less: Reclassification adjustment for losses included in net income, tax effect	48	1,067
Other comprehensive income, tax effect	(9,428)	35,897
Other comprehensive income (loss):
Unrealized holding gains (losses) arising during the period, net of tax	58,217	(211,425)
Less: Reclassification adjustment for losses included in net income, net of tax	536	8,419
Total other comprehensive income (loss)	$ 58,753	$ (203,006)

XML

Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Financial Assets:
Fair Value	$ 4,950,036	$ 4,741,625
Recurring
Financial Assets:
Total assets at fair value	4,950,036	4,741,625
Recurring | U.S. Treasury securities
Financial Assets:
Fair Value	475,784	556,438
Recurring | U.S. agency securities
Financial Assets:
Fair Value	12,690	49,058
Recurring | U.S. agency mortgage-backed securities
Financial Assets:
Fair Value	850,124	783,743
Recurring | Municipal debt securities
Financial Assets:
Fair Value	609,010	602,690
Recurring | Non-U.S. government securities:
Financial Assets:
Fair Value	63,018	62,399
Recurring | Corporate debt securities
Financial Assets:
Fair Value	1,462,596	1,414,321
Recurring | Residential and commercial mortgage securities
Financial Assets:
Fair Value	542,013	511,824
Recurring | Asset-backed securities
Financial Assets:
Fair Value	648,109	624,561
Recurring | Money market funds
Financial Assets:
Fair Value	286,692	136,591
Recurring | Quoted Prices in Active  Markets for Identical Instruments (Level 1)
Financial Assets:
Total assets at fair value	762,476	693,029
Recurring | Quoted Prices in Active  Markets for Identical Instruments (Level 1) | U.S. Treasury securities
Financial Assets:
Fair Value	475,784	556,438
Recurring | Quoted Prices in Active  Markets for Identical Instruments (Level 1) | U.S. agency securities
Financial Assets:
Fair Value	0	0
Recurring | Quoted Prices in Active  Markets for Identical Instruments (Level 1) | U.S. agency mortgage-backed securities
Financial Assets:
Fair Value	0	0
Recurring | Quoted Prices in Active  Markets for Identical Instruments (Level 1) | Municipal debt securities
Financial Assets:
Fair Value	0	0
Recurring | Quoted Prices in Active  Markets for Identical Instruments (Level 1) | Non-U.S. government securities:
Financial Assets:
Fair Value	0	0
Recurring | Quoted Prices in Active  Markets for Identical Instruments (Level 1) | Corporate debt securities
Financial Assets:
Fair Value	0	0
Recurring | Quoted Prices in Active  Markets for Identical Instruments (Level 1) | Residential and commercial mortgage securities
Financial Assets:
Fair Value	0	0
Recurring | Quoted Prices in Active  Markets for Identical Instruments (Level 1) | Asset-backed securities
Financial Assets:
Fair Value	0	0
Recurring | Quoted Prices in Active  Markets for Identical Instruments (Level 1) | Money market funds
Financial Assets:
Fair Value	286,692	136,591
Recurring | Significant Other Observable Inputs (Level 2)
Financial Assets:
Total assets at fair value	4,187,560	4,048,596
Recurring | Significant Other Observable Inputs (Level 2) | U.S. Treasury securities
Financial Assets:
Fair Value	0	0
Recurring | Significant Other Observable Inputs (Level 2) | U.S. agency securities
Financial Assets:
Fair Value	12,690	49,058
Recurring | Significant Other Observable Inputs (Level 2) | U.S. agency mortgage-backed securities
Financial Assets:
Fair Value	850,124	783,743
Recurring | Significant Other Observable Inputs (Level 2) | Municipal debt securities
Financial Assets:
Fair Value	609,010	602,690
Recurring | Significant Other Observable Inputs (Level 2) | Non-U.S. government securities:
Financial Assets:
Fair Value	63,018	62,399
Recurring | Significant Other Observable Inputs (Level 2) | Corporate debt securities
Financial Assets:
Fair Value	1,462,596	1,414,321
Recurring | Significant Other Observable Inputs (Level 2) | Residential and commercial mortgage securities
Financial Assets:
Fair Value	542,013	511,824
Recurring | Significant Other Observable Inputs (Level 2) | Asset-backed securities
Financial Assets:
Fair Value	648,109	624,561
Recurring | Significant Other Observable Inputs (Level 2) | Money market funds
Financial Assets:
Fair Value	0	0
Recurring | Significant Unobservable Inputs (Level 3)
Financial Assets:
Total assets at fair value	0	0
Recurring | Significant Unobservable Inputs (Level 3) | U.S. Treasury securities
Financial Assets:
Fair Value	0	0
Recurring | Significant Unobservable Inputs (Level 3) | U.S. agency securities
Financial Assets:
Fair Value	0	0
Recurring | Significant Unobservable Inputs (Level 3) | U.S. agency mortgage-backed securities
Financial Assets:
Fair Value	0	0
Recurring | Significant Unobservable Inputs (Level 3) | Municipal debt securities
Financial Assets:
Fair Value	0	0
Recurring | Significant Unobservable Inputs (Level 3) | Non-U.S. government securities:
Financial Assets:
Fair Value	0	0
Recurring | Significant Unobservable Inputs (Level 3) | Corporate debt securities
Financial Assets:
Fair Value	0	0
Recurring | Significant Unobservable Inputs (Level 3) | Residential and commercial mortgage securities
Financial Assets:
Fair Value	0	0
Recurring | Significant Unobservable Inputs (Level 3) | Asset-backed securities
Financial Assets:
Fair Value	0	0
Recurring | Significant Unobservable Inputs (Level 3) | Money market funds
Financial Assets:
Fair Value	$ 0	$ 0

XML

Statutory Accounting - Schedule of Statutory Net Income, Statutory Surplus and Contingency Reserve Liability (Details) - Affiliated Entity - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Essent Guaranty
Dividends Restrictions
Statutory net income	$ 123,936	$ 200,277
Statutory surplus	992,134	1,081,986
Contingency reserve liability	2,105,708	1,862,482
Essent PA
Dividends Restrictions
Statutory net income	(112)	859
Statutory surplus	53,138	56,910
Contingency reserve liability	$ 56,101	$ 57,461

XML

Statutory Accounting - Narrative (Details) - Affiliated Entity - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Essent Guaranty
Dividends Restrictions
Increase in contingency reserve	$ 57,000
Released contingency reserve	9,800	$ 2,600
Statutory net income	123,936	200,277
Essent PA
Dividends Restrictions
Increase in contingency reserve	(600)
Released contingency reserve	800	200
Statutory net income	(112)	859
Essent Re
Dividends Restrictions
Statutory capital and surplus	1,600,000		$ 1,500,000
Statutory net income	$ 72,600	$ 89,600